TransMedics za poslední měsíc přidala asi 10,2 % po zvýšení spodní hranice celoročního výhledu tržeb na 737 až 757 milionů USD. Ve 2. čtvrtletí tržby meziročně vzrostly o 20,7 % na 189,9 milionu USD, ale zisk na akcii zaostal za odhady.
A month has gone by since the last earnings report for TransMedics (TMDX - Free Report) . Shares have added about 10.2% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is TransMedics due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
TransMedics Q2 Earnings Miss Estimates, Revenues Up Y/YTransMedics delivered earnings per share of 44 cents in the second quarter of 2026, down 52.2% year over year. The figure missed the Zacks Consensus Estimate by 12%.
TMDX Revenue Mix Shows Service StrengthRevenues rose 20.7% year over year to $189.9 million and surpassed the consensus estimate by 3.1%.
Net product revenues totaled $111.2 million, up 15.7% from the prior-year quarter. The improvement was led by higher organ utilization and increased OCS adoption, particularly across the liver and heart businesses.
Service revenues represented roughly 41% of total revenues and increased 28.6% to $78.8 million. Clinical service revenues rose 19.1% to around $36 million. The stronger service contribution reflected broader logistics adoption, pricing adjustments and higher aviation-fleet utilization.
Transplant Logistics’ services revenues for second-quarter 2026 were approximately $41 million, up 39% year over year. TransMedics operated 22 owned aircraft during the quarter and covered 86% of National OCS Program missions requiring air transportation, compared with 82% coverage in the first quarter of 2026. This growth resulted from the broader adoption of TransMedics’ logistics services, increased aviation-fleet utilization and improved operating efficiency.
TMDX’s Margin TrendIn the quarter under review, TransMedics’ gross profit increased 17.2% year over year to $113.2 million. The gross margin contracted 100 basis points (bps) to 60%.
Selling, general and administrative expenses rose 31.2% year over year to $57.8 million. Research, development and clinical trials expenses surged 98.5% year over year to $31.6 million. Total operating expenses of $89.5 million increased 49.1% year over year.
Adjusted operating profit totaled $25.8 million, reflecting a decline of 29.5% from the prior-year quarter. The adjusted operating margin in the second quarter contracted 960 bps to 13.6%.
TransMedics’ Financial PositionTransMedics exited second-quarter 2026 with cash of $472.7 million compared with $461.7 million at the end of the first quarter. Total long-term debt at the end of second-quarter 2026 was $39.7 million compared with $44.5 million at the end of the first quarter.
Cumulative net cash provided by operating activities at the end of second-quarter 2026 was $41.8 million compared with $88.8 million a year ago.
TransMedics Raises Its Revenue OutlookTransMedics raised the lower end of its 2026 revenue guidance. Revenues are now expected to be between $737 million and $757 million, representing growth of approximately 22% to 25% from the 2025 level. The previous projection called for revenues of $727 million to $757 million.
The outlook excludes contributions from PAD Aviation and assumes no incremental revenues from the ENHANCE Part B and DENOVO clinical programs. Adjusted operating margin, excluding PAD Aviation, is expected to be between 12.5% and 14%, below the company’s prior expectation of approximately 16% because of accelerated OCS Kidney investments.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -31.5% due to these changes.
VGM ScoresAt this time, TransMedics has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise TransMedics has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry PlayerTransMedics is part of the Zacks Medical - Instruments industry. Over the past month, IQVIA Holdings (IQV - Free Report) , a stock from the same industry, has gained 11.8%. The company reported its results for the quarter ended June 2026 more than a month ago.
IQVIA reported revenues of $4.37 billion in the last reported quarter, representing a year-over-year change of +8.7%. EPS of $3.15 for the same period compares with $2.81 a year ago.
IQVIA is expected to post earnings of $3.25 per share for the current quarter, representing a year-over-year change of +8.3%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
IQVIA has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.
IDEX ve 2. čtvrtletí 2026 zvýšil organické tržby HST o 12 % a objednávky o 47 %, což prodloužilo viditelnost backlogu až do roku 2027. Zároveň zvedl výhled organického růstu tržeb pro rok 2026 na 5–6 % z 3–4 %.
Key Takeaways IEX's HST organic sales rose 12%, while orders jumped 47%, extending backlog visibility into 2027.IDEX raised its 2026 organic sales growth outlook to 5-6% on stronger HST orders and industrial demand.Acquisitions added 1% to second-quarter sales, while dividends returned value to shareholders. IDEX Corporation (IEX - Free Report) is benefiting from sustained demand in data center power, semiconductor, space and defense markets. Accretive acquisitions and shareholder-friendly policies also bode well.
IEX currently carries a Zacks Rank #2 (Buy). Let’s delve into the factors that have been aiding the firm for a while now.
Business Strength: IDEX is benefiting from demand across data center, semiconductor, space and defense markets within the Health & Science Technologies (HST) segment, while municipal water and mining continue to support the Fluid & Metering Technologies (FMT) segment. In second-quarter 2026, HST organic sales rose 12% and organic orders increased 47%, extending backlog visibility into 2027. FMT organic sales increased 1% and orders rose 11%, with water and mining gains partly offset by energy, agriculture and chemical softness. The company raised its 2026 organic sales growth outlook to 5-6% from 3-4%, supported by a larger HST order book and improving demand in its industrial businesses. This mix of secular and industrial demand is expected to support IDEX’s growth beyond the latest quarter.
Accretive Acquisition: IDEX continues to undertake acquisitions to expand its technology portfolio and reach higher-value markets. In second-quarter 2026, acquisitions added 1% to consolidated sales growth and 2% to HST sales growth, reflecting Micro-LAM, acquired in July 2025. Consolidated organic sales also rose 5% in second-quarter 2026, alongside the 1% acquisition/divestiture contribution. Micro-LAM expands IDEX’s optics technology offerings within HST. The September 2024 acquisition of Mott for $1 billion added applied materials science capabilities and broadened the company’s exposure to semiconductor fabrication, medical technologies and water purification.
In the past year, the company’s shares have gained 36.2% against the industry‘s 0.7% decline.
Image Source: Zacks Investment Research
Rewards to Shareholders: IEX is committed to returning value to shareholders through dividend payments and share repurchases. In second-quarter 2026, the company paid about $54 million in dividends and repurchased $77 million of shares. For the first six months of 2026, dividend payments totaled $106.7 million compared with $105.9 million a year earlier, while cash paid for share repurchases increased to $153.4 million from $100 million.
Estimate Revisions: The Zacks Consensus Estimate for IEX’s 2026 earnings is pegged at $8.82 per share, indicating an increase of 3.9% from the 60-day-ago figure. The consensus estimate for 2027 earnings is pegged at $9.68 per share, indicating a rise of 24.6% in the same period.
Other Stocks to ConsiderSome other top-ranked companies from the same space are discussed below:
Generac Holdings Inc. (GNRC - Free Report) presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The company delivered a trailing four-quarter average earnings surprise of 13.7%. In the past 60 days, the consensus estimate for GNRC’s 2026 earnings has increased 8.5%.
Applied Industrial Technologies (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). It has a trailing four-quarter average earnings surprise of 4.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2027 earnings has increased 1.7% in the past 60 days.
Helios Technologies (HLIO - Free Report) currently carries a Zacks Rank of 2. HLIO delivered a trailing four-quarter average earnings surprise of 13.1%.
In the past 60 days, the Zacks Consensus Estimate for Helios Technologies’ 2026 earnings has increased 10.4%.
Recursion Pharmaceuticals rozšiřuje onkologické portfolio o REC-1245, REC-617, REC-3565, REC-4539 a REC-7735 a s FDA jedná o schvalovací cestě pro REC-4881 ve FAP. Genentech navíc přesunul první neurologický cíl ze své spolupráce do raného discovery programu.
Key Takeaways Recursion is advancing REC-4881 in FAP while pursuing a potential registrational pathway with the FDA.RXRX is expanding its oncology pipeline with REC-1245, REC-617, REC-3565, REC-4539 and REC-7735.Genentech has advanced a neuroscience target from its RXRX collaboration, further validating its platform. Recursion Pharmaceuticals (RXRX - Free Report) uses an AI-driven drug discovery platform, Recursion Operating System (OS), to identify and develop novel therapies across its pipeline. It is advancing several clinical-stage programs, with REC-4881 emerging as its most advanced internal candidate and multiple oncology assets providing additional pipeline diversification.
REC-4881, an allosteric MEK1/2 inhibitor, is being evaluated in a phase Ib/II TUPELO study for familial adenomatous polyposis (FAP), a rare inherited disorder characterized by the development of numerous colorectal polyps. Earlier clinical data showed rapid and durable reductions in polyp burden, which Recursion described as the first clinical validation of the Recursion OS. RXRX has initiated discussions with the FDA on a potential registrational pathway, while additional phase II safety and efficacy data from the TUPELO study are expected in November 2026.
Beyond REC-4881, Recursion is advancing several oncology candidates, including REC-1245 for biomarker-enriched solid tumors and lymphoma, REC-617 for advanced solid tumors and REC-3565 for B-cell malignancies, all of which are currently undergoing early-stage development. REC-4539, an LSD1 inhibitor, also entered clinical-stage development for solid tumors, with potential applicability in hematologic malignancies. Meanwhile, REC-7735, an AI-designed PI3Kα H1047R inhibitor, has received clinical-study clearance and is expected to enter a phase I/II study in the second half of 2026 for selected PIK3CA H1047R-mutant solid tumors, adding another potential catalyst to the pipeline.
Recursion is also advancing REC-102, an ENPP1 inhibitor for hypophosphatasia, following its acquisition of full rights to the program from Rallybio. The oral candidate is designed as a potential disease-modifying treatment for hypophosphatasia and expands Recursion's presence in rare diseases. In addition, Genentech (a wholly owned subsidiary of Roche) recently advanced the first neuroscience target from its collaboration with Recursion into an early discovery program, providing another potential validation of RXRX’s proprietary platform. With multiple clinical programs advancing and several potential catalysts ahead, Recursion’s expanding pipeline could strengthen its long-term growth prospects.
RXRX Faces Competitive Pressure in the TechBio IndustryIn the TechBio space, Relay Therapeutics (RLAY - Free Report) and Schrödinger (SDGR - Free Report) are emerging as strong competitors to Recursion Pharmaceuticals, using computationally driven platforms to discover and develop novel therapies.
RLAY is currently evaluating its lead candidate, zovegalisib (RLY-2608), a mutant-selective PI3Kα inhibitor, in the phase III ReDiscover-2 study in combination with fulvestrant in previously CDK4/6-treated, PIK3CA-mutated HR+/HER2- advanced breast cancer. It is also planning to initiate a separate late-stage frontline breast cancer study of the candidate, subject to regulatory feedback, while the phase I/II ReInspire study is evaluating zovegalisib in PIK3CA-driven vascular anomalies. Relay Therapeutics is also developing RLY-8161, an NRAS-selective inhibitor, in a phase I/II study for NRAS-mutant melanoma and other solid tumors. In addition, the company is advancing a preclinical, non-inhibitory chaperone program for Fabry disease, as well as early-stage discovery programs across both precision oncology and genetic diseases.
Schrödinger’s lead proprietary pipeline consists of SGR-1505, a MALT1 inhibitor in phase I for relapsed/refractory B-cell malignancies, and SGR-3515, a Wee1/Myt1 inhibitor undergoing phase I development for advanced solid tumors. Both programs were discovered using Schrödinger's computational capabilities, with SGR-3515 showing preliminary clinical activity and SGR-1505 demonstrating encouraging activity in B-cell malignancies in earlier updates. SDGR plans to complete its ongoing early-stage studies while seeking strategic partners to advance SGR-1505 and SGR-3515 beyond phase I.
RXRX’s Stock Price, Valuation & Estimate MovementsYear to date, RXRX shares have lost 17.4% against the industry’s 9.7% growth. During the same time frame, Recursion has also underperformed the S&P 500 and the overall medical sector, as seen in the chart below.
RXRX Mixed Stock PerformanceImage Source: Zacks Investment Research
Recursion is trading at a discount to the industry, as seen in the chart below. Going by the price/book value ratio, the company’s shares currently trade at 1.97, which is less than 3.97 for the industry. The stock is trading significantly below its five-year mean of 3.22.
RXRX Stock ValuationImage Source: Zacks Investment Research
Loss estimates for 2026 have narrowed from 99 cents per share to 92 cents over the past 30 days. During the same time frame, RXRX’s 2027 loss per share estimates have narrowed from 96 cents to 92 cents.
RXRX Estimate MovementImage Source: Zacks Investment Research
Recursion currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Match Group za poslední měsíc přidala 11,2 % po zveřejnění výsledků, i když zisk na akcii i tržby za 2. čtvrtletí 2026 zaostaly za odhady. Hinge dál roste, zatímco Tinder a E&E zůstávají pod tlakem.
It has been about a month since the last earnings report for Match Group (MTCH - Free Report) . Shares have added about 11.2% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Match Group due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Match Group Inc. before we dive into how investors and analysts have reacted as of late.
Match Group Q2 Earnings & Revenues Miss Estimates, Sales Decline Y/YMatch Group reported second-quarter 2026 earnings of 92 cents per share, missing the Zacks Consensus Estimate by 5.15%.
Revenues were $853 million, down 1% year over year, and lagging the Zacks Consensus Estimate of $856 million by 0.34%. The quarter reflected improving engagement trends at Tinder and continued expansion at Hinge.
MTCH’s Q2 Operating Metrics DetailsThe company’s key operating metrics showed mixed momentum, with total payers declining 6% year over year to 13.3 million, while revenue per payer (RPP) increased 6% to $21.13. Tinder’s user trends improved, while Hinge continued to deliver strong growth through product innovation and international expansion.
MTCH Improves Tinder Engagement TrendsTinder direct revenues were $457.5 million in the second quarter, down 1% year over year and down 2% on a foreign exchange-neutral basis.
Payers declined 5% to 8.5 million, while RPP increased 4% to $17.90. Adjusted EBITDA was $233 million, down 5% year over year, with a 50% margin.
The company continued investing in Tinder’s product turnaround. Management highlighted improvements in recommendation algorithms, Trust and Safety initiatives, and new features designed to create lower-pressure ways for users to connect. Tinder’s daily active users declined 4% year over year in the quarter, representing the best performance in 10 quarters.
Match Group Sees Hinge Growth ContinueHinge remained a major growth contributor, with direct revenues rising 22% year over year to $203.5 million. Revenues increased 20% on a foreign exchange-neutral basis, supported by a 17% increase in payers to 2 million and a 4% rise in RPP to $33.11.
Match Group noted that Hinge’s global monthly active users increased 13% year over year, driven by expansion markets. The company continued broadening Hinge’s international presence, entering six new European countries and four additional countries in Latin America during the quarter.
The business is still expected to reach $1 billion in revenues in 2027, with growth expected to come from product innovation, international expansion and additional monetization opportunities.
MTCH Reports Segment Pressure From E&EEveryone Everywhere (E&E) direct revenues were $178.9 million, down 17% year over year and down 17% on a foreign exchange-neutral basis. Payers declined 21% to 2.7 million, while RPP increased 4% to $22.24. Adjusted EBITDA was $54 million, up 69%, and at a 30% margin.
The company continued restructuring the portfolio, with E&E now including Azar and Pairs. Management said the segment is benefiting from shared capabilities across Match Group, including Trust and Safety, recommendation algorithms, centralized marketing and consumer research.
The company expects E&E revenue trends to remain pressured by the Azar app redesign while maintaining a focus on improving the long-term health of the portfolio.
Match Group’s Q2 Operating DetailsTotal operating expenses declined 9% year over year to $608 million in the second quarter. Cost of revenues decreased 16% year over year, helped by alternative payment savings, while general and administrative expenses declined 22%, driven by lower headcount-related costs and legal expenses.
Adjusted EBITDA was $331 million, up 14% year over year, representing an adjusted EBITDA margin of 39%, which expanded approximately 500 basis points from 33% in the year-ago quarter.
MTCH’s Balance Sheet and Cash FlowAs of June 30, 2026, Match Group had cash, cash equivalents and short-term investments of $584 million compared with $1.02 billion as of March 31, 2026. The decline primarily reflected the use of $424 million in cash to repay the company’s 0.875% exchangeable senior notes due in June 2026.
Long-term debt, including current maturities, stood at $3.6 billion as of June 30, 2026. Match Group ended the quarter with trailing twelve-month gross leverage of 2.7x and net leverage of 2.2x. The company’s $500 million revolving credit facility remained undrawn as of June 30, 2026.
Match Group generated $370 million in operating cash flow and $353 million in free cash flow in the second quarter. It also repurchased 7.3 million shares for $245 million and paid $91 million in dividends during the period.
MTCH Provides Q3 & 2026 OutlookFor the third quarter of 2026, Match Group expects revenues of $885 million to $895 million, representing a year-over-year decline of 2% to 3%. Adjusted EBITDA is projected at $330 million to $335 million, implying a 10% year-over-year increase at the midpoint.
For full-year 2026, management expects revenues to be near the midpoint of its previously issued guidance range on an as-reported basis and at or above the midpoint on a foreign exchange-neutral basis. Adjusted EBITDA is expected to be at or above the high end of prior guidance, with margin expected to exceed the company’s 37.5% target.
The company expects Tinder direct revenues to decline in the low-single-digit percentage range for the year, an improvement from its previous outlook. It also expects free cash flow to be at the high end of its prior guidance range.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.
The consensus estimate has shifted 11.67% due to these changes.
VGM ScoresCurrently, Match Group has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. However, the stock has a grade of B on the value side, putting it in the top 40% for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Match Group has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerMatch Group belongs to the Zacks Internet - Software industry. Another stock from the same industry, Automatic Data Processing (ADP - Free Report) , has gained 4.1% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
ADP reported revenues of $5.47 billion in the last reported quarter, representing a year-over-year change of +6.8%. EPS of $2.64 for the same period compares with $2.26 a year ago.
ADP is expected to post earnings of $2.78 per share for the current quarter, representing a year-over-year change of +11.7%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for ADP. Also, the stock has a VGM Score of D.
Entegris ve 2. čtvrtletí překonal odhady: zisk na akcii činil 93 centů a tržby vzrostly na 883,2 milionu USD. Akcie jsou od posledních výsledků asi o 9,8 % níže.
It has been about a month since the last earnings report for Entegris (ENTG - Free Report) . Shares have lost about 9.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Entegris due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Entegris Q2 Earnings Beat Estimates, Revenues Rise Y/YEntegris, Inc. reported second-quarter 2026 non-GAAP earnings of 93 cents per share, up 40.9% year over year. The figure beat the Zacks Consensus Estimate of 83 cents by 12.1%, reflecting stronger semiconductor demand, operational execution and accelerating customer capital investment.
Net sales increased 11.5% to $883.2 million and topped the consensus estimate of $840 million by 5.2%. Unit-driven revenues rose 10%, while capital expenditure-related revenues advanced 15%, supported by AI-linked investments across advanced logic, memory and packaging.
ENTG's APS Growth Leads Segment MomentumAdvanced Purity Solutions revenues climbed 17% year over year to $514.6 million. Growth reflected strength across both unit-driven and capital expenditure-related demand, with liquid filtration delivering a fourth consecutive record quarter.
The microenvironments business, led by front-opening unified pods, posted its strongest performance in more than three years. Taiwan benefited from leading-edge logic and advanced packaging expansions, while North America returned to year-over-year growth. Adjusted segment margin expanded to 30.3% from 24.1%.
Entegris' Materials Business Gains SpeedMaterials Solutions revenues rose 4.6% year over year to $371.3 million. Advanced deposition materials, selective etch chemistries and chemical mechanical planarization products drove the increase.
Adjusted segment profit was $77.7 million, up 2.9%, while adjusted segment margin eased to 20.9% from 21.3%. Higher raw-material and logistics costs, along with planned direct-labor investments, were largely offset by manufacturing improvements and productivity initiatives.
ENTG Expands Margins on Better ExecutionAdjusted gross margin expanded to 47.6% from 44.6% a year earlier and improved from 46.9% in the first quarter. Management attributed the sequential gain to operational progress despite investments to support future demand.
Non-GAAP operating expenses increased 8.3% year over year to $203.9 million, mainly due to higher variable compensation tied to stronger business performance. Even so, adjusted operating margin widened to 24.5% from 20.9%, and adjusted EBITDA margin rose to 28.4% from 27.3%.
Entegris Strengthens Cash Flow and LeverageThe company generated operating cash flow of $156.2 million in the second quarter, while capital expenditures were $39.3 million. Free cash flow totaled $120.3 million in the second quarter, representing roughly 14% of sales and more than doubling from $47 million in the year-ago quarter. In the first half of 2026, Entegris generated operating cash flow of $339.2 million and free cash flow of $263.8 million.
ENTG repaid $200 million of debt during the quarter, reducing long-term debt to $3.46 billion. It ended the second quarter with cash and cash equivalents of $353.6 million. The company’s net leverage improved to 3.4 times, and management now expects leverage to finish 2026 below three times.
ENTG Sees Broader Semiconductor Investment CycleManagement raised its 2026 market expectation to 7%-8% growth in million square inches of wafers, up from the mid-single-digit assumption at the start of the year. The outlook reflects stable advanced logic and memory expectations, along with a modestly improving mainstream logic environment.
The company is tracking more than 20 major leading-edge capacity expansions globally, including advanced logic, advanced memory and advanced packaging projects. Bookings strengthened during the quarter, lifting backlog and increasing visibility into customer spending plans through the second half of 2026 and into 2027.
Entegris Initiates Q3 GuidanceFor the third quarter of 2026, Entegris expects sales between $905 million and $935 million. GAAP earnings are projected in the range of 75-83 cents per share, while non-GAAP earnings are forecast between 96 cents and $1.04.
The company expects an adjusted EBITDA margin of 28%-29% and an adjusted operating margin of 24.2%-25.1%. Management also sees fourth-quarter revenues rising about 4% from the midpoint of third-quarter guidance, which would represent mid-teens year-over-year growth.
For 2026, ENTG expects net interest expense of approximately $180 million, a non-GAAP tax rate of about 14% and capital expenditures of $250 million. The share count is projected at roughly 154 million.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in fresh estimates.
The consensus estimate has shifted 11.47% due to these changes.
VGM ScoresAt this time, Entegris has a nice Growth Score of B, a score with the same score on the momentum front. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Entegris has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerEntegris belongs to the Zacks Electronics - Semiconductors industry. Another stock from the same industry, Qualcomm (QCOM - Free Report) , has gained 7.9% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Qualcomm reported revenues of $9.95 billion in the last reported quarter, representing a year-over-year change of -4%. EPS of $2.21 for the same period compares with $2.77 a year ago.
For the current quarter, Qualcomm is expected to post earnings of $2.18 per share, indicating a change of -27.3% from the year-ago quarter. The Zacks Consensus Estimate has changed -2.4% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Qualcomm. Also, the stock has a VGM Score of F.
American Financial Group vykázala ve 2. čtvrtletí upravený zisk na akcii 2,82 USD, což překonalo odhad o 17 %. Tržby vzrostly meziročně o 5,5 % na 2,03 miliardy USD.
A month has gone by since the last earnings report for American Financial Group (AFG - Free Report) . Shares have lost about 2.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is American Financial due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for American Financial Group, Inc. before we dive into how investors and analysts have reacted as of late.
AFG Q2 Earnings Beat on Strong P&C Underwriting, Investment Income
American Financial Group, Inc. reported second-quarter 2026 net operating earnings per share of $2.82, which surpassed the Zacks Consensus Estimate by 17%. The bottom line increased 31.8% year over year, driven by underwriting income and stronger returns from its alternative investment portfolio. Total revenues increased approximately 5.5% year over year, to $2.03 billion from $1.924 billion. The top line also beat the Zacks Consensus Estimate by 0.65%.
The quarterly results benefited from record pretax Property & Casualty ("P&C") operating income, healthy premium growth, improved underwriting margins and higher investment income from alternative investments.
Behind the HeadlinesNet earned premiums rose 2.9% year over year to approximately $1.7 billion in the second quarter of 2026. The figure was slightly below both the Zacks Consensus Estimate and our estimate of $1.71 billion. Net investment income rose 20.1% year over year to $221 million in the quarter under review. The figure was higher than our estimate of $195.4 million and surpassed the Zacks Consensus Estimate of $197.9 million.
Total costs and expenses increased 1.1% year over year to $1.7 billion due to higher underwriting expenses and interest charges, partly offset by lower losses and loss adjustment expenses. Our estimate was $1.72 billion.
Segmental UpdateSpecialty P&C Insurance: The segment generated $1.9 billion in net written premiums, which improved 6% year over year, reflecting new business opportunities, favorable renewal pricing and increased exposures while maintaining disciplined underwriting. The Specialty P&C Insurance segment’s underwriting profit increased 26.3% year over year to $144 million in the quarter, driven by higher underwriting profit across Property & Transportation and Specialty Financial groups. The figure exceeded our estimate of $143 million. Pre-tax core operating earnings before income taxes of the P&C Insurance segment were $350 million, up 28.2% year over year.
Property & Transportation Group: Net written premiums increased 5% year over year to $797 million in the second quarter, driven by crop insurance growth, favorable pricing and higher exposures. The Property & Transportation Group generated underwriting profit of $57 million, more than double the $27 million reported a year ago, driven by stronger transportation and agricultural business performance. The combined ratio improved 490 basis points year over year to 90.3%.
Specialty Casualty Group: Net written premiums increased 6% year over year to $812 million. The Specialty Casualty Group generated underwriting profit of $45 million, down from $49 million in the prior-year quarter, due to lower workers' compensation and executive liability profitability, offset by strength in energy, construction and environmental liability businesses. The combined ratio deteriorated 60 basis points year over year to 94.5%.
Specialty Financial Group: Net written premiums rose 10% year over year to $306 million. In the Specialty Financial Group, underwriting profit of $42 million, up from $38 million in the prior-year quarter, was primarily driven by stronger performance in its fidelity/crime and financial institutions businesses. Catastrophe losses in Specialty Financial Group totaled $10 million in the reported quarter, narrower than the year-ago loss of $19 million. The current combined ratio of 85.6% improved 50 basis points year over year.
Financial UpdateAmerican Financial exited the second quarter of 2026 with total cash and investments of $17.1 billion, which decreased 0.7% from the 2025-end level. Long-term debt of $1.82 billion remained unchanged from the 2025-end level.
As of June 30, 2026, the company’s book value per share, excluding accumulated other comprehensive income (AOCI), was $59.85 compared with $58.38 at the end of 2025. Annualized return on equity was 20.3% in the second quarter, up 530 basis points year over year.
AFG’s Prudent Capital DeploymentAmerican Financial repurchased $26 million of its common stock in the second quarter of 2026. It paid total cash dividends of 88 cents per share, continuing its disciplined capital management strategy.
How Have Estimates Been Moving Since Then?It turns out, fresh estimates have trended upward during the past month.
The consensus estimate has shifted 19.27% due to these changes.
VGM ScoresCurrently, American Financial has a subpar Growth Score of D, however its Momentum Score is doing a lot better with an A. Charting a somewhat similar path, the stock was allocated a score of B on the value side, putting it in the top 40% for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, American Financial has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Akcie International Flavors za poslední měsíc klesly o 1,3 % a tržby ve 2. čtvrtletí meziročně vzrostly o 1,8 % na 1,95 miliardy USD, ale zisk na akcii i odhad trhu zaostaly.
It has been about a month since the last earnings report for International Flavors (IFF - Free Report) . Shares have lost about 1.3% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is International Flavors due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.
International Flavors Q2 Earnings Miss Estimates, Sales Rise Y/YInternational Flavors reported second-quarter 2026 adjusted earnings of 82 cents per share, missing the Zacks Consensus Estimate of $1.14. The company’s second-quarter 2025 adjusted earnings came in at 77 cents, excluding the results from discontinued operations.
Including one-time items, the company reported earnings of 20 cents per share compared with $2.33 in the prior-year quarter.
In late May, International Flavors announced that it inked a deal with CVC Capital Partners to sell its Food Ingredients business. The deal is in sync with International Flavors’ portfolio transformation strategy, which is expected to solidify its focus on its innovation-driven businesses. Starting second-quarter 2026, the Food Ingredients disposal group is reported as discontinued operations.
Net sales rose 1.8% year over year to $1.95 billion but missed the consensus estimate of $2.68 billion. Comparable currency-neutral sales advanced 6%, supported by broad-based growth across Taste, Health & Biosciences, and Scent.
International Flavors’ Q2 Gross Margin Improves Y/YIn the reported quarter, IFF’s cost of goods sold increased 0.5% year over year to $1.10 billion. Gross profit rose 3.5% to $853 million. The gross margin came in at 43.7% compared with 42.9% in the year-ago quarter.
Research and development expenses remained flat year over year at $170 million. Selling and administrative expenses increased 6.8% to $437 million in the second quarter. Adjusted operating EBITDA came in at $408 million, up 2.3% from the prior-year quarter’s $399 million. The adjusted operating EBITDA margin was 20.9% compared with 20.8% in the year-ago quarter.
IFF’s Q2 Segmental PerformancesNet sales in the Taste segment increased 5.2% year over year to $688 million in the June-end quarter. Adjusted operating EBITDA was $124 million, up 6% year over year from $117 million, driven by volume growth and favorable net pricing. The segment’s adjusted operating EBITDA margin was 18% compared with 17.9% in the prior-year quarter.
Sales generated in the Health & Biosciences segment were $601 million, growing 7.5% from the year-earlier quarter’s $559 million. Growth was led by Grain Processing, Food Biosciences and Animal Nutrition. Adjusted operating EBITDA was $150 million in the quarter, up 7.9% year over year from $139 million. The segment’s adjusted operating EBITDA margin was 25% compared with 24.9% a year ago.
The Scent segment’s sales were $665 million, up 10.3% year over year from $603 million. Fine Fragrance posted low-single-digit growth, with results affected by the Middle East conflict Adjusted operating EBITDA increased 10.7% to $134 million from $121 million in the prior-year quarter. The adjusted operating EBITDA margin was 20.2% compared with 20.1% in the year-ago quarter.
International Flavors’ Q2 Cash Flow & Balance Sheet UpdatesIFF had cash and cash equivalents of $569 million at the end of the second quarter of 2026, down from $590 million at the end of 2025. Long-term debt was $4.74 billion at June 30, 2026, largely unchanged from the end of 2025. Net debt to credit-adjusted EBITDA was 2.5X.
International Flavors generated $679 million in cash from operating activities in the first six months of 2026, up from $368 million in the prior-year period.
IFF's 2026 GuidanceFor 2026, International Flavors expects sales from continuing operations of $7.4 billion to $7.6 billion. Adjusted operating EBITDA is projected between $1.53 billion and $1.60 billion. The outlook excludes $3.2 billion in sales and $520 million in adjusted operating EBITDA related to discontinued operations.
The company expects comparable currency-neutral sales growth of 2-4% and comparable currency-neutral adjusted operating EBITDA growth of 4-8%. Foreign exchange is projected to benefit sales growth by 1% and adjusted operating EBITDA growth by 2%.
IFF also authorized an enhanced $2.5-billion share repurchase program, including a planned $500-million accelerated repurchase in the second half of 2026. The remaining $2 billion is expected to be executed after the Food Ingredients divestiture closes, with completion targeted by the end of 2027.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.
The consensus estimate has shifted -20.07% due to these changes.
VGM ScoresAt this time, International Flavors has a subpar Growth Score of D, a score with the same score on the momentum front. Charting a somewhat similar path, the stock has a score of F on the value side, putting it in the bottom 20% quintile for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise International Flavors has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry PlayerInternational Flavors is part of the Zacks Chemical - Specialty industry. Over the past month, Ashland (ASH - Free Report) , a stock from the same industry, has gained 3.5%. The company reported its results for the quarter ended June 2026 more than a month ago.
Ashland reported revenues of $497 million in the last reported quarter, representing a year-over-year change of +7.3%. EPS of $1.02 for the same period compares with $1.04 a year ago.
Ashland is expected to post earnings of $1.32 per share for the current quarter, representing a year-over-year change of +22.2%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.6%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Ashland. Also, the stock has a VGM Score of D.
NRG Energy za poslední měsíc po zveřejnění výsledků odepsala asi 8 %. Ve druhém čtvrtletí 2026 zisk na akcii zaostal za odhady, ale tržby meziročně vzrostly o 11 % na 7,48 miliardy USD.
A month has gone by since the last earnings report for NRG Energy (NRG - Free Report) . Shares have lost about 8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is NRG due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.
NRG Energy Q2 Earnings Lag Estimates, Revenues Increase Y/Y
NRG Energy, Inc. reported second-quarter 2026 adjusted earnings of $1.49 per share, which missed the Zacks Consensus Estimate of $1.66 by 10.2%. The bottom line also declined 11.3% from $1.68 in the year-ago quarter.
Revenues of NRG EnergyTotal revenues were $7.48 billion, which beat the Zacks Consensus Estimate of $5.89 billion by 27%. The top line also increased 11% from the prior-year quarter’s level of $6.74 billion.
Highlights of NRG’s Q2 Earnings ReleaseThe company recorded adjusted EBITDA of $1.22 billion in the second quarter, up 33.9% from $0.91 billion registered a year ago.
Total operating costs and expenses were $6.54 billion, down 2.9% from $6.74 billion in the year-ago quarter.
Operating income in the second quarter totaled $976 million.
Through July 31, 2026, NRG completed $932 million in share repurchases and distributed $202 million in common stock dividends. In 2026, the company plans to return $1 billion through share repurchases and common stock dividends of around $407 million.
NRG Energy Advances Texas Expansion PlansNRG advanced its Bring Your Own Power strategy with a global cloud and artificial intelligence hyperscaler. The parties are aligned on principal commercial terms for developing a 1.2-gigawatt combined-cycle natural gas generation facility in Texas, subject to final documentation and approvals.
The company also achieved commercial operations at the 415-megawatt T.H. Wharton facility. Its two other Texas Energy Fund projects remained on schedule and within budget.
NRG’s Financial HighlightsAs of June 30, 2026, NRG had cash and cash equivalents worth $0.16 billion compared with $4.71 billion as of Dec. 31, 2025.
As of June 30, 2026, long-term debt and finance leases amounted to $21.74 billion compared with $16.41 billion as of Dec. 31, 2025.
Cash provided by operating activities totaled $0.95 billion in the first six months of 2026, compared with $1.31 billion in the same period of 2025.
Capital expenditures amounted to $655 million in the first six months of 2026, compared with $595 million in the same period of 2025.
Total liquidity was $5.28 billion, down from $9.63 billion, primarily due to funding the acquisition of generation assets and CPower from LS Power.
NRG’s GuidanceNRG Energy expects its 2026 adjusted net income to be in the range of $1.685-$2.115 billion.
The company expects its 2026 adjusted EPS to be in the range of $7.90-$9.90. The Zacks Consensus Estimate stands at $8.60, slightly below the midpoint of the company’s guidance range.
Free Cash Flow before Growth for 2026 is anticipated to be in the range of $2.8-$3.3 billion.
NRG expects 2026 adjusted EBITDA in the band of $5.325-$5.825 billion.
How Have Estimates Been Moving Since Then?It turns out, fresh estimates have trended downward during the past month.
The consensus estimate has shifted -6.16% due to these changes.
VGM ScoresAt this time, NRG has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a score of B on the value side, putting it in the top 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, NRG has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
FDA přijala žádost sNDA společnosti United Therapeutics pro Tyvaso v idiopatické plicní fibróze; rozhodnutí se očekává na konci dubna 2027. Data ze studie TETON ukázala zlepšení FVC o 111,8 mL.
Key Takeaways United Therapeutics' Tyvaso sNDA seeks approval for IPF, with an FDA decision expected in April 2027.TETON studies showed significant FVC gains, reduced clinical worsening and favorable secondary endpoints.Integrated TETON data showed a 111.8 mL FVC benefit, supporting Tyvaso's potential in IPF. United Therapeutics (UTHR - Free Report) recently announced that the FDA has accepted its supplemental new drug application (sNDA) for review, seeking approval for expanded use of its marketed drug, nebulized Tyvaso, in idiopathic pulmonary fibrosis (IPF). A regulatory decision is expected in late April 2027. If approved, the product would be the first FDA-approved inhaled anti-fibrotic treatment for the said indication.
United Therapeutics already markets nebulized Tyvaso for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease. Besides the nebulized formulation, the drug is also approved as a dry powder inhalation (DPI) version for the same indications. The company generates majority of its revenues from the Tyvaso franchise.
IPF is a progressive lung-scarring disease that gradually impairs oxygen transfer, often leading to respiratory failure and death. It primarily affects older adults and may be associated with smoking, genetic factors, environmental exposures and acid reflux. In the United States, at least 100,000 people are estimated to live with IPF, highlighting a significant unmet medical need.
Year to date, shares of United Therapeutics have risen 0.9% compared with the industry’s 0.6% growth.
Image Source: Zacks Investment Research
UTHR’s Tyvaso sNDA for IPF Backed by TETON DataThe sNDA was submitted in June, based on positive top-line data from the TETON program, which consisted of two parallel phase III studies, TETON-1 (conducted in the United States and Canada) and TETON-2 (internationally), designed to evaluate nebulized Tyvaso in patients with IPF. Both studies met their primary endpoints, demonstrating statistically significant improvement in lung function for IPF patients, including a meaningful increase in forced vital capacity (FVC). The studies also reduced the risk of clinical worsening and showed favorable trends across key secondary endpoints.
Integrated analyses of studies reinforced these findings, showing a 111.8 mL FVC benefit and broad secondary endpoint improvements.
In addition to IPF, United Therapeutics is conducting a late-stage TETON PPF study to evaluate the therapy in progressive pulmonary fibrosis (PPF). The company completed patient enrollment in August, with top-line data anticipated in the second half of 2027.
UTHR's Zacks Rank & Stocks to ConsiderUnited Therapeutics currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the biotech sector are Precigen (PGEN - Free Report) , currently sporting a Zacks Rank #1 (Strong Buy), and AC Immune (ACIU - Free Report) and Aldeyra Therapeutics (ALDX - Free Report) , carrying a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 30 days, estimates for Precigen’s 2026 bottom line have improved from a loss of 2 cents per share to earnings of 25 cents. Over the same period, earnings estimates for 2027 have risen from 25 cents to 86 cents per share. PGEN shares have surged 68% year to date.
Precigen’s earnings beat estimates in three of the trailing four quarters and missed in the remaining one, with the average surprise being 108.96%.
Over the past 30 days, estimates for AC Immune’s 2026 loss per share have narrowed from 84 cents to 60 cents. Over the same period, earnings estimates for 2027 remained unchanged at 17 cents per share. ACIU shares have lost 9.6% year to date.
AC Immune’s earnings beat estimates in each of the trailing four quarters, with the average surprise being 33.25%.
Over the past 30 days, loss per share estimates for Aldeyra Therapeutics have narrowed from 43 cents to 39 cents for 2026. Over the same period, estimates for 2027 loss per share have narrowed from 22 cents to 16 cents. ALDX shares have plunged 71.1% year to date.
Aldeyra Therapeutics’ earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 29.25%.
Energizer za třetí fiskální čtvrtletí vykázal upravený zisk 75 centů na akcii, což je meziročně o 33,6 % méně a pod odhadem. Výnosy vzrostly o 1,2 % na 734,1 milionu USD, ale také zaostaly za očekáváním.
It has been about a month since the last earnings report for Energizer Holdings (ENR - Free Report) . Shares have lost about 7.2% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Energizer due for a breakout? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent drivers for Energizer Holdings, Inc. before we dive into how investors and analysts have reacted as of late.
Energizer Q3 Earnings Miss Estimates on Margin & Mix PressureEnergizer posted third-quarter fiscal 2026 adjusted earnings of 75 cents per share, down 33.6% year over year and missing the Zacks Consensus Estimate of 86 cents by 12.8%. Lower gross margins, unfavorable product mix and increased promotional investments weighed on profitability.
Net sales rose 1.2% to $734.1 million but missed the consensus mark of $737 million by 0.4%. Organic net sales increased 2.7%, supported by distribution gains, product innovation and strong refrigerant demand.
ENR's Organic Growth Reflects Volume GainsOrganic growth included a 1.9% volume contribution from global distribution gains and new products in the Batteries & Lights segment. Auto Care contributed 2.2% growth, primarily reflecting higher refrigerant distribution in North America.
These gains were partly offset by a 1.4% pricing decline stemming from increased promotional investments in Batteries & Lights. The expiration of an acquired brand license related to Advanced Power Solutions (APS) reduced reported sales by $17.2 million, representing a 2.4% acquisition-related headwind, while favorable currency contributed a 1% benefit.
Energizer's Margin & Cost DetailsIn the fiscal third quarter, adjusted gross profit declined 8.8% year over year to $287.7 million, while the adjusted gross margin contracted 560 basis points to 39.2%. The decline primarily reflected unfavorable product mix, increased promotional investments and the absence of prior-year out-of-period production credits. Excluding those credits, adjusted gross margin declined approximately 200 basis points. These pressures were partially offset by favorable currency impacts.
The reported gross margin fell to 38.2% from 55.1%, with the year-ago result benefiting from $112.4 million of production credits, including $78.5 million tied to fiscal 2023 and fiscal 2024 production.
Cost discipline remained a focus during the quarter. Adjusted Selling, General and Administrative Expense (SG&A) expenses declined 1.2% year over year to $122.1 million and, as a percentage of net sales, improved 40 basis points to 16.6%. The improvement was driven by approximately $8 million in Project Momentum savings and lower stock compensation expense, partly offset by higher legal costs.
Advertising and promotion expenses decreased 3.9% year over year to $41.9 million. Advertising and promotion expenses were 5.7% of net sales in the fiscal third quarter compared with 6% in the year-ago period.
Adjusted EBITDA declined 8.8% year over year to $138.7 million as lower gross margins more than offset benefits from lower SG&A, advertising and Research and Development (R&D) spending. Excluding out-of-period production credits, the decline was 8.6%. The adjusted EBITDA margin contracted about 210 basis points to 18.9%.
ENR Batteries & Lights Segment Sees Organic GrowthNet sales in the Batteries and Lights segment declined 2% year over year to $524.2 million. Organic net sales increased 0.3%, supported by expanded distribution, innovation and continued market share gains despite the APS license expiration. Favorable currency also aided reported sales.
Segment profit declined 19.5% year over year to $127.9 million. The decline primarily reflected the absence of prior-year out-of-period production credits, along with lower gross margins driven by unfavorable product mix and increased promotional investments.
Management highlighted continued category outperformance supported by innovation, including the launch of Energizer Ultimate Child Shield, the world's only coin lithium battery designed to help prevent ingestion burns if swallowed, along with expanded distribution across key retail customers.
Energizer's Auto Care Delivers Strong Sales GrowthThe Auto Care segment generated net sales of $209.9 million, up 10.4% year over year. Organic net sales increased 9.5%, driven by strong refrigerant demand and higher distribution in North America.
Segment profit declined 14.1% year over year to $20.7 million, as robust growth in lower-margin refrigerant products pressured profitability.
Management noted that while refrigerants drove third-quarter performance, premium Appearance products remain a significant long-term growth opportunity. The company continues expanding its premium Armor All Podium Series portfolio to strengthen its competitive position and improve portfolio quality.
ENR's Cash Flow Supports Deleveraging & Shareholder ReturnsFor the first nine months of fiscal 2026, Energizer generated $156 million in operating cash flow and $105 million in free cash flow, representing 4.9% of net sales. The company continued to prioritize cash generation as a key component of its long-term value creation strategy.
Debt reduction remained the company's highest capital allocation priority. Through the third quarter, Energizer reduced debt by more than $80 million and continues to expect fiscal 2026 debt repayment of $150-$200 million. The company paid a quarterly dividend of 30 cents per share, returning $20.6 million to shareholders during the quarter and approximately $65 million during the first nine months of fiscal 2026.
Management expects free cash flow to strengthen further as Project Momentum cash costs decline, capital expenditures normalize by roughly $30 million annually and the company collects the remaining $53 million of IEEPA tariff recoveries.
APS Transition Weighs on Reported Sales in Third-QuarterThe APS acquisition continued to affect reported results during the third quarter.
Energizer completed the APS acquisition on May 2, 2025, and sold batteries under an acquired brand license through Dec. 31, 2025. The expiration of that license reduced reported net sales by $17.2 million, representing a 2.4% headwind. However, sales generated as customers transitioned to Energizer's legacy brands were included within organic sales, contributing to the company's 2.7% organic sales growth.
Management said the APS transition remains an important element of its portfolio strategy as it strengthens its branded portfolio and expands distribution while migrating customers to Energizer's core brands.
Energizer Updates Fiscal 2026 OutlookLooking ahead, Energizer expects fourth-quarter organic net sales to be flat to down low single digits year over year, reflecting muted battery category trends and some refrigerant demand shifting into the third quarter.
The company expects fourth-quarter adjusted earnings of $1.25-$1.35 per share, representing approximately 25% year-over-year growth at the midpoint, driven by productivity initiatives, supply chain optimization and actions taken throughout the year to strengthen profitability.
For fiscal 2026, Energizer expects organic net sales to decline low single digits compared with its previous expectation of roughly flat organic sales with growth returning in the second half.
The company also expects adjusted earnings per share at the low end of its previously guided range of $3.30-$3.60, versus its earlier expectation for the high end of the range. Likewise, adjusted EBITDA is expected at the low end of the prior $580-$610 million range rather than the high end previously anticipated.
Management expects continued investments in distribution expansion, innovation, operational improvements and customer transitions to support continued outperformance versus the battery category, strengthen its competitive position and drive long-term earnings and free cash flow growth despite a challenging consumer environment.
How Have Estimates Been Moving Since Then?It turns out, estimates review have trended downward during the past month.
The consensus estimate has shifted -9.01% due to these changes.
VGM ScoresCurrently, Energizer has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock was allocated a score of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Energizer has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerEnergizer is part of the Zacks Consumer Products - Staples industry. Over the past month, Albertsons Companies, Inc. (ACI - Free Report) , a stock from the same industry, has gained 5.3%. The company reported its results for the quarter ended May 2026 more than a month ago.
Albertsons Companies reported revenues of $24.94 billion in the last reported quarter, representing a year-over-year change of +0.2%. EPS of $0.42 for the same period compares with $0.55 a year ago.
Albertsons Companies is expected to post earnings of $0.33 per share for the current quarter, representing a year-over-year change of -25%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.5%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #5 (Strong Sell) for Albertsons Companies. Also, the stock has a VGM Score of A.
University Bancorp ve 2Q2026 vykázala čistý zisk 2,35 mil. USD, tedy 0,45 USD na akcii, oproti ztrátě 2,02 mil. USD před rokem. Za prvních šest měsíců se zisk zvýšil na 11,26 mil. USD.
ANN ARBOR, MI / ACCESS Newswire / September 3, 2026 / University Bancorp, Inc. (OTCQB:UNIB or "UNIB") announced that it had an unaudited net income attributable to University Bancorp, Inc. common stock shareholders in 2Q2026 of $2,350,713, $0.45 per share on average shares outstanding of 5,169,518 for the second quarter of 2026, compared to an unaudited net loss of $2,015,771, $0.39 per share on average shares outstanding of 5,169,518 for 2Q2025. On a fully diluted basis, net income per share in 2Q2026 was $0.36. There were no dilutive instruments outstanding in 2Q2025.
For the six months ended June 30, 2026, net income was $11,255,597, $2.18 per share on average shares outstanding of 5,169,518 for the period, compared to $1,784,600, $0.35 per share on average shares outstanding of 5,169,518 for the six months ended June 30, 2025. On a fully diluted basis, net income per share in 1H2026 was $1.74. There were no dilutive instruments outstanding in 1H2025.
Shareholders' equity attributable to University Bancorp, Inc. common stock shareholders was $109,844,993 or $21.25 per share, based on shares outstanding at June 30, 2026, of 5,169,518, and $20.80 per share, on a fully diluted basis, based on 6,481,854 fully diluted shares outstanding.
Return on equity (ROE) at University Bancorp in 2Q2026 annualized was 12.3%, despite mortgage originations nationwide continuing to be at 30-year lows with respect to units originated. The annualized ROE for the TTM ended June 30, 2026, was 19.9% on initial shareholders' equity of $93,132,755 at June 30, 2025."
Year to date earnings in 2026 were assisted by two major factors, partially offset by one factor, that had an overall net positive impact of $5,839,445 before taxes as follows:
Mortgage Servicing Rights Valuation adjustment - With the rise in long-term mortgage interest rates during the year, the valuation of our MSRs increased $4.2M and $1.1M at 2Q2026 and 1Q2026, respectively.
Mortgage Origination Pipeline Valuation adjustment - The fair market value of the hedged mortgage origination pipeline rose as the value of locked loans rose over the prior quarter by $431,338 and $366,797 at 2Q2026 and 1Q2026, respectively.
Allowance for Loan Losses adjustment - The Allowance for Loan Losses increased from the prior quarter by $157,343 and $32,205 at 2Q2026 and 1Q2026, respectively.
Overall, our business development efforts and growth continue. For example, during 2Q2026:
On April 1, 2026, we closed on the acquisition of a faith-based mortgage company competitor to UIF, American Finance House Lariba, and the acquisition was successfully integrated into our faith-based subsidiary, UIF. UIF is a wholly owned subsidiary of University Bank.
On July 1, 2026, UNIB acquired 100% of Greater Pacific Bancshares and Bank of Whittier, NA. for a purchase price of $37.2 million of which 48% was paid in cash and the remainder paid in Notes. This acquisition provides many opportunities for expanded ability to provide faith-based financing (home, commercial real estate, vehicle) and deposits (FDIC-insured time, savings, checking and tax advantaged IRA deposit accounts). UNIB anticipates that the transaction will be accretive to earnings per share over time, and with the residential servicing transferred to Midwest Loan Services, a division of University Bank, currently targeted for November 1st, we anticipate achieving significant economies of scale. The key financial terms of the transaction are available at this link: https://www.university-bank.com/wp-content/uploads/2025/12/press-189-Supplement.pdf.
Faith-based deposits have grown to $208.3 million at June 30, 2026, and include a new product that enables the automatic sweep of idle balances in customer accounts at brokerage firms into and out of our faith-based deposit products, which is accelerating deposit growth.
University Bank is now licensed for conventional mortgage lending and home equity lending in all 50 states. After completing the rollout of our 1st Mortgage HELOC program in all 47 states where we intend to introduce the product, volumes are accelerating. We are now working on rolling out a fixed home equity second mortgage lending program tied to an industry standard credit box in 47 states, with the loans being sold to the secondary market and subserviced by our Midwest Loan Services division.
At June 30, 2026, cash & equity investment securities at UNIB, available to meet working capital needs and to support investment opportunities at UNIB were $56.1 million. UNIB also has available a $12.5 million line of credit with a balance due of $0 at June 30, 2026.
A portion of UNIB's working capital, $34.8 million (at market value), has been invested in a portfolio of publicly traded investments concentrated in four large investments. The four largest investments at June 30, 2026, were:
Currency Exchange International (Symbol CURN), a company that specializes in foreign exchange, of which we now own 762,339 shares, 12.93% of the currently outstanding shares of common stock, at an average cost of $13.38 per share.
Pulsar Helium (Symbol PSRHF), of which we now own 10,444,811 shares, 4.87% of the currently outstanding shares of common stock, at an average cost of $0.602 per share.
A $5,000,000 investment in Silver, via futures contracts, at a cost of $61.45 per ounce. In addition to this core position, we recently booked a $750,000 profit on the sale of a $2,000,000 leveraged position long a Silver ETF when Silver was $71 per ounce.
A portfolio of put options on the following indices: S&P500, KRE (S&P 500 Banks) & XLF (S&P 500 Banks, Shadow Banks, Insurance Companies & REITs), and one large regional bank. UNIB's put option portfolio was worth $2.7 million at June 30, 2026.
Other Key statistics as of June 30, 2026:
1-year annual revenue growth*,
13.74
%
10-year annual average revenue growth*
22.83
%
TTM Revenue%
$
143,276,935
1 Year ROE
11.30
%
10 Year Average ROE
24.51
%
LLR/NPAs>90 days
53.93
%
Debt to equity ratio,
24.2
%
Current Ratio,#
5.51
Efficiency Ratio, %+
85.20
%
Average Assets, University Bank
$
959,827,000
Loans Held for Sale, fair value,
$
94,597,933
NPAs >90 days
$
4,445,116
TTM ROA %
1.63
%
Tier 1 Capital Ratio %
10.40
%
NPAs/Assets %
0.36
%
Texas Ratio %
8.40
%
NIM %
4.12
%
NCOs/Loans %
0.01
%
Trailing 12 Months P-E Ratio x
6.3
Price/Book Value Ratio x
106.3
%
%Does not include the TTM revenue from Bank of Whittier, N.A., acquired on 7/1/2026.
#Parent company only current assets divided by 12-month projected cash expenses.
+Calculated as: (non-interest expense/ (net interest income + non-interest income)).
xBased on last sale of $22.02 per share.
Excluding $546,658 of goodwill & other intangibles related to the acquisition of Ann Arbor Insurance Center, net tangible shareholders' equity attributable to University Bancorp, Inc. common stock shareholders was $109,298,335 or $21.14 per share (and $134,298,355 or $20.72 on a fully diluted basis) at June 30, 2026. Please note that we view the current market values of our insurance agency as being substantially in excess of their carrying value including this goodwill.
Shareholders and investors are encouraged to refer to the financial information including the investor presentations, audited financial statements, strategic plan and prior press releases, available on our investor relations web page at: http://www.university-bank.com/bancorp/.
A detailed income statement, balance sheet and other financial information for UNIB and University Bank as of June 30, 2026, will be available here: https://www.university-bank.com/bancorp-financial-statements/.
University Bank's FDIC Quarterly Call Report, with substantial additional information including loan origination, loan investment composition, delinquency ratios and Tier 1 Capital ratios for June 30, 2026, is available here: https://cdr.ffiec.gov/public/ManageFacsimiles.aspx
About UNIB
Ann Arbor-based University Bancorp is a Federal Reserve regulated financial holding company that owns:
100% of University Bank, a bank based in Ann Arbor, Michigan;
100% of Bank of Whittier, N.A., a faith-based bank based in Whittier, California;
100% of Crescent Assurance, PCC, a captive insurance company licensed in Washington DC; and
100% of Hyrex Servicing, a master mortgage servicing firm, based in Ann Arbor, Michigan.
University Bank together with its Michigan-based subsidiaries holds and manages a total of over $36 billion in financial assets for over 185,000 customers, and our 544 employees make us the 5th largest bank based in Michigan. University Bank is an FDIC-insured, locally owned and managed community bank, and meets the financial needs of its community through its quality, creative and innovative services. Founded in 1890, University Bank® is the 15th oldest bank headquartered in Michigan. We are proud to have been selected as the "Community Bankers of the Year" by American Banker magazine and as the recipient of the American Bankers Association's Community Bank Award. University Bank is a Member FDIC. The members of University Bank's corporate family, ranked by their size of revenues are:
UIF, a faith-based banking firm based in Southfield, MI;
University Lending Group, a retail residential mortgage originator based in Clinton Township, MI;
Midwest Loan Services, a residential mortgage subservicer based in Houghton, MI;
Community Banking, based in Ann Arbor, MI, which provides traditional community banking services and wealth management;
Ann Arbor Insurance Centre, an independent insurance agency based in Ann Arbor, MI.
Mortgage Warehouse Lending, a mortgage warehouse lender based in Southfield, MI.
CAUTIONARY STATEMENT: This press release contains certain forward-looking statements that involve risks and uncertainties. Forward-looking statements include, but are not limited to, statements concerning future growth in assets, future profitability, efficiencies and economies of scale from the merger, the sustainability of past results, future products, valuations, economic, market or industry conditions, and other expectations and/or goals. Such statements are subject to certain risks and uncertainties which could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to, economic, competitive, governmental and technological factors affecting our operations, markets, products, services, interest rates and fees for services, or the operations of companies that we invest in. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to update any information or forward-looking statement.
Contact: Stephen Lange Ranzini, President and CEO
Phone: 734-741-5858, Ext. 9226
Email: [email protected]
Equity Bancshares se dohodla na akvizici Lincoln Bancorp za zhruba 123 milionů USD, čímž rozšíří svou působnost v Iowě. Sloučená banka má mít aktiva v objemu asi 9,1 miliardy USD.
Equity Bancshares NYSE: EQBK has agreed to merge with Lincoln Bancorp, the parent company of Lincoln Savings Bank, in a transaction valued at approximately $123 million that would expand Equity’s footprint in Iowa.
The deal is expected to close in the fourth quarter of 2026, subject to customary conditions, with Lincoln Savings Bank slated to convert to Equity Bank’s systems in the second quarter of 2027. Equity said the combined company is projected to have about $9.1 billion in assets, $6.7 billion in loans and $7.7 billion in deposits after reducing excess liquidity.
Lincoln Savings Bank operates 16 branches across central and northeast Iowa and had $1.7 billion in assets, according to Equity Bank CEO Rick Sems. The acquisition would add locations in Des Moines, Waterloo, Cedar Falls and surrounding Cedar Valley communities to Equity’s existing presence across Kansas, Missouri, Oklahoma, Nebraska and Arkansas.
Get Equity Bancshares alerts:
Transaction Terms and Financial Outlook Lincoln shareholders are expected to receive approximately 1.89 million shares of Equity stock and $29.5 million in cash. Equity put the consideration at about 1.05 times Lincoln’s tangible book value. Following the merger, Equity shareholders are projected to own approximately 91.6% of the combined company, while Lincoln shareholders would own 8.4%.
Equity CFO Chris Navratil said the transaction is expected to be accretive to earnings per share by approximately 5.1% in 2027, 7.5% in 2028 and 10.1% in 2029. The company estimated tangible book value dilution at closing of 3.8%, with an earn-back period of roughly 2.6 years.
The company has modeled cost savings equal to 30% of Lincoln’s consolidated non-interest expense. Those savings are expected to be realized at 50% in 2027, 75% in 2028 and fully thereafter. Equity estimated pretax transaction expenses of about $23.7 million.
Navratil said Equity expects a “modest step backward” in margin and return on assets as Lincoln is incorporated in 2027, followed by a normalization in 2028 and expansion in 2029. He attributed the increasing accretion forecast primarily to the timing of cost-savings realization.
Iowa Expansion and Local Operations Chairman and CEO Brad Elliott described Iowa as a long-standing growth priority for Equity. He said the acquired markets fit Equity’s mix of rural and metropolitan banking operations, while providing opportunities for long-term organic growth.
“This transaction is not about changing Lincoln’s model,” Elliott said. “It is about building on it.”
Equity said it intends to retain all Lincoln branches, maintain local leadership and preserve local decision-making. Doug Anderson and Mike Cisney will continue leading the Iowa markets, Elliott said.
Lincoln Chair Sally Hollis said the company sought a partner that could provide additional resources, technology and scale while preserving its community banking culture. Lincoln Savings Bank was founded in 1902 and has grown into one of Iowa’s largest private community banks, she said.
Lincoln Savings Bank CEO Sean Willett said the combination is expected to offer customers broader product and service access, create additional career opportunities for employees and provide further support for communities.
Credit Review and Growth Plans Equity said its due diligence included a review of approximately 70% of Lincoln’s total loans, 78% of its commercial portfolio and all classified, non-performing and watch credits. The company modeled an $18 million gross credit mark, equal to 1.5% of gross loans, and a $27.8 million loan interest-rate discount, equal to 2.3%.
Elliott said Lincoln had previously identified certain credits and had been working through them for the past two to three years. He said Equity believes those credits have been appropriately marked and expressed confidence that they can be resolved before or after closing.
In response to analyst questions, Elliott said Lincoln had reset its portfolio roughly three years ago by reducing certain types of lending and rebuilding its origination platform. He said the bank had returned to a building phase in recent quarters.
Sems said Lincoln’s loan portfolio is similar to Equity’s and includes a tax-credit business that Equity plans to retain. Elliott added that the portfolio is granular rather than concentrated in large relationships, which he said aligns with Equity’s approach.
Equity expects to manage Lincoln’s deposit mix gradually, rather than making broad pricing changes immediately after closing. Sems said the process typically takes about two years, with attention directed first to higher-cost deposits and individual customer relationships.
Capital Position and Path Toward $10 Billion Equity projected pro forma capital ratios of 10.6% for common equity tier 1 capital, 13.4% for total risk-based capital, 9.0% for leverage and 8.6% for tangible common equity to tangible assets. Navratil said the ratios would remain above regulatory and internal thresholds.
The combined company’s projected $9.1 billion asset base would place Equity closer to the $10 billion threshold. Elliott said the company has spent several years building its risk-management infrastructure and believes it is prepared to cross that level if the appropriate opportunity arises.
Navratil estimated that the interchange-related impact of surpassing $10 billion in assets could be between $7 million and $13 million. He said Equity estimates it would need roughly $400 million to $900 million in additional assets, depending on profitability assumptions, to offset that effect.
About Equity Bancshares (NYSE:EQBK)Equity Bancshares, Inc is the bank holding company for Equity Bank, a regional financial services provider headquartered in Wichita, Kansas. As a publicly traded company on the New York Stock Exchange under the ticker EQBK, Equity Bancshares operates a network of branches and lending offices across Kansas, Missouri, Oklahoma, Illinois and Colorado. Its geographic footprint spans both urban and rural markets, reflecting a focus on supporting small businesses, agricultural enterprises and individual consumers throughout the Midwest.
The company's core business activities encompass a full spectrum of commercial and consumer banking services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Should You Invest $1,000 in Equity Bancshares Right Now?Before you consider Equity Bancshares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equity Bancshares wasn't on the list.
While Equity Bancshares currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Marathon Petroleum za poslední měsíc přidala asi 30 % po silných výsledcích za 2. čtvrtletí, kdy EPS vyskočil na 17,73 USD a tržby na 52,34 miliardy USD.
It has been about a month since the last earnings report for Marathon Petroleum (MPC - Free Report) . Shares have added about 30% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Marathon Petroleum due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
Marathon Petroleum Q2 Earnings Beat on Strong Refining MarginsMarathon Petroleum reported second-quarter 2026 earnings of $17.73 per share, which beat the Zacks Consensus Estimate of $14.52 by 22.1%. Earnings per share also surged 347.7% from the year-ago level of $3.96 per share, primarily reflecting significantly stronger Refining & Marketing performance.
Findlay, OH-based Marathon Petroleum reported revenues and other income of $52.34 billion, up 53.5% year over year and above the Zacks Consensus Estimate of $34.83 billion by 50.3%. Refining & Marketing margin rose sharply to $36.33 per barrel from $17.58 a year ago, and also beat our consensus mark by 11.17%
Inside Marathon Petroleum’s SegmentsRefining & Marketing (R&M): This segment reported adjusted EBITDA of $6.66 billion, up significantly from $1.89 billion in the year-ago quarter, and the reported figure was also 14.75% above our consensus estimate. The improvement primarily reflected higher crack spreads across all regions. Adjusted EBITDA per barrel increased to $24.84 from $6.79 a year earlier.
Midstream: This unit mainly reflects Marathon Petroleum’s general partner and majority limited partner interests in MPLX LP — a publicly traded master limited partnership that owns, operates, develops and acquires pipelines and other midstream assets.
Segment adjusted EBITDA was $1.78 billion, up 8.3% from $1.64 billion in the second quarter of 2025, and the reported figure was also 5.51% above our consensus estimate. This increase was primarily driven by higher rates and throughputs, including contributions from equity affiliates and acquisitions, partly offset by the divestiture of non-core gathering and processing assets.
Renewable Diesel: The Renewable Diesel segment reported adjusted EBITDA of $258 million against a loss of $19 million in the corresponding period of 2025, and the reported figure was also 186.45% above our consensus estimate. The improvement reflected a stronger margin environment, higher throughputs and improved regulatory credit values.
Renewable Diesel margin increased to $321 million from $49 million a year ago. Following the completion of the Martinez turnaround in the first quarter, utilization reached 95% in the reported quarter. Management also highlighted feedstock optimization as a contributor to the segment's performance.
MPC's Refining Operating MetricsCrude capacity utilization during the quarter was 94% compared with 97% in the year-ago period. Net refinery throughput was 2,944 thousand barrels per day (mbpd), down from 3,060 mbpd a year earlier. However, refined product sales volumes increased slightly to 3,842 mbpd from 3,835 mbpd.
MPC achieved Refining & Marketing margin capture of 112%. Management attributed the strong capture to crude sourcing and optimization, inventory discipline, favorable clean-product margins and higher jet production. Refining operating costs increased to $5.72 per barrel from $5.34, while planned turnaround costs totaled $275 million compared with $250 million a year ago.
Financial AnalysisMarathon Petroleum reported total costs and expenses of $45.02 billion in the second quarter of 2026 compared with $31.90 billion in the year-ago period. Capital expenditures and investments totaled $1.39 billion, up from $1.07 billion a year earlier, with $1.02 billion directed toward the Midstream segment.
As of June 30, 2026, the company had cash and cash equivalents of $7.77 billion and total consolidated debt of $32.82 billion, with a debt-to-capitalization of 56.1%. MPC returned more than $2.8 billion of capital to its shareholders during the quarter, including $2.53 billion in share repurchases. The company had $6.1 billion remaining under its share repurchase authorizations.
MPC's 2026 capital spending outlook, excluding MPLX, remains $1.5 billion. Approximately 65% of the planned spending is focused on value-enhancing investments, while the remaining 35% is allocated to sustaining operations.
During the second quarter, the El Paso yield improvement and Robinson product flexibility investments were placed in service. The Robinson project enables approximately 10,000 barrels per day of incremental jet fuel production, while the El Paso investment enhances the refinery's ability to produce specialty gasoline for key markets.
GuidanceFor the third quarter of 2026, MPC expects crude oil throughput of 2,820 mbpd and total refinery throughput of 3,005 mbpd. Refinery utilization is projected at 94%.
The company expects refining operating costs of $5.60 per barrel, distribution costs of $1.65 billion and planned turnaround costs of $290 million. Corporate expenses are projected at $260 million, including approximately $30 million of depreciation and amortization.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a flat trend in estimates revision.
VGM ScoresCurrently, Marathon Petroleum has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. However, the stock has a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Marathon Petroleum has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerMarathon Petroleum belongs to the Zacks Oil and Gas - Refining and Marketing industry. Another stock from the same industry, PBF Energy (PBF - Free Report) , has gained 23.4% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
PBF Energy reported revenues of $11.68 billion in the last reported quarter, representing a year-over-year change of +56.2%. EPS of $6.22 for the same period compares with -$1.03 a year ago.
For the current quarter, PBF Energy is expected to post earnings of $6.84 per share, indicating a change of +1415.4% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
PBF Energy has a Zacks Rank #1 (Strong Buy) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of A.
Acadia ve 2. čtvrtletí překonala odhady: EPS činil 18 centů a tržby 308 milionů USD. Firma zároveň zvýšila celoroční výhled tržeb na 1,24–1,30 miliardy USD.
It has been about a month since the last earnings report for Acadia Pharmaceuticals (ACAD - Free Report) . Shares have added about 0.5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Acadia due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
ACAD Q2 Earnings and Revenues Beat, '26 View Raised on Product SalesAcadia reported second-quarter 2026 earnings of 18 cents per share, which surpassed the Zacks Consensus Estimate of 6 cents. The company had reported earnings of 16 cents per share in the year-ago quarter.
Revenues of $308 million beat the Zacks Consensus Estimate of $294 million, reflecting a 16% year-over-year increase. Growth was supported by higher marketed product sales.
ACAD's Q2 Earnings in DetailAcadia’s revenues comprise net product sales from its two marketed drugs, Daybue and Nuplazid. Reported revenues increased from $264.6 million in the second quarter of 2025 to $308 million in the reported quarter.
The company’s quarterly performance benefited from continued demand for both products. Daybue growth was supported by the uptake of the recently launched Daybue STIX formulation, while Nuplazid benefited from volume growth and increased new-patient prescriptions.
Acadia's Nuplazid Sales Rise Year Over YearReported net product sales of Nuplazid were $183.2 million in the second quarter of 2026, up 9% from $168.5 million in the year-ago period. The drug is approved in the United States for treating hallucinations and delusions associated with Parkinson’s disease psychosis. Nuplazid sales beat the Zacks Consensus Estimate of $181.5 million.
Management stated that Nuplazid’s growth was primarily volume-driven. New-patient prescriptions increased 20% year over year and reached their highest quarterly level since the first quarter of 2018. Acadia also continued to expand engagement with priority health care providers through its enlarged field force.
ACAD's Daybue Sales Jump on STIX UptakeDaybue reported net product sales of $124.8 million, up 30% from $96.1 million in the second quarter of 2025. Daybue is approved in the United States for treating Rett syndrome in adult and pediatric patients two years of age and older. The reported figure beat the Zacks Consensus Estimate of $111.3 million.
Growth was driven largely by volume and strong uptake of Daybue STIX. Approximately 40% of U.S. Daybue patients were receiving STIX by the end of the quarter. The company also recorded a quarterly high in the number of patients returning to Daybue treatment.
Acadia stated that around 60% of total referrals during the quarter came from treatment-naive patients, while 40% represented returning patients. For STIX specifically, 55% of patients switched from the oral solution, while the remaining 45% were new or returning patients.
Acadia’s Operating Expenses Rise in Q2Research and development (R&D) expenses were $82 million in the second quarter of 2026, up 5% from $78 million in the year-ago period.
Selling, general and administrative (SG&A) expenses increased 20% year over year to $160 million from $134 million. The increase reflected investments in expanding the Nuplazid and Daybue field forces and higher marketing spending to support both brands.
Acadia had cash, cash equivalents and investment securities worth $956 million as of June 30, 2026, compared with $851 million as of March 31, 2026.
Acadia Raises Its 2026 Revenue OutlookFollowing the strong quarterly performance, Acadia raised its total revenue guidance for 2026 to a range of $1.24 billion to $1.30 billion. The previous guidance range was $1.22 billion to $1.28 billion.
The company increased its Daybue global net product sales forecast to $480-$510 million from the prior range of $460-$490 million. The revised outlook reflects strong U.S. demand, uptake of STIX and expected contributions from international markets.
Nuplazid net product sales guidance was maintained at $760-$790 million. Management expects the expanded field force to have a greater impact on Nuplazid’s performance later in the year as sales representatives deepen engagement with targeted physicians.
Acadia now expects R&D expense in the range of $355-$380 million, down from the previous range of $385-$410 million. SG&A expenses continue to be expected between $660 million and $700 million.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates review.
The consensus estimate has shifted 59.62% due to these changes.
VGM ScoresAt this time, Acadia has a nice Growth Score of B, however its Momentum Score is doing a bit better with an A. However, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Acadia has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerAcadia belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Incyte (INCY - Free Report) , has gained 7.5% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Incyte reported revenues of $1.67 billion in the last reported quarter, representing a year-over-year change of +37.7%. EPS of $3.09 for the same period compares with $1.57 a year ago.
For the current quarter, Incyte is expected to post a loss of $3.31 per share, indicating a change of -246.5% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
Incyte has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of A.
Mosaic za poslední měsíc přidala asi 10,1 %, i když se její výhled výrazně zhoršil. Ve 2. čtvrtletí firma vykázala čistou ztrátu 273 milionů USD a snížila letošní investiční výdaje na 1,2 miliardy USD z původních 1,25 miliardy USD.
It has been about a month since the last earnings report for Mosaic (MOS - Free Report) . Shares have added about 10.1% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Mosaic due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.
Mosaic’s Q2 Earnings Beat Estimates, Sales Miss on Lower VolumesMosaic posted second-quarter 2026 net loss of $273 million or 86 cents per share, down sharply from a profit of $411 million or $1.29 per share in the year-ago quarter.
Barring one-time items, adjusted earnings were 13 cents per share, down 74.5% from adjusted earnings of 51 cents a year ago. The figure beat the Zacks Consensus Estimate of 9 cents.
Net sales declined 6% year over year to $2,824.1 million from $3,005.7 million in the prior-year quarter. Revenues missed the Zacks Consensus Estimate of $3,046.4 million. Lower sales volumes and elevated raw material costs, particularly sulfur, more than offset the benefit of higher phosphate and potash prices.
Segment Highlights Mosaic’s Phosphate segment generated net sales of $1.25 billion, up from $1.17 billion a year ago. Sales volumes declined to 1.4 million tons from 1.5 million tons due to production curtailments. Net sales missed our estimate of $1.27 billion. Gross margin deteriorated to negative $4 per ton from $67 per ton a year ago as higher sulfur and ammonia costs offset stronger DAP pricing. The average DAP selling price increased to $773 per ton from $668 per ton.
The Potash segment delivered net sales of $650 million, down from $711 million a year ago. Sales volumes fell to 2 million tons from 2.3 million tons because of turnaround activities and the Carlsbad divestiture. However, net sales beat our estimate of $603.8 million. Gross margin improved to $103 per ton from $89 per ton, supported by higher realized prices. The average MOP selling price rose to $275 per ton from $261 per ton.
Mosaic Fertilizantes reported net sales of $1.03 billion, down from $1.18 billion in the year-ago quarter. Sales volumes declined to 1.5 million tons from 2.2 million tons, reflecting curtailed domestic production and softer demand. Revenue missed our estimate of $1.21 billion. Gross margin fell to $4 per ton from $73 per ton, while the average finished product selling price increased to $585 per ton from $474 per ton. Higher sulfur costs and lower production volumes weighed on profitability.
FinancialsMosaic ended the quarter with cash and cash equivalents of $294 million compared with $276.6 million at the end of 2025. Long-term debt (net of current maturities) increased to $4,767.7 million from $4,250.9 million at year-end 2025.
Cash flow from operating activities totaled $167.4 million in the second quarter, down from $609.5 million a year ago. Capital expenditures were $320.3 million, resulting in negative free cash flow of $152.9 million. Mosaic paid a regular dividend of 22 cents per share during the quarter.
OutlookMosaic reduced its 2026 capital expenditure guidance to $1.2 billion from the prior expectation of $1.25 billion while maintaining its potash production outlook of about 9 million tons. For the third quarter, phosphate sales volumes are expected to be 1.1-1.4 million tons with DAP prices of $820-$840 per ton, while potash sales volumes are projected at 2-2.2 million tons with MOP prices of $270-$290 per ton. The company now expects SG&A expenses of $510-$530 million, net interest expense of $220-$240 million and cash taxes of $250-$300 million for 2026.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -64.19% due to these changes.
VGM ScoresAt this time, Mosaic has a poor Growth Score of F, a score with the same score on the momentum front. However, the stock has a score of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Mosaic has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
It has been about a month since the last earnings report for Kimco Realty (KIM - Free Report) . Shares have lost about 3.2% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Kimco Realty due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Kimco Realty Corporation before we dive into how investors and analysts have reacted as of late.
Kimco Q2 FFO Meet Estimates as Leasing Gains Lift OccupancyKimco reported second-quarter 2026 FFO of 46 cents per share, in line with the Zacks Consensus Estimate. The metric increased 4.5% from 44 cents in the year-ago quarter. Total revenues rose 4.9% year over year to $550.8 million and surpassed the consensus mark of $545 million by 1.06%.
Results benefited from strong leasing activity and higher minimum rents. Pro-rata leased occupancy reached 96.4%, matching the company’s all-time high, while same-property net operating income (NOI) grew 3.5%.
Rental Revenues Rise, Costs Remain MixedNet revenues from rental properties increased to $546.4 million from $520.9 million in the prior-year quarter.
Operating and maintenance expenses increased to $95.1 million from $91.1 million, while real estate taxes rose to $71.2 million from $66.6 million. However, general and administrative expenses declined to $29.9 million from $32.4 million.
Leasing Execution Drives Rent SpreadsKimco executed 461 leases covering 2.5 million square feet during the second quarter. Blended pro-rata cash rent spreads on comparable spaces were 13.1%, comprising 40.4% on new leases, 6.1% on renewals and 8% on options.
Small-shop occupancy increased 70 bps year over year and 40 bps sequentially to a record 92.9%. Pro-rata anchor occupancy improved 110 bps from the prior-year period to 97.8%. The pro-rata leased versus economic occupancy rates spread was 400 bps, representing $75 million in future rents from signed leases that have not yet commenced.
Recycles Capital Through Asset SalesDuring the second quarter, the company sold The Milton, a 253-unit multifamily building at Pentagon Centre, for $142.3 million. Kimco’s pro-rata share of the sales price was $78.2 million, and the transaction carried an approximately 4.9% capitalization rate. It also sold the 44,000-square-foot Shoppes at Bears Path for $7.8 million.
After quarter-end, Kimco sold four Costco-anchored assets for aggregate proceeds of approximately $127 million. It acquired Pompano Marketplace, a Walmart-anchored center, for $53 million and Sunshine Plaza, a Publix-anchored property, for $56 million using 1031 exchange proceeds.
Strengthens LiquidityKimco ended the quarter with $2.7 billion of immediate liquidity. This included $700 million of cash, cash equivalents and restricted cash, along with full availability under its $2 billion unsecured revolving credit facility.
The company issued $600 million of 3.50% exchangeable senior notes due 2031. In connection with the offering, it repurchased roughly 4.1 million common shares for $104.7 million at $25.38 per share.
Raises Its 2026 FFO OutlookKimco increased its 2026 FFO guidance to $1.83-$1.84 per share from $1.81-$1.84.
The revised outlook assumes same-property NOI growth of 3-3.5% compared with the previous 2.8-3.5% range. Credit loss is projected at 55-75 bps of total pro-rata rental revenues, an improvement from the prior 65-90 bps forecast.
How Have Estimates Been Moving Since Then?It turns out, fresh estimates flatlined during the past month.
VGM ScoresAt this time, Kimco Realty has a subpar Growth Score of D, however its Momentum Score is doing a lot better with a B. Charting a somewhat similar path, the stock has a grade of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Kimco Realty has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Energy Transfer zvýšila výhled pro rok 2026: upravený EBITDA nyní očekává na 18,8–19,1 miliardy USD. Ve 2. čtvrtletí zisk i tržby výrazně překonaly odhady.
It has been about a month since the last earnings report for Energy Transfer LP (ET - Free Report) . Shares have added about 5.9% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Energy Transfer LP due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for Energy Transfer LP before we dive into how investors and analysts have reacted as of late.
Energy Transfer Q2 Earnings Beat Estimates on NGL Growth, View Up
Energy Transfer LP reported second-quarter 2026 earnings of 59 cents per unit, beating the Zacks Consensus Estimate of 39 cents by 51.28%. The bottom line increased 84.4% from 32 cents a year ago.
Total RevenuesRevenues of $34.33 billion surpassed the consensus estimate of $31.09 billion by 10.42% and climbed 78.4% year over year. Record NGL transportation and export volumes, along with stronger crude oil and midstream activity, supported the quarter.
Energy Transfer's Segment DetailsNGL and refined products transportation and services revenues increased 29.9% to $7.72 billion. Segment adjusted EBITDA rose 26.6% to $1.31 billion, reflecting stronger marketing, terminal, transportation, storage and fractionation margins.
NGL transportation volumes climbed 13% to a record 2.64 million barrels per day. Terminal volumes rose to 1.86 million barrels per day. Fractionation volumes increased 3% to 1.19 million barrels per day. Higher Permian volumes and stronger exports aided throughput.
Midstream revenues declined 10% to $2.82 billion, but segment adjusted EBITDA increased 15.1% to $884 million. Gathered volumes rose 4% to a record 22.14 million BBtu per day, helped by higher dry-gas gathering and increased Permian processing activity.
Crude oil transportation and services revenues surged 92.3% to $11.05 billion. Segment adjusted EBITDA grew 13.9% to $834 million. Transportation volumes increased 4% to a record 7.34 million barrels per day, supported by higher activity across the Texas, Permian and Bakken systems.
Intrastate transportation and storage revenues fell 36% to $596 million, while segment adjusted EBITDA increased 32.7% to $377 million. Wider basis differentials and early volumes from the Hugh Brinson Pipeline more than offset lower transported volumes and higher expenses.
Interstate transportation and storage revenues rose 3.2% to $609 million, and segment adjusted EBITDA gained 2.3% to $481 million. Higher parking, storage and liquids revenues offset lower utilization on the Trunkline, Gulf Run and Mississippi River systems.
ET's Investments Add to Earnings GrowthRevenues from the investment in the Sunoco LP segment increased 164.5% to $14.26 billion. The segment adjusted EBITDA more than doubled to $982 million, primarily reflecting recent acquisitions and higher contributions from unconsolidated affiliates.
The investment in USA Compression Partners generated revenues of $342 million, up 36.8%. The segment adjusted EBITDA advanced 30.2% to $194 million, driven by the J-W Power acquisition and growth in USAC's legacy operations.
ET's Operational HighlightsTotal costs and expenses were $30.76 billion, up 81.7% year over year, mainly due to a sharp increase in the cost of products sold. Operating expenses, depreciation, depletion and amortization, and selling, general and administrative expenses also increased.
Operating income rose 54.8% to $3.57 billion. Interest expense, net of capitalized interest, increased 8% to $934 million. Net income attributable to partners advanced 79.5% to $2.09 billion.
ET's Cash Flow and Liquidity ImproveAdjusted EBITDA increased 31% to $5.07 billion. Distributable cash flow attributable to partners, as adjusted, rose 32% to $2.59 billion. Second-quarter growth capital expenditures were $1.10 billion, while maintenance capital expenditures were $307 million.
Current assets totaled $23.11 billion at June 30, 2026, compared with $18.23 billion at the end of 2025. Long-term debt, less current maturities, was $68.39 billion. The revolving credit facility had $3.76 billion of available borrowing capacity.
Energy Transfer Raises 2026 Financial GuidanceEnergy Transfer now expects 2026 adjusted EBITDA of $18.8-$19.1 billion, up from the prior range of $18.2-$18.6 billion. The partnership projects growth capital spending of $5.6-$5.9 billion.
The Hugh Brinson Pipeline entered commercial service and is expected to reach full Phase I capacity of 1.5 Bcf per day by Sept. 1, 2026. ET also completed upgrades adding more than 90,000 barrels per day of capacity to the Lone Star Express pipeline and placed the Mustang Draw I processing plant into service.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in estimates revision.
The consensus estimate has shifted 12.93% due to these changes.
VGM ScoresAt this time, Energy Transfer LP has a great Growth Score of A, a score with the same score on the momentum front. Following the exact same course, the stock was allocated a grade of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Interestingly, Energy Transfer LP has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerEnergy Transfer LP belongs to the Zacks Oil and Gas - Production Pipeline - MLB industry. Another stock from the same industry, Oneok Inc. (OKE - Free Report) , has gained 10.1% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Oneok reported revenues of $12.05 billion in the last reported quarter, representing a year-over-year change of +52.8%. EPS of $1.53 for the same period compares with $1.34 a year ago.
For the current quarter, Oneok is expected to post earnings of $1.49 per share, indicating no change from the year-ago quarter. The Zacks Consensus Estimate has changed +2.4% over the last 30 days.
Oneok has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
Archrock snížil výhled upravené EBITDA pro rok 2026 na 865–885 mil. USD z 865–915 mil. USD kvůli slabší poptávce v aftermarket services a vyšším nákladům.
It has been about a month since the last earnings report for Archrock Inc. (AROC - Free Report) . Shares have lost about 4.8% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Archrock Inc. due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Archrock Misses Q2 Earnings & Revenue Estimates on AMS Weakness
Archrock reported second-quarter 2026 adjusted earnings of 38 cents per share, down 2.6% from 39 cents per share a year earlier. The bottom line missed the Zacks Consensus Estimate of 46 cents by 17.4%.
Revenues of $371.2 million declined 3.1% from $383.2 million a year ago. The top line missed the consensus mark of $390.4 million by 4.9%.
The weak quarterly results were primarily due to softness in aftermarket services (AMS), which offset solid contract operations performance.
Period-end horsepower utilization remained high at 94.4%, while contract operations adjusted gross margin percentage improved from the year-ago period.
AROC's Contract Operations Remain Resilient
Contract operations revenues rose 3.4% to $329.3 million from $318.3 million. The increase reflected higher rates, an additional month of contribution from the NGCS acquisition and revenues from horsepower additions, partly offset by active horsepower sales used to high-grade the fleet.
Contract operations adjusted gross margin increased 5.6% to $234.6 million, while the adjusted gross margin percentage rose to 71% from 70%. Total operating horsepower ended the quarter at 4.5 million compared with 4.7 million a year earlier, with the decline largely driven by the sale of approximately 165,000 non-strategic operating horsepower.
Archrock's Aftermarket Services Lose Momentum
Aftermarket services revenues fell 35.2% to $42 million from $64.8 million in the second quarter of 2025. The decline was due to lower parts sales, the absence of non-recurring overhauled-engine sales that benefited the prior-year quarter and reduced demand for major maintenance activity.
The adjusted gross margin for the segment declined 33.6% to $9.9 million from $14.9 million. However, the adjusted gross margin percentage improved to 24% from 23%, reflecting disciplined execution and a focus on higher-quality, higher-margin work.
AROC's Margin Gains Offset Some Cost Pressure
Total adjusted gross margin increased to $244.5 million from $237.1 million a year ago. The adjusted gross margin percentage expanded to 66% from 62%, helped by the stronger profitability of contract operations and the improved margin rate in aftermarket services.
Selling, general and administrative expenses rose 9.4% to $39.6 million from $36.2 million. Higher long-term incentive compensation, primarily driven by the stock price increase, was a key factor. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) remained flat at $212.6 million compared with $212.7 million in the prior-year quarter.
Archrock Generates Solid Cash Flow
Net cash provided by operating activities was $160.8 million in the quarter. The adjusted free cash flow totaled $67 million, while adjusted free cash flow after dividends was $28.4 million. The total capital expenditure was $98 million.
AROC Raises Dividend
The board raised the quarterly dividend by around 10% to 23 cents per share from 21 cents a year earlier. Dividend coverage was 3.1X, supporting the company's continued emphasis on shareholder returns alongside growth investment.
Archrock Maintains Balance Sheet Flexibility
As of June 30, 2026, AROC’s long-term debt was $2.35 billion, while the leverage ratio improved to 2.6X from 3.3X a year ago. Available liquidity totaled $631 million at the quarter-end.
During the quarter, Archrock redeemed $800 million of 6.25% senior notes due 2028 using borrowings under its revolving credit facility. The company ended June with $113.2 million in remaining share repurchase authorization and did not repurchase shares during the quarter.
AROC Tightens 2026 EBITDA Guidance
Archrock tightened its 2026 adjusted EBITDA guidance to $865-$885 million from $865-$915 million. The revision reflects higher contract compression make-ready costs, anticipated second-half lube oil cost pressure, softer aftermarket services demand and higher selling, general and administrative costs tied to long-term incentive compensation.
The company maintained 2026 growth capital spending guidance of $250-$275 million and expects the total capital expenditure to be between $400 million and $445 million. Archrock introduced cumulative growth capital guidance of $1.4 to $1.6 billion for 2027 to 2030, aimed at adding 1 million horsepower to meet expected demand. The company signed an eight-year agreement with a strategic customer covering approximately 665,000 horsepower, with a two-year extension option.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates review.
The consensus estimate has shifted -9.93% due to these changes.
VGM ScoresAt this time, Archrock Inc. has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. Charting a somewhat similar path, the stock has a score of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Archrock Inc. has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry PlayerArchrock Inc. is part of the Zacks Oil and Gas - Field Services industry. Over the past month, FMC Technologies (FTI - Free Report) , a stock from the same industry, has gained 15%. The company reported its results for the quarter ended June 2026 more than a month ago.
FMC Technologies reported revenues of $2.76 billion in the last reported quarter, representing a year-over-year change of +9%. EPS of $0.91 for the same period compares with $0.68 a year ago.
For the current quarter, FMC Technologies is expected to post earnings of $0.89 per share, indicating a change of +18.7% from the year-ago quarter. The Zacks Consensus Estimate has changed +4.3% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for FMC Technologies. Also, the stock has a VGM Score of A.
EOG Resources za poslední měsíc přidala asi 11 %. Ve 2. čtvrtletí překonala odhady díky vyšším objemům a cenám, když upravený zisk na akcii dosáhl 5,07 USD a tržby 8,62 miliardy USD.
It has been about a month since the last earnings report for EOG Resources (EOG - Free Report) . Shares have added about 11% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is EOG Resources due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
EOG Q2 Earnings Beat Estimates on Higher Volumes & PricesEOG Resources, Inc. reported second-quarter 2026 adjusted earnings of $5.07 per share, up 118.5% year over year and above the Zacks Consensus Estimate of $5.01 by 1.2%. Revenues jumped 57.4% to $8.62 billion and beat the consensus mark of $7.87 billion by 9.6%.
The strong quarter reflected higher oil prices and impressive production.
EOG's Impressive Production LevelsTotal production increased 24.4% from 1,134.1 thousand barrels of oil equivalent per day (MBoE/D) in the year-ago quarter. Our model predicted a 22.4% year-over-year increase in the metric for the June quarter of this year.
Crude oil and condensate output rose 8.8%, while natural gas liquids volumes soared 34.2% to 346.8 thousand barrels per day (MBbl/D).
Natural gas production climbed 38.6% to 3,089 million cubic feet per day (MMcf/D). The company also established oil production in the United Arab Emirates after successful tests of two one-mile lateral wells, each averaging more than 25,000 barrels of cumulative oil production during the first 30 days.
EOG Resources Benefits From Strong PricingThe composite realized price for crude oil and condensate was $98.15 per barrel, up 51.4% from $64.82 a year earlier. Natural gas liquids fetched $24.41 per barrel, a 7.5% increase.
The composite natural gas price declined 2.4% to $2.89 per Mcf. Even so, stronger oil realizations more than offset the softer gas price and supported a sharp increase in crude oil and condensate revenues to $4.90 billion from $2.97 billion.
EOG's Operating Costs Rise as Production ExpandsLease and well expenses increased to $467 million from $396 million, while gathering, processing and transportation costs rose to $676 million from $455 million. The increases reflected the company's larger production base.
On a per-unit basis, lease and well costs improved to $3.64 per Boe from $3.84. Gathering, processing and transportation costs rose to $5.27 per Boe from $4.41, while non-GAAP cash operating costs increased to $10.57 per Boe from $9.94.
EOG's Free Cash Flow Supports ReturnsAdjusted cash flow from operations reached $4.39 billion, up from $2.50 billion in the prior-year period. After $1.59 billion of capital expenditures, free cash flow totaled $2.80 billion versus $973 million a year ago.
EOG paid $540 million in regular dividends and repurchased $1.29 billion of shares during the June quarter.
EOG Resources Retains Balance Sheet FlexibilityCash and cash equivalents were $4.91 billion at June 30, 2026, up from $3.85 billion at the end of the first quarter. Current and long-term debt was $7.93 billion.
Net debt declined to $3.02 billion from $4.08 billion sequentially. The net debt-to-total capitalization ratio improved to 8.7% from 11.7%, preserving financial flexibility while the company continued substantial shareholder distributions.
EOG's 2026 Growth PlanFor the third quarter, EOG expects crude oil and condensate production of 546 to 551 MBbl/D and total output of 1,389.7 to 1,434.7 MBoE/D. Capital expenditures are projected at $1.6 to $1.7 billion.
For 2026, the company forecasts crude oil and condensate volumes of 546.3 to 551.1 MBbl/D and total production of 1,378.3 to 1,423.1 MBoE/D. Full-year capital expenditures are expected to range from $6.3 billion to $6.7 billion, while management projects oil production to increase 5% and total production 14% in 2026.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.
The consensus estimate has shifted 6.42% due to these changes.
VGM ScoresCurrently, EOG Resources has a strong Growth Score of A, a score with the same score on the momentum front. Following the exact same course, the stock has a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Interestingly, EOG Resources has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerEOG Resources is part of the Zacks Oil and Gas - Exploration and Production - United States industry. Over the past month, EQT Corporation (EQT - Free Report) , a stock from the same industry, has gained 8.8%. The company reported its results for the quarter ended June 2026 more than a month ago.
EQT reported revenues of $1.81 billion in the last reported quarter, representing a year-over-year change of +13.2%. EPS of $0.39 for the same period compares with $0.45 a year ago.
EQT is expected to post earnings of $0.49 per share for the current quarter, representing a year-over-year change of -5.8%. Over the last 30 days, the Zacks Consensus Estimate has changed -12.2%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for EQT. Also, the stock has a VGM Score of C.
Ciena Corporation (CIEN) Q3 2026 Earnings Call September 3, 2026 8:30 AM EDT
Company Participants
Gregg Lampf - Vice President of Investor Relations
Gary Smith - CEO, President & Director
Marc Graff - Senior VP & CFO
Scott McFeely - Executive Advisor
Conference Call Participants
George Notter - Wolfe Research, LLC
Tal Liani - BofA Securities, Research Division
Meta Marshall - Morgan Stanley, Research Division
Joseph Cardoso - JPMorgan Chase & Co, Research Division
Ruben Roy - Stifel, Nicolaus & Company, Incorporated, Research Division
Ryan Koontz - Needham & Company, LLC, Research Division
Timothy Long - Barclays Bank PLC, Research Division
Jeffrey Koche - Raymond James & Associates, Inc., Research Division
Timothy Savageaux - Northland Capital Markets, Research Division
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to the Ciena Fiscal Q3 2026 Financial Results Call. [Operator Instructions]
I will now hand the conference over to Gregg Lampf, Vice President, Investor Relations. Gregg, please go ahead.
Gregg Lampf
Vice President of Investor Relations
Thank you, Jennifer. Good morning, and welcome to Ciena's 2026 Fiscal Third Quarter Conference Call. On the call today is Gary Smith, President and CEO; and Marc Graff, CFO. Scott McFeely, Executive Adviser, is also with us for Q&A.
In addition to this call and the press release, we've posted to the Investors section of our website an accompanying investor presentation that reflects this discussion as well as certain highlighted items from the quarter. Our comments today speak to our recent performance, our views on current market dynamics and drivers of our business as well as a discussion of our financial outlook. Today's discussion includes certain adjusted or non-GAAP measures of Ciena's results of operations. A reconciliation of these non-GAAP measures to our GAAP results is included in today's release.
Before turning the call over to Gary, I'll remind you that during this call, we'll
LIT za posledních 48 hodin vzrostl o více než 15 % a dostal se nad 3,94 USD, ale stále naráží na hranici 4 USD. Příjmy Lighter v srpnu stouply o 24 % na 2,62 mil. USD a poplatky o 30 % na 3,5 mil. USD.
Lighter [LIT], the native token of the perpetual decentralized exchange (DEX), rallied over 15% in the past 48 hours.
The latest pump lifted the token from below $3.50 to over $3.94. This raised hopes that $5 could be the next target if $4 is cleared. However, the token has struggled to crack above $4 despite an 110% explosive run in August.
Ahead of the Fed rate decision on the 15th of September, the altcoin could extend its sideways structure below $4 despite strong traction on the DEX.
Will Lighter crypto stay below $4, or eye $5? On the daily charts, the token has toiled below $4 since late August. Unsurprisingly, August’s mega rally was due for some cool-off as the Relative Strength Index (RSI) hit overbought territory.
The ATR (Average True Range, red) has gone flat and begun trending downwards, indicating that the volatility seen in August has eased and tapered. Unless the metric shoots up with strong trading volume, any breakout above $4 could become a “fakeout.”
Source: LIT/USDT, TradingView The sideways thesis could be invalidated if the broader crypto market extends its recovery. In such a scenario, LIT could clear the $4 overhead hurdle and eye $4.50 or $5.1.
Robinhood Chain improves Lighter crypto DEX growth The DEX saw $39B in perp volume in August, a slight increase from $36B seen in July. Part of the traction was from Robinhood integration. Lighter powers perps on Robinhood Wallet. The same infrastructure is behind the perps markets on Robinhood Chain, an Ethereum L2.
Recently, the fintech firm said that perps volume on its platform from Lighter hit $7.3B in two months. This was one of the factors behind the mid-week LIT rally.
Source: X That said, the DEX’s revenue rose 24% from $2.14M to $2.62M amid the renewed traction in August.
Over the same period, the DEX’s fees jumped by 30% from $2.7M to $3.5M. Since most of the revenue goes to LIT buyback, it could boost the altcoin’s uptrend prospects if the traction persists.
Source: DeFiLlama Overall, Lighter has seen strong growth recently, partly due to Robinhood integration. But the token’s plan to clear the $4 overhead hurdle may depend on macro factors.
Final Summary LIT surged 15%, but the $4 overhead roadblock persisted ahead of the Fed rate decision. Lighter revenue increased by 24% to $2.6M in August and could boost LIT buyback.
Chemours za poslední měsíc přidal asi 7,5 %, ale odhad zisku se za stejnou dobu výrazně snižuje. Firma zároveň čeká ve 3. čtvrtletí pokles konsolidovaných čistých tržeb o 5 % až na nulu.
It has been about a month since the last earnings report for Chemours (CC - Free Report) . Shares have added about 7.5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Chemours due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Chemours' Q2 Earnings & Revenues Lag Estimates on Lower VolumesChemours reported a net loss of $274 million or a loss of $1.81 per share for the second quarter of 2026. This compares favorably with the year-ago quarter’s net loss of $380 million or a loss of $2.53 per share.
Barring one-time items, earnings were 42 cents per share, which missed the Zacks Consensus Estimate of 43 cents by roughly 2.3%. Adjusted earnings also declined from 61 cents per share in the year-ago quarter.
The company reported second-quarter net sales of $1,591 million, reflecting a 1% decrease from the previous-year quarter. The figure missed the Zacks Consensus Estimate of $1,674.1 million by roughly 5%. Net sales were affected by a 4% decrease in volumes, partly offset by a 2% increase in price and a 1% favorable currency impact.
Adjusted EBITDA declined 5% year over year to $247 million for the quarter from $260 million. The decrease was due to higher costs in APM associated with the Washington Works outage and lower sales following the SPS Capstone line closure, partly offset by pricing increases across all segments.
Segment HighlightsThe TT division recorded revenues of $661 million in the second quarter, marking a 1% increase from the previous year. The figure missed our estimate of $663.6 million. The year-over-year increase was driven by a 2% rise in global pricing and a 1% currency tailwind, which more than offset a 2% decline in global volumes.
In the TSS segment, revenues decreased 1% year over year to $591 million in the reported quarter. The figure missed our estimate of $637.3 million. The decline was due to a 4% fall in volumes, partly offset by a 2% increase in price and a slight currency tailwind. Lower volumes primarily reflected weaker North American stationary AC aftermarket sales of Opteon blends compared with elevated demand in the prior-year quarter.
TSS adjusted EBITDA increased 3% year over year to $213 million, while adjusted EBITDA margin improved one percentage point to 36%, aided by higher pricing and the timing of certain costs.
Revenues in the APM unit amounted to $326 million, which declined 6% year over year. The figure missed our estimate of $338.2 million. The downside was mainly caused by a 9% decrease in volumes, partly offset by a 2% increase in price and a slight currency tailwind. The volume decline primarily reflected the SPS Capstone line closure, while Performance Solutions sales rose 8% year over year on strength in data center and semiconductor end markets.
FinancialsOperating cash flow in the second quarter was $158 million compared with $93 million in the year-ago quarter. Capital expenditures were $44 million compared with $43 million in the prior-year quarter. Free cash flow increased to $114 million from $50 million a year earlier.
As of June 30, 2026, Chemours had consolidated gross debt of $3.9 billion. Debt, net of $671 million in unrestricted cash and cash equivalents, was $3.2 billion. Total liquidity was $1.6 billion, and the net leverage ratio was approximately 4.4.
OutlookFor the third quarter, the company expects consolidated net sales to decline in the range of 5% to flat sequentially. Consolidated adjusted EBITDA is expected to be in the range of $175-$205 million. Corporate expenses are expected to be $40-$45 million. The company also expects capital expenditures of around $65 million and free cash flow of at least $50 million.
Chemours expects TSS’ net sales to decrease sequentially in the mid-teens to 20% range in the third quarter, reflecting less favorable seasonality and weaker Opteon blends aftermarket demand. Adjusted EBITDA is projected to be between $125 million and $140 million.
TT’s net sales are expected to increase sequentially in the low-to-mid-single-digit percentage range, driven by recent pricing announcements, with stable volumes. Adjusted EBITDA is expected to be in the range of $70-$80 million.
APM’s net sales are expected to increase sequentially in the mid-to-high-single-digit percentage range, driven by normalized operations at Washington Works and continued strength in Performance Solutions. Adjusted EBITDA for APM is expected to be between $20 million and $30 million.
For 2026, Chemours expects net sales to grow in the range of 1-5% year over year and adjusted EBITDA of $775-$825 million. Capital expenditures are expected in the range of $250-$280 million, with free cash flow conversion above 25%. The company continues to target a net leverage ratio of around 3.8x by year-end 2026.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -46.39% due to these changes.
VGM ScoresCurrently, Chemours has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a score of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Chemours has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerChemours belongs to the Zacks Chemical - Diversified industry. Another stock from the same industry, Air Products and Chemicals (APD - Free Report) , has gained 4.9% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Air Products and Chemicals reported revenues of $3.16 billion in the last reported quarter, representing a year-over-year change of +4.6%. EPS of $3.47 for the same period compares with $3.09 a year ago.
Air Products and Chemicals is expected to post earnings of $3.60 per share for the current quarter, representing a year-over-year change of +6.2%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.4%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Air Products and Chemicals. Also, the stock has a VGM Score of D.
A month has gone by since the last earnings report for Leidos (LDOS - Free Report) . Shares have added about 5.5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Leidos due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.
Leidos Holdings’ reported second-quarter 2026 non-GAAP earnings of $3.26 per share, beating the Zacks Consensus Estimate of $2.90 by 12.4%. Earnings increased 1.6% from $3.21 in the year-ago quarter.
On a GAAP basis, earnings per share were $2.81, down from $3.01 a year ago. Management attributed the year-over-year decline in GAAP results to discrete costs tied to the Entrust acquisition and the pending joint venture involving security-related businesses.
LDOS' Total RevenuesTotal revenues came in at $4.56 billion, up 7.2% year over year and above the Zacks Consensus Estimate of $4.36 billion by 4.5%. Organic revenues increased 3.9% to $4.41 billion.
The company said revenues grew on higher customer demand for defense technology products, energy and air traffic management solutions, and intelligence mission support. Acquisition and divestiture revenues totaled $150 million compared with $9 million in the prior-year quarter.
Demand remained solid in the quarter. Net bookings totaled $4.9 billion, translating into a book-to-bill ratio of 1.1. The trailing-12-month book-to-bill ratio was also 1.1, supporting year-over-year growth in both total and funded backlog.
LDOS' Total RevenuesTotal revenues came in at $4.56 billion, up 7.2% year over year and above the Zacks Consensus Estimate of $4.36 billion by 4.5%. Organic revenues increased 3.9% to $4.41 billion.
The company said revenues grew on higher customer demand for defense technology products, energy and air traffic management solutions, and intelligence mission support. Acquisition and divestiture revenues totaled $150 million compared with $9 million in the prior-year quarter.
Demand remained solid in the quarter. Net bookings totaled $4.9 billion, translating into a book-to-bill ratio of 1.1. The trailing-12-month book-to-bill ratio was also 1.1, supporting year-over-year growth in both total and funded backlog.
LDOS’ BacklogBacklog at quarter-end was $48.71 billion, including $10.22 billion funded and $38.49 billion unfunded. Total backlog increased 5% year over year, while funded backlog jumped 44%.
By segment, Intelligence & Digital backlog totaled $18.41 billion, Health was $6.61 billion, Homeland was $9.93 billion and Defense was $13.76 billion. Backlog as of July 3, 2026, included $371 million acquired through the Entrust transaction within the Homeland segment.
Operational Statistics of LDOSCost of revenues totaled $3.74 billion compared with $3.47 billion in the prior-year quarter. Selling, general and administrative expenses increased to $283 million from $217 million, while acquisition, integration and restructuring costs rose to $27 million from $2 million.
Operating income was $514 million, down from $571 million in the year-ago period. The operating margin contracted to 11.3% from 13.4%. Interest expense increased to $69 million from $55 million.
Adjusted EBITDA declined to $631 million from $647 million. The adjusted EBITDA margin was 13.8% compared with 15.2% a year ago. The prior-year quarter benefited from several one-time, non-operational gains, including a $25 million insurance reimbursement for legal costs.
Leidos’ Segmental PerformanceIntelligence & Digital revenues rose to $1.50 billion from $1.41 billion, supported by recent contract awards and higher Intelligence Community mission-support volumes. The segment also included $9 million of revenues from Kudu Dynamics. Non-GAAP operating margin remained unchanged at 10.1%.
Health revenues declined to $1.09 billion from $1.18 billion, primarily due to lower medical disability examination volumes. Non-GAAP operating margin decreased to 23.8% from 26.3%.
Homeland revenues increased to $1.02 billion from $771 million, driven by continued demand in the Air Traffic and Energy businesses. Results included $141 million from Entrust. Non-GAAP operating margin improved to 12.1% from 9.3% on a better mix of security products, improved program performance and lower indirect expenses.
Defense revenues were $955 million compared with $899 million a year ago, reflecting increased demand for several defense technology product lines. Non-GAAP operating margin was 9.9% compared with 10% in the prior-year period.
LDOS’ FinancialsCash and cash equivalents were $748 million at quarter-end compared with $1.11 billion as of Jan. 2, 2026. Long-term debt, net of the current portion, increased to $6.01 billion from $4.63 billion over the same period.
Net cash provided by operating activities totaled $793 million for the quarter, up from $486 million in the prior-year period.
Leidos returned $127 million to shareholders, including $72 million in share repurchases and $55 million in dividend payments.
LDOS’ 2026 GuidanceLeidos raised its 2026 revenue outlook to $18.20-$18.40 billion from the prior range of $18.00-$18.40 billion. The Zacks Consensus Estimate for revenues is pegged at $18.12 billion, which is below the company’s guided range.
Non-GAAP earnings are now projected at $12.20-$12.50 per share compared with the previous range of $12.10-$12.50. The Zacks Consensus Estimate for earnings is pegged at $12.30 per share, which lies below the midpoint of the company’s guided range.
The company also raised its cash flows provided by operating activities outlook to approximately $1.85 billion from approximately $1.80 billion.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
VGM ScoresCurrently, Leidos has a great Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock has a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Leidos has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerLeidos belongs to the Zacks Computers - IT Services industry. Another stock from the same industry, Roper Technologies (ROP - Free Report) , has gained 5.4% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Roper Technologies reported revenues of $2.11 billion in the last reported quarter, representing a year-over-year change of +8.5%. EPS of $5.38 for the same period compares with $4.87 a year ago.
For the current quarter, Roper Technologies is expected to post earnings of $5.79 per share, indicating a change of +12.7% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.1% over the last 30 days.
Roper Technologies has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of F.
Key Takeaways Truist Financial still trails its 2019 merger goals despite stronger earnings and improved ROTCE in 2026.TFC's assets rose 18% since the merger, but loans grew about 10%, and shares fell 7.2% since December 2019.TFC targets modest 2026 NII growth as credit risks, rising costs and weaker digital sales test Lyons. Truist Financial’s (TFC - Free Report) new president and CEO, Mike Lyons, is taking charge at a critical point for the bank. Lyons, who assumed the role on Sept. 1, brings more than 30 years of financial-services experience spanning banking, payments and technology. Former CEO Bill Rogers has moved to executive chair until his planned April 2027 retirement.
Nearly 7 Years After the Merger, TFC Still Trails Its AmbitionsLyons inherits a bank whose profitability is improving, but the numbers highlight how far Truist remains from the aspirations set when BB&T and SunTrust completed their merger of equals in December 2019. The deal targeted a 22% return on average tangible common equity (ROTCE) and a 51% efficiency ratio, along with $1.6 billion of annual run-rate cost synergies by 2022.
In the first half of 2026, Truist’s earnings jumped 30% year over year, and ROTCE improved to 14.6% from 12.3% at June 2025-end. Yet that remains roughly 740 basis points (bps) below the merger-era 22% return target. The efficiency ratio was 58.0%, about 700 bps above the original 51% goal. TFC’s current long-term ROTCE target of 16-18% is also below the return profile envisioned in 2019.
ROTCE Outlook
Image Source: Truist Financial Corporation
Truist’s Scale is Yet to Produce Strong Organic GrowthTruist ended 2019 with $473 billion of assets, $299.8 billion of loans held for investment (LHI) and $334.7 billion of deposits. By June 2026, assets had risen to $556 billion, while LHI was about $329.8 billion and deposits $409.4 billion. While assets expanded roughly 18% since the merger, LHI grew only about 10%, an annualized pace of roughly 1.5%.
That is a modest payoff from a franchise created to lead attractive Southeast and Mid-Atlantic markets and form the sixth-largest U.S. bank. TFC’s share price also underscores muted value creation. Since December 2019, the company’s shares are down 7.2%, lagging the industry’s rally of 45.1%. Its close peers, PNC Financial Services (PNC - Free Report) and M&T Bank (MTB - Free Report) , have gained 58.2% and 42.9%, respectively, over the same time frame.
Price Performance
Image Source: Zacks Investment Research
Over the past seven years, PNC Financial and M&T Bank have expanded their capabilities and geographic reach through acquisition and partnership. Further, these two banks are taking steps to expand their branch network across high-growth markets.
Shareholder payouts also highlight Truist’s relatively sluggish post-merger progress. Truist’s annual common dividend increased from $1.71 per share in 2019 to $2.08 in 2025 and has remained unchanged since 2023. In contrast, PNC Financial’s dividend climbed from $4.20 to $6.60, and M&T Bank’s rose from $4.10 to $5.70 over the same period.
Moreover, while Truist continues to pay 52 cents quarterly in 2026, PNC Financial and M&T Bank have lifted their latest quarterly payouts to $2.00 and $1.50, respectively.
TFC: NII, Credit Risks and Digital Execution Will Test LyonsTruist must address the subpar net interest income (NII) growth while managing credit risks that could limit profitability. Taxable-equivalent revenues rose 5% year over year in the first six months of 2026, but net interest margin (NIM) slipped 2 bps to 3%, underscoring pressure on spread income. The company projects a modest 1-1.5% NII growth for 2026.
5-Quarter NII and NIM Trend
Image Source: Truist Financial Corporation
To improve NII and NIM, Lyons will need to restructure the bank’s bond portfolio, improve asset repricing and deposit-cost discipline. He may even consider divesting non-strategic businesses such as subprime auto lending to improve balance sheet productivity.
Commercial lending represents another important headwind. Truist’s commercial loan book totaled approximately $201.6 billion as of June 30, 2026, or about 61% of its loan portfolio. This makes asset quality and credit costs particularly sensitive to weak property values, elevated vacancies and refinancing pressures. Though these loans have floating interest rates and shorter durations, Lyons will have to maintain strict underwriting standards, increase reserves where necessary and actively manage criticized and non-performing assets as economic pressure weighs on commercial borrowers.
5-Quarter LHI Trend
Image Source: Truist Financial Corporation
Digital banking will also be central to Lyons’ efforts to strengthen customer engagement and improve operating efficiency. Digital transactions represented 71% of Consumer and Small Business Banking transactions in the second quarter, but digital sales accounted for only 29% of total sales and fell nearly 480 bps year over year. Better digital origination, personalization and cross-selling could improve customer acquisition and deepen relationships, helping offset slower balance sheet growth.
Truist’s cost base has stabilized from the elevated post-merger levels, but non-interest expenses rose in 2025 and the first half of 2026, driven by higher personnel costs and continued investments in technology and digital capabilities, including AI-enabled tools. While these investments will likely support productivity over the longer term, continued reinvestment may limit operating leverage and constrain bottom-line growth.
Truist’s solid capital position provides Lyons with meaningful strategic flexibility. The bank ended June with a 10.9% CET1 ratio and returned $1.8 billion to shareholders during the quarter. The bigger challenge is deploying that capital effectively, converting technology investments and franchise scale into stronger loan growth, improved NII, disciplined credit costs and returns that move closer to the ambitions set at the time of the 2019 merger.
At present, TFC carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Akcie společnosti Idexx za poslední měsíc klesly asi o 7,8 %, i když ve 2. čtvrtletí firma překonala odhady zisku i tržeb. Zároveň zvýšila výhled tržeb i EPS pro rok 2026.
A month has gone by since the last earnings report for Idexx Laboratories (IDXX - Free Report) . Shares have lost about 7.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Idexx due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent catalysts for IDEXX Laboratories, Inc. before we dive into how investors and analysts have reacted as of late.
IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up IDEXX Laboratories reported second-quarter 2026 earnings of $4.27 per share, up 18% year over year. The figure surpassed the Zacks Consensus Estimate by 8.1%.
Comparable constant-currency EPS of $4.07 improved 15% year over year.
IDXX’s Q2 Revenues Revenues rose 10% to $1.22 billion and topped the Zacks Consensus Estimate by 1.3%. Results benefited from volume-driven Companion Animal Group (“CAG”) Diagnostics’ recurring revenues, increased diagnostic utilization and continued adoption of IDEXX’s innovations. CAG Diagnostics’ recurring revenues advanced 11% as reported and 10% organically.
IDXX's CAG Arm Drives GrowthCAG revenues increased 9.4% year over year to $1.12 billion. Organic growth was 8.7%. International CAG revenues climbed 13.4% as reported and 11.5% organically, while U.S. revenues advanced 7.4%.
IDEXX VetLab consumables revenues increased 14.7% to $430.3 million, with organic growth of 13.6%. Performance was supported by higher testing utilization, recent product launches, net new customer gains and an 11% expansion of the global premium instrument installed base.
Reference laboratory diagnostic and consulting services revenues rose 10.6% to $406.7 million. Organic growth was 10.3%, driven by higher testing volumes and customer additions. Rapid assay product revenues increased 1.3% to $101.6 million.
IDEXX's Water and LPD Segments Post GainsWater revenues advanced 15% year over year to $58.6 million and 13% organically. This growth reflected solid performances in the United States and Europe.
Livestock, Poultry and Dairy revenues increased 11% to $35.2 million, with organic growth of 9%. Strength in the Americas supported the improvement.
IDXX's Margins Expand on Recurring Volume GrowthGross profit increased 12% to $779.1 million. Gross margin expanded 140 basis points to 64%, supported by recurring revenue volume gains, operational productivity initiatives and net price realization.
Operating expenses rose 10% to $353.5 million as IDEXX invested in commercial capabilities, innovation and information technology. Operating profit climbed 14% to $425.6 million, while operating margin expanded 140 basis points to 35%.
IDEXX’s Financial PositionIDEXX exited the second quarter of 2026 with cash and cash equivalents of $196.9 million compared with $200.5 million at the end of the first quarter.
Cumulative net cash provided by operating activities was $613.4 million compared with $423.7 million in the prior-year period.
IDEXX Updates Its 2026 Financial OutlookIDEXX has updated its 2026 revenue guidance to $4.70-$4.75 billion from $4.68-$4.76 billion. The midpoint increased $5 million despite a projected $15-million headwind from updated foreign exchange assumptions.
The company now expects reported revenue growth of 9.1-10.3% and organic growth of 8.5-9.7%. The Zacks Consensus Estimate is currently pegged at $4.72 billion, indicating 9.6% year-over-year growth.
IDEXX raised its 2026 earnings outlook to $14.69-$14.94 per share from $14.45-$14.90. The Zacks Consensus Estimate is currently pegged at $14.81.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.
VGM ScoresAt this time, Idexx has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock has a grade of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Idexx has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerIdexx is part of the Zacks Medical - Instruments industry. Over the past month, Glaukos (GKOS - Free Report) , a stock from the same industry, has gained 5%. The company reported its results for the quarter ended June 2026 more than a month ago.
Glaukos reported revenues of $185.61 million in the last reported quarter, representing a year-over-year change of +49.5%. EPS of -$0.14 for the same period compares with -$0.24 a year ago.
Glaukos is expected to post a loss of $0.12 per share for the current quarter, representing a year-over-year change of +25%. Over the last 30 days, the Zacks Consensus Estimate has changed +4.8%.
Glaukos has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
Coherent čeká ve fiskálním roce 2027 růst tržeb o 50,1 % a zisku na akcii o 67,2 %. Akcie ale obchodují za 26,5násobek forwardového zisku a firmě dál tlačí na cash flow vyšší investice.
Key Takeaways Coherent's fiscal 2027 revenues are projected to rise 50.1% y/y, with earnings expected to grow 67.2%.Coherent's fiscal 2027 earnings estimate rose 13% in four weeks, reinforcing the near-term revision trend.Coherent trades at 26.5X forward earnings as capex rises and operating cash flow remains under pressure. Coherent Corp. (COHR - Free Report) combines accelerating AI-optics demand with a valuation that already requires substantial execution. Fiscal 2027 consensus revenue and earnings call for another sharp step up after fiscal 2026, while capacity spending and supply constraints leave little room for operational misses.
For investors deciding whether to buy now or wait, the key issue is whether earnings revisions and margin gains can outrun premium valuation, cash-flow pressure and concentration in Datacenter and Communications.
COHR's AI Growth Case Remains PowerfulThe Zacks Consensus Estimate calls for fiscal 2027 revenues of $10.68 billion, implying 50.1% year-over-year growth. Fiscal 2028 revenues are projected to increase another 34.9% to $14.41 billion. Fiscal 2027 earnings of $9.38 per share compare with $5.61 in fiscal 2026, reflecting projected growth of 67.2%.
AI-optics strength also extends across adjacent suppliers. Lumentum Holdings Inc. (LITE - Free Report) reported fiscal fourth-quarter 2026 revenues of $1.01 billion and forecast $1.225-$1.275 billion for the first quarter of fiscal 2027. Fabrinet (FN - Free Report) reported fiscal 2026 revenues of $4.64 billion, up 35.7%, with data-center products representing 47.9% of revenues.
Coherent's Earnings Estimates Are Moving HigherThe Zacks Consensus Estimate for fiscal 2027 earnings has moved 13% higher over the past four weeks and 18.2% over 12 weeks. The estimate for the current quarter increased 10.1% over the latest month, reinforcing the favorable near-term revision trend.
Coherent expects current-quarter revenues of $2.2-$2.4 billion and non-GAAP earnings of $1.85-$2.05 per share. The company also guided non-GAAP gross margin to 39.5%-41.5%, keeping margin expansion central to the earnings-growth case.
COHR's Valuation Already Carries a PremiumCOHR trades at 26.50X forward 12-month earnings, above the Zacks sub-industry's 20.65X, the Zacks sector's 18.07X and the S&P 500's 19.91X. That premium raises the performance bar because investors are paying more than the broader comparison groups for expected earnings.
Image Source: Zacks Investment Research
Image Source: Zacks Investment Research
Image Source: Zacks Investment Research
The stock's current multiple also matches its five-year median of 26.5X. Shares have declined 24.3% over the past three months but are up 203.7% over the past year. The median comparison shows that the recent weakness has not created an obvious historical valuation discount.
Coherent Must Prove Cash Flow Can Catch UpFiscal 2026 additions to property, plant and equipment rose to $1.10 billion from $440.8 million. Operating cash flow moved the other way, falling to $79.5 million from $633.6 million, while fourth-quarter capital expenditures reached $556 million.
Management expects capital expenditures to rise sequentially again in the current quarter and says data-center investments carry a roughly 18-month payback period. The spending supports capacity expansion, but cash generation may remain uneven until manufacturing and product ramps mature.
COHR's Buy Signal Meets Weak Style ScoresThe near-term signal favors COHR, but the broader setup remains mixed. The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
This emphasizes favorable earnings-estimate revisions over a one- to three-month horizon, while its Momentum Score of A indicates favorable timing for momentum-oriented investors.
The Value Score of D, Growth Score of F and VGM Score of F are less supportive. Because the Growth Score considers both growth prospects and financial-statement quality, while the VGM Score combines value, growth and momentum factors, investors have reason to weigh valuation and cash-flow execution alongside the favorable Rank and Momentum Score.
Gartner ve 2. čtvrtletí překonal odhady zisku i tržeb a zvýšil celoroční výhled na EPS na nejméně 14 USD z 13,25 USD. Akcie jsou za měsíc asi o 0,2 % výše.
It has been about a month since the last earnings report for Gartner (IT - Free Report) . Shares have added about 0.2% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Gartner due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Gartner, Inc. before we dive into how investors and analysts have reacted as of late.
Gartner Surpasses Q2 Earnings EstimatesGartner reported better-than-expected second-quarter 2026 results, with both earnings and revenues surpassing the Zacks Consensus Estimate.
Adjusted earnings of $4.37 per share beat the consensus estimate of $3.77 by 15.9% and increased 23.8% from the year-ago quarter’s $3.53. The improvement reflected higher operating profit and a considerably lower diluted share count.
Revenues of $1.68 billion surpassed the consensus mark of $1.65 billion by 1.8%. Reported revenues declined 0.6% year over year because the prior-year period included revenues from the divested Digital Markets operation. Adjusted revenues increased 2.8% on a reported basis and 1.8% on a foreign-currency-neutral basis.
IT’s Contract Value Growth AcceleratesGlobal contract value reached $5.28 billion, increasing 1.7% year over year and 0.3% sequentially on a foreign-currency-neutral basis. The improvement from 1% year-over-year growth in the first quarter indicates that subscription demand is gradually stabilizing.
Global Technology Sales contract value was approximately $4 billion, rising 1.1% year over year and remaining nearly flat sequentially. Global Business Sales contract value increased 3.3% year over year and 1.2% sequentially to $1.28 billion.
Global wallet retention was 98.2%, up from 97.7% in the preceding quarter but below 101.3% a year earlier. Client retention improved sequentially to 85.2% from 85%, compared with 84.6% in the year-ago quarter. Contract value per enterprise advanced to $414,000 from $376,000 a year ago, partly offsetting a 4.5% decline in client enterprises to 12,775.
Gartner’s Q2 Segmental PerformanceInsights revenues increased 2.1% year over year, or 1% on a foreign-currency-neutral basis, to $1.29 billion. Segment contribution rose 4% to $999 million. The contribution margin expanded 150 basis points to 77.5%, demonstrating the scalability of Gartner’s subscription-oriented research platform.
Conferences delivered the strongest revenue growth. Segment revenues advanced 15.5% year over year, or 14.2% on a foreign-currency-neutral basis, to $244 million. Contribution jumped 19.6% to $145 million, while the contribution margin expanded 210 basis points to 59.5%.
Same-conference revenues increased 12%, although attendee levels declined 1.4%. Gartner held 18 destination conferences during the quarter compared with 19 a year earlier, while destination conference attendance decreased slightly to 28,057 from 28,295.
Consulting remained the weakest segment. Revenues declined 8.8% year over year to $142 million, while contribution fell 12.6% to $54 million. The contribution margin contracted 170 basis points to 37.9%.
Labor-based consulting revenues decreased 12.8% to $96 million, whereas contract optimization revenues increased 0.9% to $46 million. Consulting backlog rose 9.1% to $214 million, offering some support for future revenues. Billable headcount fell 11.3% to 842, while utilization improved 32 basis points to 65.1%.
IT’s Profitability and Cash Flow ImproveAdjusted EBITDA excluding the divested operation increased 6.4% year over year, or 4.4% on a foreign-currency-neutral basis, to $466 million. The corresponding margin expanded 90 basis points to 27.8%.
GAAP operating income advanced 15.7% to $378.5 million. The operating margin improved to 22.6% from 19.4% a year earlier, aided by lower service, product-development and administrative expenses.
Net income increased 14.4% to $275.5 million. Earnings climbed 33.1% to $4.14 per share, with the faster per-share increase supported by a reduction in shares to 66.6 million from 77.4 million.
Operating cash flow rose 3.8% to $398 million. With capital expenditures declining to $20 million from $36 million, free cash flow increased 8.9% to $378 million. The trailing-12-month free cash flow was approximately $1.3 billion.
Gartner repurchased 3.6 million shares for $547 million during the quarter. Year-to-date repurchases totaled approximately $1.08 billion. The company had about $1.2 billion remaining under its repurchase authorization as of July 31 after the board approved an additional $500 million in July.
Gartner ended the quarter with $1.49 billion in cash and approximately $3 billion in debt. Gross debt to adjusted EBITDA was 1.8 times, while net leverage stood at 0.9 times.
Gartner’s 2026 GuidanceGartner now expects 2026 adjusted revenues of at least $6.38 billion, compared with the previous outlook of $6.41 billion.
Insights revenues are now projected to be at least $5.17 billion, down from the prior guidance of $5.20 billion. The outlooks for Conferences and Consulting revenues were maintained at no less than $695 million and $510 million, respectively.
Despite the revenue adjustment, the company raised its profitability forecast. Adjusted EBITDA excluding the divested operation is now expected to be at least $1.57 billion, up from $1.55 billion. Adjusted EPS guidance for 2026 increased to at least $14 from $13.25, while the free cash flow forecast rose to at least $1.19 billion from $1.16 billion.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.
The consensus estimate has shifted 5.82% due to these changes.
VGM ScoresCurrently, Gartner has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. However, the stock was allocated a score of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Gartner has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerGartner belongs to the Zacks Consulting Services industry. Another stock from the same industry, Equifax (EFX - Free Report) , has gained 4.6% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Equifax reported revenues of $1.7 billion in the last reported quarter, representing a year-over-year change of +10.6%. EPS of $2.25 for the same period compares with $2.00 a year ago.
For the current quarter, Equifax is expected to post earnings of $2.21 per share, indicating a change of +8.3% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.1% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Equifax. Also, the stock has a VGM Score of C.
Vertiv klesl z 52týdenního maxima o zhruba 32 %, i když ve 2. čtvrtletí opět překonal odhady a zvýšil celoroční výhled EPS na 6,65 až 6,75 USD. Loop Capital vidí růst téměř o 100 % při cílové ceně 500 USD.
Vertiv has quietly shed nearly a third of its value from its peak even as earnings beats pile up and estimates keep climbing higher. One analyst has a target so far above current prices it sounds almost absurd, but the…
Vertiv (NYSE:VRT | VRT Price Prediction) closed the most recent session at $256.70, while the average Wall Street price target sits at $338.15. That leaves a consensus gap of roughly 32% between where the stock trades and where analysts think it belongs.
Vertiv sells the power and thermal plumbing that keeps AI data centers alive: UPS systems, switchgear, chillers, coolant distribution units, and liquid-cooling loops that sit between hyperscalers and the GPUs they are racing to deploy (we profiled seven of these infrastructure suppliers, from power to cooling, in a free report here: 7 Stocks Powering the AI Boom). That positioning turned VRT into one of the market’s cleanest AI infrastructure names and made it a favorite of momentum funds after it joined the S&P 500 in March 2026.
The gap matters because the stock has quietly come undone from its highs even as the operating story keeps getting better. That disconnect has Wall Street increasingly vocal, with one shop calling for a rally of roughly 100% from here.
A 32% Drawdown Off the Highs Nobody Is Talking About Vertiv has shed about 32% from its 52-week high of $379.86, a drawdown large enough to qualify as a bear market in a single name. Shares are down 2.41% over the past month and 2.7% over the past week, extending a slow bleed that began after the April peak near $319.
The catalyst had nothing to do with earnings quality. Vertiv’s Q2 2026 report was the fifth straight beat, with $1.52 in adjusted EPS, $3.27 billion in revenue up 24.12% year over year, and adjusted operating margin of 22.6%, up 410 basis points. Management raised full-year EPS guidance to $6.65 to $6.75. Yet shares opened the next session near $232 after filing at $270.
The market seized on management’s comments about “minor timing shifts” in Q2 revenue tied to multi-phase project execution and supply-chain congestion. Investors read that as a crack in the AI capex story. Layer in tariff overhangs, an EMEA segment that grew only 1.7%, and profit-taking after a scorching run, and the selloff snowballed.
Why Loop Capital Sees a 100% Rally From Here Analysts remain firmly constructive. Of 28 firms covering VRT, 3 rate it Strong Buy, 21 Buy, 4 Hold, and none Sell. The consensus EPS estimate for 2026 has climbed to $6.71 from $6.48 just 30 days ago, and the 2027 number has moved to $9.10. Recent revisions are running heavily to the upside, with 21 upward revisions versus only three cuts over the past month for 2026.
The loudest bull is Loop Capital Markets, which carries the highest active published Street target of $500.00. From here, that implies close to a 100% move. Loop’s thesis models aggressive long-term revenue and margin expansion driven by Vertiv’s dominant market share in liquid cooling (CDUs, chillers) and power management infrastructure for next-generation AI data center architectures. In plain English: Loop believes VRT is the toll booth for the 800-volt DC power and closed-loop liquid cooling transition already being validated with NVIDIA GB300 and Vera Rubin platforms.
Management’s own commentary supports the bull case. CEO Gio Albertazzi told investors “the momentum is strong. It’s broad-based, and it’s accelerating,” pointing to a Q2 backlog and pipeline that continue to expand across hyperscale, colocation, and neocloud customers. A $1.45 billion deal to acquire a microgrid firm, announced this week, deepens VRT’s grid-tie capability just as AI power constraints tighten.
The bull timeline is concrete. Q3 organic growth is guided to 34% to 36%, which would give the market a clean data point on whether the H2 backlog conversion story is real. Loop’s $500 needs that ramp plus continued mix shift toward higher-content liquid-cooling deployments.
Vertiv Fell Alone While Its Power Peers Held Firmer The AI power complex sold off unevenly. Vertiv is the outlier, having given back more than any close peer despite posting the cleanest fundamentals.
Eaton (NYSE:ETN) trades at $390.85 against a $475.57 average target, implying about 22% upside. Coverage skews bullish with 22 Buys, 4 Holds, and 1 Strong Sell. ETN is down 10.59% in the past month but still 23.73% YTD; Wall Street’s implied upside here is meaningfully smaller than VRT’s.
Generac (NYSE:GNRC) sits at $180.76 versus a $283.88 target, or roughly 57% upside, with 14 Buys and 7 Holds. GNRC has fallen 12.52% in the past week on data-center backlog concerns, giving it the widest peer-group gap outside of Loop’s outlier VRT call.
Super Micro Computer (NASDAQ:SMCI) trades near $37.00 against a $42.38 target, implying just 14.5% upside. The rating deck reflects lingering doubt: 5 Buys, 11 Holds, 3 Sells. SMCI’s setup is the weakest of the group on both upside and analyst posture.
Across the primary and its peers, GNRC carries the largest consensus upside, but the standout single-analyst call sits with Vertiv thanks to Loop’s $500. On a rating-quality basis, VRT’s Buy-heavy book is the cleanest in the group.
How the VRT Numbers Actually Stack Up Vertiv trades at $256.70 with a $338.15 consensus target across 28 analysts, implying about 32% upside to the group average and closer to 95% to Loop’s Street-high $500. Targets are one data point among many.
Performance tells the dislocation story. VRT is up 58.52% YTD and 107.22% over one year. The S&P 500, by comparison, is up 12.21% YTD and 19.51% over the same twelve months. VRT has vastly outrun the index over a year yet has stalled recently, down 2.41% in the past month while the S&P added 0.99%.
Valuation runs rich. Shares trade at a 42x forward earnings multiple on $6.71 in 2026 EPS. That is the price of a name growing organic sales in the 30s with expanding margins and a net cash balance sheet.
Where I Actually Come Down on Vertiv Here Vertiv looks compelling at these levels if the bull case holds. Q3 delivers the guided 34%-plus organic growth, the H2 timing shifts resolve as management promised, and liquid-cooling attach rates keep climbing as GB300 and Vera Rubin platforms roll out. That path gets consensus to $338 comfortably and gives Loop’s $500 a real runway toward 2027 as EPS scales toward $9.10. But the risk/reward inverts if the bear case bites. Multi-phase project complexity turns into recurring push-outs, tariffs squeeze the price-cost equation, hyperscale capex digestion arrives sooner than expected, and a 42x forward multiple compresses fast on any growth wobble.
My lean is constructive. Estimates are moving up, not down, and the operating results support the bullish revisions. Loop’s 100% rally call is aggressive and depends on 2027 execution, but the base-case 32% gap to consensus looks like the market punishing complexity commentary while the underlying thesis remains intact. Investors who can stomach a high-beta name with a rich multiple are being offered a better entry than they’ve had in months.
Contact [email protected] for any questions or corrections.
Macerich za poslední měsíc klesl o 7,8 % po poslední výsledkové zprávě. Ve 2. čtvrtletí ale FFOA 35 centů na akcii i tržby 249,7 mil. USD překonaly odhady a obsazenost vzrostla na 94 %.
A month has gone by since the last earnings report for Macerich (MAC - Free Report) . Shares have lost about 7.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Macerich due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Macerich Company (The) before we dive into how investors and analysts have reacted as of late.
Macerich's Q2 FFO & Revenues Beat Estimates on Strong Portfolio NOIThe Macerich Company reported second-quarter 2026 funds from operations as adjusted (FFOA) of 35 cents per share, up 2.9% year over year and beating the Zacks Consensus Estimate by 6.06%. Total revenues of $249.7 million were nearly unchanged from a year earlier and topped the consensus mark by 3.24%.
The results benefited from stronger Go-Forward Portfolio centers’ NOI, rising occupancy and healthy tenant demand. Portfolio tenant sales reached $919 per square foot for the trailing 12 months.
Portfolio NOI Gains MomentumGo-Forward Portfolio centers NOI, excluding lease termination income, increased 3.8% year over year during the second quarter. Including lease termination income, NOI advanced 3.7%.
Leasing Pipeline Supports GrowthMacerich signed leases covering approximately 1.3 million square feet on a comparable-center basis during the reported quarter. New-store leased square footage increased 1% from the prior-year period.
New-store leases are expected to generate approximately $124 million of gross revenues at the company’s share, above the revenues generated in 2024 from prior uses of those same spaces. The estimate includes stores already open, signed-not-open leases and leases in documentation that commenced or are expected to start between 2024 and 2028. Management said its leasing “speedometer” reached 88%, exceeding the company’s midyear target of 85%.
MAC’s Occupancy & Tenant Sales ImproveAs of June 30, 2026, leased portfolio occupancy was 94%, up 200 basis points (bps) from 92% in the year-ago period. Occupancy also improved 60 bps sequentially from 93.4% at the end of the first quarter of 2026.
Go-Forward Portfolio centers posted leased occupancy of 95.5%. The high level of committed space provides a foundation for additional rent commencement, as tenants complete construction and open stores.
Tenant productivity also strengthened. Portfolio tenant sales per square foot for spaces below 10,000 square feet rose to $919 for the trailing 12 months from $849 in the comparable prior-year period. Go-Forward Portfolio centers recorded an even higher $954 in sales per square foot for spaces less than 10,000 square feet.
Macerich Advances Its Annapolis Mall StrategyDuring the second quarter, MAC completed the acquisition of Annapolis Mall, a Class A regional mall spanning approximately 1.4 million square feet in Annapolis, MD, for $260 million. It also acquired an adjacent 13.1-acre vacant Sears parcel for $12 million.
The transaction was initially funded with cash on hand and $150 million of borrowings under the revolving credit facility. Management said the onboarding process has progressed smoothly, with Uniqlo now open and Dick’s House of Sport scheduled to open.
Macerich Bolsters Liquidity Through Equity RaisesMacerich completed an underwritten public offering of 22.08 million common shares at $21 per share, generating net proceeds of $448.2 million. The proceeds were used to repay borrowings under the revolving credit facilty, fund investments at Annapolis Mall and support general corporate purposes.
The company also entered into forward sale agreements covering 16.1 million shares at a public offering price of $23.90. As of the filing date, Macerich had approximately $1.2 billion of liquidity, including $900 million of available capacity under its revolving credit facility.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.
VGM ScoresAt this time, Macerich has a subpar Growth Score of D, though it is lagging a bit on the Momentum Score front with an F. However, the stock has a grade of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of this revision indicates a downward shift. Notably, Macerich has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Timken po poslední výsledkové zprávě oslabil asi o 8,5 % za zhruba měsíc. Firma zároveň zvýšila celoroční odhad upraveného zisku na akcii na 6,05 až 6,35 USD.
It has been about a month since the last earnings report for Timken (TKR - Free Report) . Shares have lost about 8.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Timken due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.
Timken Beats Q2 Earnings Estimates on Higher Volumes, Raises ViewTimken reported second-quarter 2026 adjusted earnings of $1.83 per share, up 28.9% year over year. The figure beat the Zacks Consensus Estimate of $1.63 by 12.3%.
Including one-time items, Timken reported earnings of 41 cents per share compared with $1.12 a year earlier. The decline reflected, among other items, impairment, restructuring and reorganization charges tied to the belts business.
Sales increased 7.5% year over year to $1.26 billion and surpassed the Zacks Consensus Estimate of $1.23 billion by 2.6%. Higher volumes across both segments, pricing, the Bijur Delimon acquisition and favorable currency translation aided growth. Organic sales increased 4.4%.
Adjusted EBITDA increased to $247.2 million from $208.2 million in the prior-year quarter. The adjusted EBITDA margin expanded 190 basis points to 19.6%. The current-quarter figure included an $8 million net benefit from IEEPA tariff refunds.
Timken's Segment Performance in Q2Engineered Bearings segment revenues increased 3.8% year over year to $807 million. The improvement was primarily driven by higher volumes, increased pricing and favorable foreign currency translation.
The segment's adjusted EBITDA rose to $161.3 million from $153.4 million. Adjusted EBITDA margin improved to 20% from 19.7%. Positive price/mix, higher volumes, tariff refunds and favorable currency effects more than offset increased operating costs.
Industrial Motion revenues jumped 14.6% year over year to $453.9 million. The increase reflected stronger demand across most platforms and end markets, contributions from the Bijur Delimon acquisition, pricing gains and favorable foreign currency translation.
Adjusted EBITDA for the segment surged to $105.6 million from $72.6 million in the year-ago quarter. The margin expanded to 23.3% from 18.3%, aided by higher volumes, positive price/mix, tariff refunds and acquisition contributions. These benefits were partly offset by higher operating costs.
Timken's Cash Flow and Leverage Stay BalancedNet cash provided by operating activities was $107.1 million compared with $111.3 million in the prior-year period. Free cash flow improved 2.9% to $80.5 million as capital expenditures declined to $26.6 million from $33.1 million.
Timken ended June with cash and cash equivalents of $399.1 million compared with $364.4 million at the end of 2025. Net debt increased to $1.68 billion from $1.56 billion, while the net debt-to-adjusted EBITDA ratio remained at 2.0.
During the quarter, the company returned $45 million to shareholders through dividends and share repurchases. It also raised its quarterly dividend by 3% and repurchased approximately 155,000 shares.
Timken Raises 2026 Earnings and Revenue OutlookTimken raised its full-year 2026 adjusted earnings guidance to $6.05-$6.35 per share. Management cited first-half performance, continued momentum and disciplined execution in raising the outlook.
The company now expects 2026 revenues to increase approximately 5.5% at the midpoint from 2025. This compares with its prior expectation for 5% growth at the midpoint. The higher sales outlook reflects continued progress under Timken's Elevate to Outperform strategy and improving customer demand.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
VGM ScoresCurrently, Timken has a average Growth Score of C, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Timken has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Bruker ve 2. čtvrtletí překonal odhady zisku na akcii o 49 centů, ale tržby ve výši 838,5 milionu USD za nimi zaostaly. Firma zároveň zvýšila celoroční výhled tržeb na 3,54–3,57 miliardy USD.
It has been about a month since the last earnings report for Bruker (BRKR - Free Report) . Shares have added about 12.5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Bruker due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Bruker Corporation before we dive into how investors and analysts have reacted as of late.
Bruker Q2 Earnings Beat, Revenues Miss EstimatesBruker posted second-quarter 2026 adjusted earnings of 49 cents per share, up 53.1% year over year. The figure beat the Zacks Consensus Estimate of 38 cents by 28.9%.
Quarterly revenues rose 5.2% to $838.5 million but missed the Zacks Consensus Estimate of $853.57 million by 2.2%.
BSI Bookings Signal Better DemandBSI revenues increased 4.7% year over year to $767.3 million, with organic growth of 2.3%. The segment’s order book rose 10% organically, driven by more than 50% growth in semiconductor orders and more than 20% growth in biopharma bookings.
Segment Mix Favors CALID and BESTBioSpin revenues edged up 0.2% year over year to $195.7 million. CALID revenues rose 8.6% to $310.3 million, while Nano revenues increased 3.6% to $261.3 million.
BEST revenues climbed 11.9% to $74.2 million, with organic growth of 8.9%, net of intercompany eliminations.
Margins Expand on Cost ActionsAdjusted gross margin expanded 350 basis points year over year to 52.1%. Non-GAAP operating margin widened 510 bps to 14.1%, with adjusted operating income rising 64.6% to $118.5 million.
Bruker delivered about $30 million of cost savings in the quarter and remains on track for more than $140 million of annualized savings in 2026. GAAP results included a $134.9 million non-cash goodwill impairment charge, contributing to a GAAP operating loss of $65.3 million.
Bruker Updates 2026 OutlookBruker now expects 2026 revenues of $3.54-$3.57 billion, representing 3%-4% reported growth. Organic growth remains projected at 1%-2%, while the foreign-currency tailwind is now expected at 0.5%, down from 1.5%.
Adjusted earnings guidance remains $2.10-$2.15 per share, implying 15%-17% growth. The company still targets 250-300 bps of adjusted operating margin expansion. For the third quarter, management expects organic revenue to be roughly flat to slightly higher, with about $20 million of semiconductor revenue shifting into the fourth quarter.
How Have Estimates Been Moving Since Then?It turns out, fresh estimates have trended downward during the past month.
The consensus estimate has shifted -24.1% due to these changes.
VGM ScoresCurrently, Bruker has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. Charting a somewhat similar path, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Bruker has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
ATI zvýšila výhled pro rok 2026 na upravenou EBITDA, zisk i volný cash flow díky silné poptávce v letectví a obraně. Ve 2. čtvrtletí tržby v tomto segmentu vzrostly o 13 % a backlog vzrostl o 18 % na rekordních 4,4 miliardy USD.
Key Takeaways ATI raised 2026 adjusted EBITDA, earnings and free cash flow guidance amid strong demand.Aerospace and defense Q2 sales rose 13%, while ATI's backlog climbed 18% to a record $4.4 billion.ATI's Q2 adjusted EBITDA jumped 37% as margins expanded 440 basis points to 22.6%. ATI Inc. (ATI - Free Report) is benefiting from investments in capacity expansion coupled with consistent demand growth in its key sectors. A raised outlook and margin expansion also boost investors’ confidence.
We are positive about ATI’s prospects and believe that the time is right for you to add the stock to the portfolio, as it looks promising and is poised to carry the momentum ahead.
Let's see what makes ATI stock an attractive investment option at the moment.
Positive Analyst Sentiment for ATI StockEarnings estimates for ATI have been going up over the past 60 days. The Zacks Consensus Estimate for 2026 has increased by 10.3%. The consensus estimate for 2027 has also been revised 10.8% upward over the same time frame. The favorable estimate revisions instill investor confidence in the stock.
The Zacks Consensus Estimate for ATI’s 2026 earnings is pegged at $4.84, suggesting a 49.4% increase from the previous year’s tally. Earnings are projected to increase by 22.7% in 2027.
Image Source: Zacks Investment Research
ATI’s Impressive Earnings Surprise HistoryATI has outpaced the Zacks Consensus Estimate in each of the trailing four quarters. In this time frame, it has delivered an earnings surprise of roughly 12.7%, on average.
ATI’s Superior Return on Equity (ROE)ROE is a measure of a company’s efficiency in utilizing shareholders’ funds. ROE for the trailing 12-months for ATI is 29.3%, above the industry’s level of 15.4%.
Image Source: Zacks Investment Research
Upbeat OutlookFor full-year 2026, ATI raised adjusted EBITDA guidance to $1.14-$1.2 billion from its previous outlook of $1.01-$1.06 billion. Adjusted earnings guidance was increased to $4.9-$5.18 per share from $4.2-$4.48 previously. The company also lifted its full-year adjusted free cash flow forecast to $550-$600 million from the earlier range of $465-$525 million. Management expects targeted investments and operational execution to increase available capacity as demand for aerospace and defense materials remains strong.
An OutperformerATI’s shares have gained 161.4% compared with the industry’s rise of 0.5% in the past year.
Image Source: Zacks Investment Research
Aerospace and Defense Strength Fuels GrowthATI continues to benefit from robust aerospace and defense demand, providing strong multi-year growth visibility. In the second quarter of 2026, aerospace and defense sales rose 13% year over year, while backlog reached a record $4.4 billion, up 18%. Jet-engine revenue increased 13%, with management expecting high-teens full-year growth.
Defense revenue surged 36% to a record high, supported by a renewed naval nuclear agreement through 2030 that is expected to more than double annual revenue versus the prior contract. ATI also expects mid- to high-single-digit airframe growth in 2026. ATI's content on next-generation engines is more than double that of legacy platforms, positioning the company to benefit from a higher number of newer aircraft platforms.
Margin Expansion and Capacity Investments Add UpsideATI's operational transformation is strengthening profitability. Second-quarter adjusted EBITDA jumped 37% year over year to $284.4 million, while margin expanded 440 basis points to 22.6%. The elevATIon program has increased throughput, while targeted titanium and nickel investments are expected to raise nickel capacity by 15-20% by early 2028 and support approximately $350 million of incremental annual nickel-based revenue. These initiatives, combined with a loyal customer base, position ATI for sustained earnings growth.
ATI’s Zacks Rank & Other Key PicksATI currently sports a Zacks Rank #1 (Strong Buy).
Some other top-ranked stocks in the Basic Materials space are Neo Performance Materials Inc. (NOPMF - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avient Corporation (AVNT - Free Report) .
While NOPMF currently sports a Zacks Rank #1, CRS and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for NOPMF’s 2026 earnings is pinned at $1.4 per share, indicating a 185.71% year-over-year increase. NOPMF’sshares have gained 89.6% over the past year.
The Zacks Consensus Estimate for CRS’ fiscal 2027 earnings is pegged at $12.92 per share, indicating a rise of 20.07% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.39%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’sshares have gained 16.9% over the past year.
It has been about a month since the last earnings report for Toast (TOST - Free Report) . Shares have lost about 2.2% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Toast due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Toast Q2 Earnings Beat on ARR and Location Growth, Outlook RaisedToast reported second-quarter 2026 earnings of 34 cents per share, beating the Zacks Consensus Estimate of 32 cents. Revenues rose 23.1% year over year to $1.91 billion and beat the consensus mark by $35.08 million, a 1.9% surprise.
Growth was led by subscription and financial technology solutions, supported by a larger location base and continued product adoption. Annualized recurring run-rate increased 25% to $2.41 billion, while Toast added a record 9,500 net locations.
Toast's Revenue Streams Deliver Broad-Based GrowthSubscription services revenues increased 27.8% year over year to $290 million. Financial technology solutions revenues rose 23% to $1.57 billion, while hardware and professional services revenues increased 2.1% to $48 million.
GAAP subscription and financial technology solutions gross profit advanced 30.9% to $585 million. On a non-GAAP basis, these recurring gross profit streams increased 28.2% to $595 million, reflecting growth in both software and payments economics.
Toast Expands Locations and Payment VolumeTotal locations increased 22% year over year to approximately 180,000. Gross Payment Volume rose 22% to $60.7 billion, while GPV per location was flat. Management noted better-than-expected core GPV, helped by strong same-store sales trends and a modest World Cup benefit late in June.
SaaS ARR increased 27%, while payments ARR grew 23%. Total take rate reached 98 basis points, up 5 basis points year over year. Non-payments fintech solutions, led by Toast Capital, generated $57 million of gross profit and contributed 9 basis points to take rate.
Toast Advances AI and New Market ExpansionToast IQ Grow, the company's digital marketing agent, is on track to become its fastest-growing product to $10 million in ARR. Management said early adoption has been strong, with the product already operating at positive margins and showing improving gross margins as it scales.
The company is also investing across enterprise, international and retail markets. ARR from these new total addressable markets is expected to nearly double to $200 million in 2026. Recent developments include Toast becoming an endorsed food and beverage vendor for Best Western, expanding its TGI Fridays relationship in the U.K. and launching initial fuel-payment deployments.
Toast Delivers Margin Gains Despite Higher InvestmentAdjusted EBITDA increased 38% year over year to $221 million, and the margin expanded 240 basis points to 37%.
Sales and marketing expenses rose 22% on a non-GAAP basis as Toast added capacity across its core business and new markets. Research and development expenses increased 23%, reflecting investment in agentic AI, vertical-specific products and internal AI tools aimed at improving productivity.
Toast Maintains Liquidity While Repurchasing SharesFree cash flow totaled $130 million, down from $208 million a year earlier, mainly because Toast chose to hold more hardware inventory. Net cash provided by operating activities was $144 million compared with $223 million in the prior-year quarter.
Cash and cash equivalents plus marketable securities totaled $1.71 billion as of June 30. Toast repurchased more than 19 million shares for $486 million through the first half of 2026, leaving approximately $100 million under its authorization.
Toast Raises Its 2026 OutlookFor the third quarter, Toast expects non-GAAP subscription services and financial technology solutions gross profit of $615-$625 million, representing 22%-24% year-over-year growth. Adjusted EBITDA is projected at $210-$220 million.
For 2026, recurring gross profit guidance was raised to $2,325-$2,355 million, implying 23%-25% growth compared with the prior 21%-23% outlook. Adjusted EBITDA guidance increased to $805-$825 million from $790-$810 million.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates review.
VGM ScoresCurrently, Toast has a strong Growth Score of A, a score with the same score on the momentum front. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Toast has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
It has been about a month since the last earnings report for BellRing Brands (BRBR - Free Report) . Shares have lost about 15% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is BellRing Brands due for a breakout? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for BellRing Brands Inc. before we dive into how investors and analysts have reacted as of late.
BellRing Brands Q3 Earnings Miss Estimates, Net Sales Increase Y/YBellRing Brands reported third-quarter fiscal 2026 results wherein earnings declined year over year and missed the Zacks Consensus Estimate. However, revenues increased year over year and came ahead of the consensus mark.
The company posted adjusted earnings of 30 cents per share for the third quarter of fiscal 2026, down 45.5% from 55 cents in the prior-year quarter. The figure missed the Zacks Consensus Estimate of 37 cents.
Net sales increased 4.2% to $570.4 million from $547.5 million in the year-ago quarter and exceeded the Zacks Consensus Estimate of $562 million. Higher Premier Protein shake volume, driven by distribution gains and robust Dymatize sales growth, supported revenues, while significant input cost inflation, including tariffs, higher freight expenses and inventory-related charges, weighed on profitability.
Premier Protein net sales increased 0.7% year over year. Volume rose 1.5%, while price/mix declined 0.8%, reflecting incremental promotional investments. Premier Protein ready-to-drink (RTD) shake sales increased 1.2% from the prior-year quarter. Volume grew 3.1%, whereas price/mix declined 1.9%. Premier Protein RTD consumption increased 6% year over year. Premier Protein RTD consumption rose 50.9% in e-commerce, 26.1% in food and 10.1% in mass channels, while club consumption declined 7.6%.
Dymatize net sales climbed 26.7% year over year. Volume increased 6%, while price/mix improved 20.7%, reflecting pricing actions implemented to offset inflationary costs and distribution gains in international markets. Dymatize consumption increased 2.7% from the year-ago period. By channel, e-commerce sales increased 18%, while mass sales declined 11.9%, specialty and all other sales fell 3.9%, food sales decreased 12.2%, and club sales dropped 53%.
BRBR's Margin & Cost PerformanceAdjusted gross profit declined 17.9% to $157.9 million from $192.4 million in the prior-year quarter. Adjusted gross margin contracted 740 basis points to 27.7% from 35.1%. The decline reflected significant input cost inflation, including tariffs, higher freight expenses and a $10 million charge related to excess shake bottle inventory. The inventory charge reduced adjusted gross margin by 180 basis points. Selling, general and administrative expenses declined 35.2% to $93.7 million from $144.5 million, including reorganization charges of $5.4 million. As a percentage of sales, SG&A improved to 16.4% from 26.4%.
Adjusted EBITDA decreased 34.9% to $78.3 million from $120.3 million a year earlier. Management said that the excess shake bottle inventory charge and higher-than-expected freight costs were the primary reasons adjusted EBITDA came in below internal expectations. Operating profit increased 46% to $65.4 million from $44.8 million, as lower reported SG&A expenses more than offset the decline in gross profit.
BRBR's Other Financial InformationCash and cash equivalents totaled $50.4 million as of June 30, 2026, compared with $71.8 million as of Sept. 30, 2025. Inventories increased to $480.6 million from $330.4 million, while long-term debt rose to $1,135.3 million from $1,084.3 million over the same period. Operating cash flow for the first nine months of fiscal 2026 declined to $65 million from $91.5 million in the comparable prior-year period. During the first nine months of fiscal 2026, BellRing repurchased 4.9 million shares for $133.1 million. As of June 30, 2026, the company had $506.9 million remaining under its existing share repurchase authorization.
BellRing’s OutlookFor the fourth quarter of fiscal 2026, BellRing expects net sales to be flat at the midpoint of its outlook. Premier is anticipated to post low-single-digit sales growth, including an approximate 100-basis-point headwind from powders. The company also projects double-digit growth in RTD shake volumes, with the benefit expected to be largely offset by weaker price/mix stemming from elevated promotional activity across the club, mass and e-commerce channels.
BellRing forecasts an adjusted EBITDA margin of approximately 10% for the fourth quarter. The margin outlook reflects the impact of seasonal promotional spending, continued commodity and freight cost inflation ahead of planned pricing actions, as well as initiatives to reduce excess shake bottle inventory, which are expected to lower the quarterly adjusted EBITDA margin by roughly 100 basis points.
For fiscal 2026, BellRing increased its net sales outlook to $2.335-$2.375 billion, representing 1-3% year-over-year growth compared with its earlier expectation of flat to 2% growth.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -41.34% due to these changes.
VGM ScoresCurrently, BellRing Brands has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, BellRing Brands has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerBellRing Brands is part of the Zacks Food - Miscellaneous industry. Over the past month, Medifast (MED - Free Report) , a stock from the same industry, has gained 3.2%. The company reported its results for the quarter ended June 2026 more than a month ago.
Medifast reported revenues of $76.38 million in the last reported quarter, representing a year-over-year change of -27.6%. EPS of -$0.28 for the same period compares with $0.04 a year ago.
Medifast is expected to post a loss of $0.40 per share for the current quarter, representing a year-over-year change of -90.5%. Over the last 30 days, the Zacks Consensus Estimate has changed +33.3%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #2 (Buy) for Medifast. Also, the stock has a VGM Score of D.
Teledyne těží z oživení komerční letecké dopravy, které podporuje poptávku po avionice i aftermarketu. Ve 2. čtvrtletí 2026 rostly aftermarketové tržby a OEM objednávky zůstaly silné.
Key Takeaways Teledyne is benefiting from recovering air travel and demand for avionics and ground-based applications.Strong aircraft orderbooks and higher fleet utilization support Teledyne's OEM and aftermarket demand.Teledyne's commercial aerospace aftermarket sales grew in Q2 2026, while OEM orders remained strong. Teledyne Technologies (TDY - Free Report) is benefiting from the steady recovery in commercial air travel, which is supporting demand for its onboard avionics systems and ground-based applications for commercial aircraft. The company is well-positioned to benefit from both strong aircraft manufacturer orderbooks and resilient aftermarket demand.
According to the International Air Transport Association’s (IATA) June 2026 outlook, global air travel demand is expected to increase 2.1% in 2026, measured in Revenue Passenger Kilometers. Rising demand is encouraging airlines to increase aircraft orders from manufacturers such as Boeing and Airbus. However, aircraft production remains below demand, resulting in higher aircraft utilization and supporting a strong aftermarket for components supplied by Teledyne.
Teledyne is positioned to benefit from favorable trends across both the original equipment and aftermarket markets. Strong aircraft manufacturer orderbooks, combined with increased utilization of existing fleet, should support demand for the company’s aerospace products and services in the coming quarters. The continued recovery in commercial air travel is also expected to provide a favorable backdrop for the company’s Aerospace and Defense segment.
During the second quarter of 2026, Teledyne faced tougher year-over-year comparisons. However, commercial aerospace aftermarket sales continued to grow, while OEM orders for aircraft deliveries in 2026 remained strong. These trends highlight sustained demand across both channels.
With improving air travel demand, robust aircraft orderbooks and healthy aftermarket activity, Teledyne remains well-positioned to capitalize on the commercial aerospace recovery and support growth in its Aerospace and Defense segment in the ensuing quarters.
Aerospace Stocks to Keep on the Radar
Other aerospace companies benefiting from the recovery in commercial aviation and healthy aftermarket demand are discussed below:
TransDigm Group (TDG - Free Report) : TransDigm is benefiting from strong commercial aftermarket demand for its highly engineered aerospace components. Commercial aftermarket revenues increased approximately 17% year over year in the third quarter of fiscal 2026, supported by strength across commercial transport markets.
RTX Corporation (RTX - Free Report) : Through its Pratt & Whitney and Collins Aerospace businesses, RTX provides aircraft engines, avionics, components and aftermarket services. Rising aircraft utilization and continued demand for maintenance and replacement parts should support its commercial aerospace aftermarket business.
The Zacks Rundown for TDY
Shares of TDY have gained 10.9% in the past year compared with the industry’s 0.5% growth.
Image Source: Zacks Investment Research
The company shares are trading at a discount on a relative basis, with its forward 12-month Price/Sales being 4.11X compared with its industry’s average of 7.50X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for TDY’s 2026 and 2027 earnings has moved north over the past 60 days.
Image Source: Zacks Investment Research
TDY stock currently carries a Zacks Rank #2 (Buy).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Toro (TTC) oznámila zisk 1,33 USD na akcii a tržby 1,23 miliardy USD, obojí nad odhady. Zisk vzrostl z 1,24 USD na akcii a tržby z 1,13 miliardy USD před rokem.
Toro (TTC - Free Report) came out with quarterly earnings of $1.33 per share, beating the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $1.24 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +2.31%. A quarter ago, it was expected that this landscaping, maintenance and irrigation equipment maker would post earnings of $1.5 per share when it actually produced earnings of $1.6, delivering a surprise of +6.67%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Toro, which belongs to the Zacks Tools - Handheld industry, posted revenues of $1.23 billion for the quarter ended July 2026, surpassing the Zacks Consensus Estimate by 3.05%. This compares to year-ago revenues of $1.13 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Toro shares have added about 26% since the beginning of the year versus the S&P 500's gain of 12%.
What's Next for Toro?While Toro has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Toro was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.97 on $1.12 billion in revenues for the coming quarter and $4.60 on $4.77 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Tools - Handheld is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the broader Zacks Consumer Discretionary sector, Caleres Inc. (CAL - Free Report) , has yet to report results for the quarter ended July 2026. The results are expected to be released on September 9.
This footwear wholesaler and retailer is expected to post quarterly earnings of $0.37 per share in its upcoming report, which represents a year-over-year change of +5.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Caleres Inc.'s revenues are expected to be $702.5 million, up 6.7% from the year-ago quarter.
The Villages Health souhlasila se smírem na 541,5 milionu USD kvůli údajnému falešnému kódování diagnóz pro Medicare Advantage v letech 2020 až 2024. Péče v The Villages pokračuje pod CenterWell.
A retirement community's top health provider quietly told the government it had been overbilling Medicare for years, then filed for bankruptcy before the consequences arrived. What happened next reshaped who owns the clinics, who absorbs the loss, and what federal…
The Justice Department’s late August 2026 announcement of a $541.5 million settlement with The Villages Health was framed around the coding period, but the sharpest number in the record came from the company’s own file, according to Healthcare Dive. According to Healthcare Dive, by 2024 about half of the primary care provider’s patient diagnosis codes were unsupported, based on an outside consultant’s review. The provider serves the largest retirement community in the United States. Its coding book, by that measure, had come untethered from its patients’ actual medical conditions.
What the Coding Allegedly Was The U.S. Department of Justice alleges that from 2020 to 2024, the company submitted false diagnosis codes for Medicare Advantage patients to increase its reimbursement in the privatized Medicare program. Per the settlement, the company altered patient medical records and inserted additional diagnosis codes, in some cases years after the visit occurred. Unsupported codes included severe obesity, blood defects and immunodeficiency, submitted to Humana (NYSE:HUM | HUM Price Prediction), UnitedHealthcare and Blue Cross Blue Shield of Florida.
Medicare Advantage plans receive a fixed monthly payment per enrollee, adjusted by that person’s diagnoses. A sicker-looking chart produces a larger check. That is the incentive upcoding exploits. The claims resolved are allegations, and there has been no determination of liability.
Timeline: Self-Report to Sale Per Healthcare Dive, The Villages Health identified and notified the government of its overbilling at the end of 2024, sizing its own bill. It then filed for Chapter 11 bankruptcy in the summer of 2025. Humana’s CenterWell division agreed to acquire the operating business in July 2025, according to Healthcare Dive. That stalking-horse bid set off an auction. A bankruptcy court approved the winning bid in the fall of 2025, with the purchase price rising to $68 million, and the deal closed in late 2025, according to Healthcare Dive. CenterWell added eight primary care centers and two specialty care centers to its network, according to Healthcare Dive. The acquisition price and the settlement figure sit on the same page: $68 million and $541.5 million.
How the Settlement Actually Works The settlement is against the pre-sale legal entity, The Villages Health System LLC, still in bankruptcy. Rather than a direct or immediate payment by CenterWell or Humana, the federal government receives an allowed, nondischargeable claim against the bankruptcy estate, to be resolved in the ongoing Chapter 11 process alongside other creditors. The insurers that received the inflated payments are returning those overpayments to the government, with those amounts credited against the total. The company received cooperation credit for self-disclosing through the federal healthcare fraud reporting portal, which is a substantial reason the figure is not higher.
A National Enforcement Pattern Emerges The same month, the Justice Department resolved two other Medicare Advantage upcoding matters: one with Monogram Health, and one with Complete Health, a value-based primary care operator active in three states. Risk-adjustment integrity has become a live enforcement lane. MedPAC has warned in its January 2026 work that upcoding continues to inflate what Medicare Advantage costs the trust fund relative to traditional Medicare.
What It Means for Patients Care in The Villages was not interrupted. The centers remain open under CenterWell ownership, staffed by the same clinicians patients already knew. The bill lands elsewhere: on the Medicare trust fund, which is to say on taxpayers and on the beneficiaries who fund and draw from it. That is the constituency this settlement was written to make whole.
Contact [email protected] for any questions or corrections.
Ciena vykázala rekordní čtvrtletí s EPS 2,11 USD a tržbami 1,67 miliardy USD, ale akcie klesly o 10 % po výhledu tržeb na 1,75 miliardy USD ± 50 milionů ve 4. čtvrtletí fiskálního roku, což bylo v souladu s očekáváním.
Ciena just posted a record quarter with earnings well above estimates, yet its stock cratered 10% while networking peers Arista and Cisco held firm or climbed. The divergence points to a specific pressure point that separates Ciena's story from the…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Ciena Corporation‘s (NYSE:CIEN | CIEN Price Prediction) fiscal third-quarter beat wasn’t enough to save its stock this morning. An in-line fourth-quarter revenue outlook overshadowed record results and sparked a sharp de-rating in a name that had rallied hard on the AI networking build. Interestingly, Ciena’s peer-group stocks are holding firm, which makes the divergence the story of the session.
Ciena stock is down 10% to $320.38, cutting into a year that had shares up 51% through the prior close. The pullback extends a rough stretch, with Ciena now down 18% over the past month. Today’s move deepens a de-rating already in progress.
Meanwhile, Arista Networks (NYSE:ANET) stock is up 3% to $191.65, isolating Ciena’s specific guidance issue from the broader networking demand story. Meanwhile, Cisco Systems (NASDAQ:CSCO) stock is down 0.1% to $109.31. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY), which tracks the S&P 500 index, is up 1% to $773.17, and the iShares U.S. Technology ETF (NYSEARCA:IYW) is trading higher, so Ciena’s slide isn’t a broad-tape problem.
Guidance Reset Overshadows Record Quarter Ciena reported adjusted earnings per share of $2.11 for the quarter ended August 1, 2026, against a $1.72 analyst consensus, with revenue of $1.67 billion versus a $1.63 billion estimate, up 37% from $1.22 billion a year earlier. Ciena’s adjusted gross margin expanded to 46.4% from 41.9% in the prior-year period, a clean quality print behind the top-line acceleration. Ciena CEO Gary Smith stated, “Today’s outstanding financial performance demonstrates Ciena’s leadership in providing industry-leading, high-speed connectivity solutions as AI continues to drive compounding waves of network investment.”
The problem sits in the forward number. Ciena guided its fiscal fourth-quarter revenue to $1.75 billion plus or minus $50 million, a midpoint that only aligns with the $1.7 billion analyst consensus rather than clearing it. Ciena also raised its full fiscal year 2026 revenue guidance to $6.42 billion, up 35% year over year at the midpoint, but for a stock priced for acceleration, matching isn’t beating, according to Ciena Corporation.
Networking Peers Diverge as Concentration Risk Bites Two Ciena customers together accounted for 41.7% of quarterly revenue, meaning the AI-driven demand is real but narrow, according to Ciena Corporation. Ciena CFO Marc Graff called the period a record quarter, yet that concentration weighs heavier on the Ciena multiple when the forward guide only matches expectations. That mix is what powered today’s de-rating.
Arista Networks stock was up 42% year to date (YTD) through the prior close and is extending gains today on continued AI fabric momentum. Arista posted Q2 FY2026 non-GAAP EPS of $1.02 on $3.04 billion in revenue in its August report, its first three-billion-dollar quarter. Management pointed to Ethernet-based AI networking as a durable share opportunity, with a full-year revenue outlook of approximately $12.6 billion.
Cisco stock was up 44% year to date through the prior close after booking $4 billion in AI infrastructure orders in Q4 FY2026 and guiding fiscal 2027 AI infrastructure revenue to $7.5 billion. Cisco characterized the environment as a networking supercycle. Arista Networks and Cisco holding firm while Ciena resets is the cleanest evidence that this is a company-level issue, not a sector verdict.
Scorecard The table sets today’s session move against the YTD anchor through the prior close for each covered name. Ciena’s reset stands out against modest peer gains.
Name Session Move YTD Through Prior Close Ciena down 10% up 51% Arista Networks up 3% up 42% Cisco Systems down 0.1% up 44% What to Watch Next Ciena’s preliminary fiscal 2027 outlook calls for at least 30% revenue growth on a backlog of $8.5 billion exiting Q3 FY2026, so the December fourth-quarter report becomes the next real inflection point for the stock. Management framed the environment as a multi-year, supply-constrained investment cycle. That keeps the debate about pace and share rather than direction.
Position sizing in Ciena shares should account for both the customer concentration and the tendency of supply-constrained networking names to trade on incremental order signals rather than trailing beats. A moderate approach makes sense while the guide-versus-consensus gap sorts out. Ciena’s elevated valuation raises the bar for any forward number, and today’s tape shows what happens when it isn’t cleared.
The broader read is that AI networking demand remains intact, with Arista Networks and Cisco both carrying rich YTD gains. Follow-through in those two names during the afternoon session may indicate whether today’s Ciena move stays contained or spreads to peers. Ultimately, the IYW ETF trading higher today reinforces the containment case rather than a sector-wide unwind.
Contact [email protected] for any questions or corrections.
It has been about a month since the last earnings report for Teradata (TDC - Free Report) . Shares have added about 7.7% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Teradata due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Teradata Corporation before we dive into how investors and analysts have reacted as of late.
Teradata Q2 Earnings Surpass Estimates, Revenues Increase Y/YTeradata Corporation reported second-quarter 2026 non-GAAP earnings of 69 cents per share, up 46.8% year over year. The figure surpassed the Zacks Consensus Estimate by 25.46%.
Revenues of $410 million increased 0.5% from the year-ago quarter and beat the consensus by 2.91%. Total annual recurring revenues (ARR) increased 1% as reported and 2% in constant currency to $1.509 billion.
TDC Builds Cloud & Subscription MomentumPublic cloud ARR advanced 8% year over year as reported and 9% in constant currency to $686 million. Cloud represented 45% of total ARR at quarter-end compared with 43% in the year-ago period.
Subscription ARR reached $750 million, down from $756 million a year earlier but above $729 million in the first quarter. Maintenance and software upgrade rights ARR declined to $73 million from $99 million.
TDC Q2 Top Line in DetailRecurring revenues reached $363 million, up 3% as reported and 2% in constant currency and represented 89% of total revenues. Product sales rose 4% year over year and 3% in constant currency to $371 million.
Perpetual software license, hardware and other revenues, accounting for 2% of total revenues, surged 167% year over year and 313% in constant currency to $8 million.
Consulting services revenues, representing 9.5% of total revenues, fell 24% year over year and 23% in constant currency to $39 million.
TDC's Operating DetailsNon-GAAP gross margin expanded 220 basis points year over year to 60.5%, helped by a higher recurring-revenue mix. Recurring revenue gross margin improved 30 basis points to 67.8%, partly reflecting continued progress in cloud gross margin.
Non-GAAP selling, general and administrative expenses declined 8.4% year over year to $98 million. Research and development expenses fell 3.1% to $62 million.
Non-GAAP operating margin improved to 21.5% from 16.4%, reflecting higher gross margin and a more optimized cost structure.
Teradata Pushes Deeper Into Agentic AIThe company launched the Teradata Autonomous Knowledge Platform during the quarter and brought major components, including AI Studio, to general availability early in the third quarter. The platform combines cloud, on-premise and hybrid deployment options with governed data, AI tools and agent capabilities.
Teradata also introduced Teradata Factory, a Dell-built on-premise system with integrated CPUs and GPUs for private AI workloads. Management highlighted early customer orders and interest, particularly among regulated organizations and customers with data sovereignty requirements. The partnership gives TDC access to Dell’s technology and go-to-market reach.
TDC’s Balance Sheet Remains StrongAs of June 30, 2026, Teradata had cash and cash equivalents of $414 million compared with $493 million as of Dec. 31, 2025. The company ended the quarter with net cash of $323 million after paying off the $450 million balance on its term loan.
Teradata generated $106 million in cash flow from operations during the quarter, up from $43 million in the year-ago period. Free cash flow increased to $105 million from $39 million, while adjusted free cash flow rose to $127 million from $39 million.
The company also repurchased approximately 1.3 million shares for $40 million during the quarter. Management continues to target the return of at least 50% of adjusted free cash flow through share repurchases.
TDC Provides Q3 & 2026 OutlookFor the third quarter of 2026, Teradata expects non-GAAP earnings of 55-59 cents per share. Total revenues are projected to decline 6% to 4% year over year, while recurring revenues are expected to decrease 4% to 2%. Management attributed the second-half revenue pattern to the timing of upfront revenue recognition from on-premises subscriptions during the first half.
For 2026, Teradata guided its non-GAAP earnings outlook to $2.65-$2.73 per share and adjusted free cash flow forecast to $330-$350 million. Cash flow from operations is expected to be between $665 million and $685 million, including an after-tax net benefit of $315 million from the SAP settlement.
The company reaffirmed its forecast for total ARR growth of 2-4% year over year, recurring revenue growth of flat to 2%, and total revenue performance ranging from a 2% decline to flat.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates review.
The consensus estimate has shifted -13.49% due to these changes.
VGM ScoresCurrently, Teradata has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a score of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Teradata has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
A month has gone by since the last earnings report for Paylocity (PCTY - Free Report) . Shares have added about 4.6% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Paylocity due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Paylocity Holding Corporation before we dive into how investors and analysts have reacted as of late.
Paylocity Q4 Earnings Beat Estimates, Revenues Increase Y/YPaylocity reported fourth-quarter fiscal 2026 non-GAAP net income of $1.84 per share, which increased 17.9% year over year and beat the Zacks Consensus Estimate by 19.48%.
Total revenues increased 11% year over year to $444.7 million and surpassed the Zacks Consensus Estimate by 3.18%.
Top-line growth was driven by the 12.4% increase in recurring and other revenues (roughly 93% of total revenues) to $415.6 million. Interest income on funds held for clients (about 7% of total revenues) declined 5.6% year over year to $29.1 million.
Quarterly Details of PCTYPaylocity's adjusted gross profit was $327.5 million, up 10.4% from the year-ago period, though the adjusted gross margin contracted roughly 40 basis points (bps) to 73.6%. Non-GAAP operating income rose 13.8% year over year to $120.2 million, with the non-GAAP operating margin expanding about 70 bps to 27%.
Adjusted EBITDA increased 11.3% from the year-ago quarter to $145.5 million, with the adjusted EBITDA margin up roughly 10 bps to 32.7%. Adjusted EBITDA excluding interest income on funds held for clients rose 16.5% year over year to $116.4 million, with margin (as a percentage of recurring and other revenues) up roughly 100 bps to 28%.
GAAP net income for the quarter was $60.3 million, or $1.12 per share, up 24.1% and 30.2%, respectively, from $48.6 million, or 86 cents per share, in the year-ago quarter.
Balance Sheet & Cash Flow DetailsAs of June 30, 2026, Paylocity's cash and cash equivalents were $271.9 million, down from $299.7 million as of March 31, 2026.
Long-term debt totaled $81.3 million as of the end of fiscal 2026, down 50% from $162.5 million a year earlier, reflecting repayment of approximately $81.3 million on the outstanding credit facility balance (originally drawn to fund the October 2024 acquisition of Airbase Inc.) during fiscal 2026.
Net cash provided by operating activities for fiscal 2026 was $533.3 million (30.1% of total revenues), up 27.5% from $418.2 million (26.2% of total revenues) in fiscal 2025. Free cash flow rose 24.8% year over year to $427.8 million, or 24.2% of total revenues, compared with $342.8 million, or 21.5%, in fiscal 2025.
Paylocity repurchased $398.1 million, or approximately 2.8 million shares, of common stock during fiscal 2026, bringing cumulative repurchases since May 2024 to $697.8 million, or approximately 4.6 million shares. Approximately $1.3 billion remained available under the share repurchase authorization as of June 30, 2026.
Acquisitions & Product DevelopmentsIn April 2026, Paylocity completed the acquisition of Grayscale Labs, Inc., an AI-powered recruiting automation company, expanding its recruiting capabilities to help clients engage candidates earlier and move faster through hiring workflows.
The company also launched Paylocity Elevate Solutions, pairing its unified platform with dedicated payroll and HR experts to handle implementation, ongoing payroll processing and HR execution on clients' behalf, comprising Elevate Implementation, Elevate Payroll and Elevate HR.
The company also disclosed a change in accounting convention: beginning in fiscal 2027, deferred contract costs will be amortized over an eight-year useful life, up from seven years, a shift expected to lift fiscal 2027 adjusted EBITDA margins by approximately 120-140 bps.
Management also pointed to continued investment in its AI platform capabilities across HR, Finance and IT workflows as a key driver of the company's product strategy heading into fiscal 2027.
PCTY Issues Q1 & Fiscal 2027 GuidanceFor the first quarter of fiscal 2027, Paylocity expects total revenues in the range of $439.5-$444.5 million, indicating approximately 8% growth from the year-ago period. Recurring and other revenues are projected between $414 million and $419 million, implying approximately 10% growth.
Adjusted EBITDA is projected in the range of $152-$156 million, while adjusted EBITDA excluding interest income on funds held for clients is expected between $126.5 million and $130.5 million.
For fiscal 2027, Paylocity projects total revenues between $1.88 billion and $1.895 billion, implying approximately 7% growth over fiscal 2026. Recurring and other revenues are expected in the range of $1.777-$1.792 billion, suggesting approximately 8% growth.
Adjusted EBITDA is expected between $690 million and $700 million, while adjusted EBITDA excluding interest income on funds held for clients is projected between $587 million and $597 million.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates review.
The consensus estimate has shifted 15.39% due to these changes.
VGM ScoresCurrently, Paylocity has a average Growth Score of C, however its Momentum Score is doing a bit better with a B. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Paylocity has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerPaylocity is part of the Zacks Internet - Software industry. Over the past month, Snap (SNAP - Free Report) , a stock from the same industry, has gained 4.9%. The company reported its results for the quarter ended June 2026 more than a month ago.
Snap reported revenues of $1.6 billion in the last reported quarter, representing a year-over-year change of +18.9%. EPS of $0.06 for the same period compares with -$0.01 a year ago.
For the current quarter, Snap is expected to post earnings of $0.16 per share, indicating a change of +166.7% from the year-ago quarter. The Zacks Consensus Estimate has changed +50% over the last 30 days.
Snap has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of A.
A month has gone by since the last earnings report for Ametek (AME - Free Report) . Shares have lost about 8.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Ametek due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent catalysts for AMETEK, Inc. before we dive into how investors and analysts have reacted as of late.
AMETEK Q2 Earnings Surpass Expectations, Revenues Rise Y/YAMETEK, Inc. reported second-quarter 2026 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate.
AMETEK reported its second-quarter non-GAAP earnings of $2.09 per share, which beat the Zacks Consensus Estimate by 5%. The figure increased 17% year over year.
AMETEK’s top line of $2.04 billion surpassed the Zacks Consensus Estimate by 4.5%. The figure increased 15% year over year.
The company experienced an increase in sales in its largest EIG segment, along with a year-over-year improvement in the EMG segment.
AMETEK’s Q2 2026 DetailsEIG sales (64.6% of total revenues) in the second quarter were $1.32 billion, up 14% from the year-ago quarter’s reported figure. Our model estimate for EIG sales was pegged at $1.26 billion.
In the second quarter, revenues from EMG (35.4% of total revenues) were $723.2 million, up 17% from the year-ago quarter. Our model estimate for EMG sales was pegged at $688.6 million.
For the second quarter, adjusted operating income increased 18% year over year to $544.4 million. The operating margin expanded 60 basis points (bps) from the year-ago quarter.
EIG's second-quarter adjusted operating income was $384.7 million, up 12% year over year.
EMG’s adjusted operating income in the quarter increased 32% to $190.5 million.
AME’s Balance Sheet DetailsAs of June 30, 2026, AME had cash and cash equivalents of $495.4 million compared with the previous quarter’s $481.25 million.
As of June 30, 2026, AME’s long-term debt was $1.056 billion, down marginally from the previous quarter’s $1.062 billion.
AME Raises Guidance for 2026For 2026, AME expects overall sales to increase 10% year over year, up from the prior guidance of overall sales to be up in the high single digits. The company expects its adjusted earnings per share to be in the range of $8.20-$8.30, indicating an increase of 10% to 12% year over year, up from its prior guidance of $7.94-$8.14.
For the third quarter of 2026, the company expects overall sales to be up in the high single digits compared with the same period last year. Adjusted earnings for the third quarter are expected to be in the range of $2.08-$2.10, indicating a year-over-year increase of 10-11%.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.
VGM ScoresCurrently, Ametek has a average Growth Score of C, however its Momentum Score is doing a lot better with an A. However, the stock has a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Ametek has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Par Pacific za poslední měsíc přidala 14,7 % po silných výsledcích za 2. čtvrtletí, kdy upravený zisk na akcii vyskočil na 10,10 USD a tržby na 2,97 miliardy USD.
It has been about a month since the last earnings report for Par Petroleum (PARR - Free Report) . Shares have added about 14.7% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Par Petroleum due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.
Par Pacific Beats on Q2 Earnings EstimatesPar Pacificreported second-quarter 2026 adjusted earnings of $10.10 per share, surging 555.8% from $1.54 a year ago. The figure beat the Zacks Consensus Estimate of $8.20 by 23.2%.
Quarterly revenues jumped 56.8% year over year to $2.97 billion and topped the consensus estimate of $2.48 billion by 19.9%.
The strong quarterly results were driven by strong refining economics and commercial execution as the refining adjusted gross margin reached $680.4 million despite total throughput declining 2.8% to 181.4 thousand barrels per day (Mbpd).
PARR's Refining Margins Power the QuarterThe Refining segment generated operating income of $629.9 million, up sharply from $81.3 million in the prior-year quarter. Segment adjusted EBITDA rose to $552 million from $108.4 million, underscoring the stronger margin environment across the refining system.
The adjusted gross margin per throughput barrel climbed to $41.22 from $13.65. The combined market index increased to $32.94 per barrel from $13.76, while production costs grew to $7.71 per barrel from $7.20.
Par Pacific's Hawaii Economics StrengthenThe Hawaii Index averaged $46.06 per barrel compared with $8.57 a year earlier. Hawaii throughput declined to 73.2 Mbpd from 88.1 Mbpd, but the refinery's adjusted gross margin expanded to $57 per barrel from $10.18.
The quarterly margin included a favorable net price lag impact of $76.5 million, or $11.49 per barrel, as lower June product prices benefited volumes sold using prior-period pricing. Production costs increased to $6.43 per barrel from $4.18. Management said that the Hawaii turnaround was substantially complete, with most processing units online.
PARR's Other Refineries Post Broad GainsMontana throughput increased to 52.7 Mbpd from 44.2 Mbpd. Its adjusted gross margin rose to $37.22 per barrel from $22.30, while production costs fell to $10.16 per barrel from $14.18.
Washington throughput was 41.2 Mbpd compared with 40.8 Mbpd, and adjusted gross margin advanced to $20.31 per barrel from $11.47. Wyoming throughput increased to 14.3 Mbpd from 13.5 Mbpd, while the adjusted gross margin reached $34.03 per barrel versus $18.57. Wyoming's results included a negative first-in, first-out (FIFO) inventory impact of $3.2 million, or $2.48 per barrel.
Par Pacific Retail Softens as Logistics HoldThe Retail segment reported operating income of $14.6 million, down from $20.8 million. Adjusted EBITDA declined to $17.3 million from $23.3 million, while fuel sales volume was nearly flat at 30.7 million gallons versus 30.8 million gallons.
Same-store fuel volumes decreased 0.8%, though inside sales revenues improved 1.0%. Logistics operating income slipped to $22.5 million from $23.7 million. The adjusted gross margin increased to $35.1 million from $34.4 million, while adjusted EBITDA remained steady at $29.8 million.
PARR Profitability Expands on Refining UpsideConsolidated adjusted EBITDA was $571.3 million compared with $137.8 million in the year-ago quarter. GAAP net income attributable to Par Pacific stockholders rose to $462.1 million, or $9.35 per diluted share, from $59.5 million, or $1.17 per share.
Operating income increased to $634.6 million from $96.8 million. Interest expenses and financing costs declined to $14.3 million from $22.1 million, though the quarter included $11.5 million in debt extinguishment and commitment costs, and $144 million in income tax expenses.
Par Pacific Ends Q2 With $1.4B in LiquidityNet cash provided by operations totaled $282.6 million, including working capital outflows of $312.2 million and deferred turnaround spending of $19.5 million. Excluding those items, the operating cash flow was $614.3 million. Investing activities used $39.7 million, while financing activities used $223 million.
Par Pacific ended June with $185 million in cash, gross term debt of $505.7 million, and net term debt of $320.7 million. Total liquidity stood at $1.4 billion. The company also completed a $500-million senior unsecured notes offering and reduced term debt by more than $130 million.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.
The consensus estimate has shifted -9.53% due to these changes.
VGM ScoresCurrently, Par Petroleum has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a D. However, the stock has a score of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions indicates a downward shift. It comes with little surprise Par Petroleum has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerPar Petroleum is part of the Zacks Oil and Gas - Refining and Marketing industry. Over the past month, Equinor (EQNR - Free Report) , a stock from the same industry, has gained 14.3%. The company reported its results for the quarter ended June 2026 more than a month ago.
Equinor reported revenues of $35.18 billion in the last reported quarter, representing a year-over-year change of +39.9%. EPS of $1.33 for the same period compares with $0.64 a year ago.
Equinor is expected to post earnings of $1.46 per share for the current quarter, representing a year-over-year change of +294.6%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Equinor. Also, the stock has a VGM Score of A.
Credo Technology Group vidí další růst AEC díky pěti hyperscalerům, většímu prosazení u zákazníků a zájmu neocloudových firem. Přechod na porty 1,6T s rychlostí 200 gigabitů na linku přidává další příležitost.
Key Takeaways Credo sees AEC growth supported by five hyperscalers, Neocloud traction and rising customer penetration.Credo views the shift to 200-gig-per-lane 1.6T ports as another growth opportunity for its AEC business.Neocloud expansion could diversify Credo's customer base. Credo Technology Group Holding Ltd. (CRDO - Free Report) continues to see a healthy growth runway for its Active Electrical Cables (AECs) business, supported by deeper penetration at hyperscalers, rising data rates and growing traction with Neocloud customers.
AECs are a system-level product for CRDO and its core growth engine. Credo believes its system-level approach, which combines silicon, firmware, manufacturing tests and qualification, remains a key differentiator.
The company now has deep relationships with five hyperscalers, alongside expanding engagement with Neocloud customers. Importantly, Credo continues to see higher AEC penetration within existing customers as deployments scale, while the shift toward 200-gig-per-lane 1.6T ports provides another growth opportunity.
The Neocloud opportunity could help diversify Credo’s customer base. Credo’s customer concentration, with its four largest customers accounting for 33%, 28%, 13% and 10% of first-quarter fiscal 2027 revenues, respectively. Management continues to expect three to four customers to contribute greater than 10% of revenues in the upcoming quarters.
Heavy reliance on a few hyperscalers can introduce volatility, particularly as customer mix can fluctuate from quarter to quarter.
Credo is actively working to reduce this reliance through a diversification strategy across hyperscalers, neo clouds and other customers. Neo cloud providers are emerging players in the AI infrastructure space. This set of cloud providers is heavily focused on building AI infrastructure to support a wide range of applications, from model development to inference AI and even Agentic AI workloads. This bodes well for CRDO’s AECs business.
Still, AEC growth rates are likely to moderate as the business scales. Management noted that AEC revenues more than doubled from fiscal 2024 to fiscal 2025 and more than tripled from fiscal 2025 to fiscal 2026. With optics ramping from a smaller base, that business is expected to grow faster.
However, Credo faces intense competition in the semiconductor industry from players such as Marvell Technology (MRVL - Free Report) and Broadcom (AVGO - Free Report) .
Mapping Competitive TerrainMarvell Technology reported second-quarter fiscal 2027 data center revenues of $2.17 billion, up 46% year over year and 18% sequentially. Tailwinds across interconnect, switching and custom businesses remain the key growth drivers. Connectivity demand for AI infrastructure is driving demand for interconnect and switching products, particularly scale-out applications. Marvell Technology expects copper and optical interconnects to coexist for several years, even as larger scale-up deployments increasingly migrate toward optics.
Management raised its fiscal 2027 revenue outlook to roughly $12 billion, up from the prior view of approximately $11.5 billion. Data center revenues are now expected to grow about 60% this year, up from 50% expected earlier. For fiscal 2028, Marvell Technology expects revenues of approximately $18 billion, representing roughly 50% year-over-year growth, with data-center revenues projected to increase more than 60%.
Broadcom represents significant competitive pressure given its broad AI networking footprint. Third-quarter fiscal 2026 AI semiconductor revenues grew 221% year-over-year and up 54% sequentially to $16.7 billion. The company highlighted increasing adoption of its custom accelerators (XPUs) across its six XPU customers. XPU shipments grew more than 3.5 times year on year and represented 73% of AI revenues. The company expects fiscal 2026 AI revenues of about $58 billion, up 186% year over year and approximately $115 billion in fiscal 2027. Broadcom further sees AI semiconductor revenues doubling again to roughly $230 billion in fiscal 2028.
Alongside custom accelerators, networking is expected to remain a major growth engine, with management expecting AI networking revenues to grow at a pace similar to XPUs over the next few years.
CRDO Price Performance, Valuation and EstimatesShares of CRDO are down 30.6% in the past month compared with the Electronics-Semiconductors industry’s decline of 8.1%.
Image Source: Zacks Investment Research
CRDO is trading at a forward 12-month price/earnings ratio of 24.03X, higher than the Electronics-Semiconductors sector’s multiple of 13.31X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CRDO earnings for fiscal 2027 has seen a marginal upward revision over the past 60 days.
Image Source: Zacks Investment Research
CRDO currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A month has gone by since the last earnings report for Mattel (MAT - Free Report) . Shares have added about 1.2% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Mattel due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Mattel Q2 Earnings Miss Estimates on Costs, Revenues Beat on VehiclesMattel reported second-quarter 2026 results, with adjusted earnings missing the Zacks Consensus Estimate but net sales surpassing the same. Revenues improved, while the bottom line declined sharply from the prior-year quarter.
The company posted adjusted earnings of 1 cent per share, down from 21 cents a year earlier. The figure missed the Zacks Consensus Estimate of 3 cents by 66.7%, as higher advertising, selling and administrative expenses and margin pressure weighed on profitability.
Net sales of $1.13 billion increased 10% year over year and surpassed the consensus mark of $1.08 billion by 4.2%. Growth was led by North America, Vehicles and the Action Figures, Building Sets, Games and Other category. Vehicles gross billings rose 11% in constant currency.
MAT’s Sales Rise on Broad Geographic GrowthNorth America net sales increased 12% year over year. International net sales advanced 9% as reported and 5% in constant currency, supporting broad-based top-line growth during the quarter.
Regional gross billings increased in North America, EMEA and Asia Pacific. North America gross billings rose 12% in constant currency to $613 million, while EMEA increased 7% to $363 million. Latin America was comparable at $165 million, and Asia Pacific advanced 4% to $126 million. Management believes U.S. retailer ordering patterns have now largely stabilized.
Mattel’s Vehicles and Games Drive Portfolio GainsWorldwide Vehicles gross billings increased 14% as reported and 11% in constant currency to $463 million, primarily driven by Hot Wheels. The company expects Hot Wheels to achieve its ninth consecutive record year, supported by demand from children and adult collectors.
Action Figures, Building Sets, Games and Other gross billings surged 35% as reported and 33% in constant currency to $358 million. Growth was reflected in Games, including the contribution from Mattel's 163 digital titles, and Action Figures tied to theatrical releases. Mattel Brick Shop also performed well during the quarter.
MAT’s Dolls and Preschool Categories Remain SoftDolls gross billings declined 5% as reported and 7% in constant currency to $318 million, primarily due to lower Barbie sales. Weakness in Barbie and Polly Pocket was partly offset by growth in K-Pop Demon Hunters and Disney Princess and Frozen products. Management expects Barbie to return to growth in 2027.
Infant, Toddler and Preschool gross billings fell 11% as reported and 13% in constant currency to $128 million, mainly reflecting a decline in Fisher-Price. However, Little People delivered high-double-digit growth, aided by new partnerships.
Mattel’s Margins Contract as Spending IncreasesAdjusted gross margin declined 260 basis points year over year to 48.6%. The contraction reflected the gross incremental cost of tariffs, inflation, higher royalties and unfavorable foreign exchange. Contributions from Mattel163, tariff-mitigation efforts and cost savings provided partial offsets.
Advertising expenses increased $45.2 million to $124.3 million, reflecting Mattel163, marketing and engagement activities and strategic investments. Adjusted selling and administrative expenses rose 11% to $383.6 million. Consequently, adjusted operating income declined 60% to $38.8 million, while adjusted EBITDA fell to $95.5 million from $170 million.
MAT’s Cash Position Falls as Buybacks ContinueFor the first six months of 2026, cash flows used for operating activities were $202.1 million, compared with $275.3 million a year earlier. The improvement reflected more favorable working-capital usage, partly offset by lower net income excluding noncash items.
Mattel ended the quarter with $523.9 million in cash and equivalents, $829.8 million in inventories and $2.33 billion in long-term debt. The company repurchased $100 million of shares during the quarter, bringing the year-to-date total to $300 million.
Mattel Reaffirms 2026 Earnings & Sales OutlookManagement reaffirmed its 2026 outlook, projecting constant-currency net sales growth of 3% to 6%. Adjusted gross margin is expected to be approximately 50%, while adjusted operating income is forecast between $580 million and $630 million.
Mattel continues to expect adjusted earnings of $1.27-$1.39 per share and an adjusted tax rate of approximately 24%. The company also reaffirmed its $400 million share-repurchase target for the year.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.
VGM ScoresAt this time, Mattel has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. However, the stock was allocated a score of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Mattel has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerMattel is part of the Zacks Toys - Games - Hobbies industry. Over the past month, Hasbro (HAS - Free Report) , a stock from the same industry, has gained 2.6%. The company reported its results for the quarter ended June 2026 more than a month ago.
Hasbro reported revenues of $1.14 billion in the last reported quarter, representing a year-over-year change of +16.2%. EPS of $1.28 for the same period compares with $1.30 a year ago.
For the current quarter, Hasbro is expected to post earnings of $1.88 per share, indicating a change of +11.9% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.8% over the last 30 days.
Hasbro has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
IPG Photonics ve 2. čtvrtletí zvýšila upravený zisk na akcii o 93 % na 58 centů a tržby o 11 % na 278,58 milionu USD, ale akcie za měsíc klesly asi o 16,6 %.
A month has gone by since the last earnings report for IPG Photonics (IPGP - Free Report) . Shares have lost about 16.6% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is IPG due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
IPGP Q2 Earnings Beat Estimates on Industrial Solutions GrowthIPG Photonics Corporation reported second-quarter 2026 adjusted earnings of 58 cents per share, up 93% year over year. The figure beat the Zacks Consensus Estimate by 45%.
Revenues of $278.58 million rose 11% year over year but missed the consensus mark by 0.2%. Strong demand across Industrial Solutions, particularly battery manufacturing, supported growth. Emerging growth products represented 58% of revenues, up from 53% in the prior quarter.
IPGP Revenue Mix Tilts Toward Industrial SolutionsIndustrial Solutions revenues increased 16% year over year to $237 million and accounted for 85% of total sales. Growth was driven by higher welding, marking, cleaning and additive manufacturing revenues. Sequentially, the segment advanced 4%, led by welding and cleaning applications.
Battery manufacturing remained an important demand driver for welding products. The performance helped IPGP deliver its third consecutive quarter of double-digit year-over-year revenue growth. Changes in foreign exchange rates added roughly 2% to total revenues.
IPG Photonics Sees Mixed Advanced Solutions TrendsAdvanced Solutions revenues declined 9% year over year to $41.5 million. Lower micromachining and defense sales more than offset growth in semiconductor applications. However, revenues improved 10% sequentially as semiconductor and micromachining demand strengthened.
The company continues to pursue expansion opportunities in higher-growth applications. Its planned acquisition of Lumibird Medical is expected to establish a larger medical laser platform, including ophthalmology treatment and diagnostic systems, while complementing IPG Photonics’ existing urology presence.
IPGP Records Broad Growth Across AsiaAsia revenues increased 19% year over year, primarily reflecting stronger welding sales. The region also posted sequential growth as demand for Industrial Solutions remained robust.
Europe revenues rose 5% from the year-ago quarter, supported by cleaning and additive manufacturing applications. North American sales decreased 2% due to lower cutting, medical and defense revenues, although marking and defense sales improved sequentially.
IPGP Operating DetailsGAAP gross margin increased 310 basis points year over year to 40.4%. Adjusted gross margin expanded 290 basis points to 40.7%. Both measures also improved sharply from the first quarter.
The margin gains reflected lower product costs, reduced inventory provisions and $4.7 million in tariff refunds recorded during the quarter. Operating expenses, excluding foreign exchange and other items, were $91.4 million, up 1% year over year but down 2% sequentially. Expenses benefited from a $1.8 million German research and development tax credit.
Adjusted EBITDA rose 54% to $48.5 million, exceeding the upper end of management’s second-quarter guidance.
Adjusted operating income surged 246% year over year to $23.9 million.
IPG Photonics Maintains Debt-Free Balance SheetIPG Photonics ended the quarter with $871 million in cash and short-term investments and $33 million in long-term investments. The company had no debt.
For the second quarter of 2026, Cash generated from operations was $37.8 million.
IPGP Issues Q3 Guidance Amid Tariff UncertaintyFor the third quarter of 2026, IPGP expects revenues between $265 million and $295 million. Adjusted gross margin is projected to be in the range of 37.5% to 40.5%, while adjusted operating expenses are expected to be between $92 million and $95 million.
Adjusted earnings are forecasted to be between 30 cents and 60 cents per share. Adjusted EBITDA is expected to be in the range of $35 million-$51 million.
How Have Estimates Been Moving Since Then?It turns out, estimates review have trended upward during the past month.
The consensus estimate has shifted 5.58% due to these changes.
VGM ScoresAt this time, IPG has a nice Growth Score of B, however its Momentum Score is doing a bit better with an A. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, IPG has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
ONE Gas za druhé čtvrtletí překonal odhady: upravený zisk na akcii činil 82 centů, zatímco výnosy klesly na 411,64 milionu USD. Firma zároveň zvýšila výhled upraveného EPS pro rok 2026 na 4,83–4,95 USD.
It has been about a month since the last earnings report for ONE Gas (OGS - Free Report) . Shares have added about 0.9% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is ONE Gas due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
OGS Q2 Earnings Surpass Estimates on Higher Rates, Sales Decline
ONE Gas, Inc. reported second-quarter 2026 adjusted earnings of 82 cents per share, beating the Zacks Consensus Estimate of 65 cents by 26.2%. The bottom line surged 51.9% from 54 cents in the year-ago quarter, aided by higher revenues from new rates and lower net interest expense.
OGS’ RevenuesONE Gas recorded revenues of $411.64 million, which missed the Zacks Consensus Estimate of $440 million by 6.5%. The top line also decreased 2.9% from $423.74 million in the prior-year quarter.
OGS Revenue Trends and Volume MixNatural gas sales were $357.8 million, down 3.2% from $369.5 million in the second quarter of 2025. Transportation revenues increased 2.6% to $31.8 million, while other revenues rose 11% to $11.1 million. Securitization customer charges declined 17.4% to $10.9 million.
The company generated $16.4 million of incremental revenues from new rates, $1.4 million from higher residential sales, primarily reflecting customer growth in Oklahoma and Texas, and $1.3 million from increased line-extension revenues in Oklahoma.
ONE Gas Earnings Drivers and Regulatory ProgressTotal natural gas volumes delivered were 66.6 billion cubic feet, down 1.5% on a year-over-year basis. OGS served 2,308,000 customers, up 0.3% year over year.
Sales volumes fell 15.9% to 15.9 billion cubic feet, while transportation volumes increased 4.1% to 50.7 billion cubic feet.
Total operating expenses were $238.7 million, up 2% year over year. The increase was due to higher operations and maintenance expenses, which rose 6.6% to $139.6 million, reflecting higher employee-related costs, outside services and fleet expenses.
Operating income totaled $82.7 million, up 15% from $71.9 million recorded in the year-ago quarter.
Net interest expense declined 11.8% to $31.1 million, primarily due to lower-rate commercial paper borrowings and the implementation of Texas House Bill 4384. These factors supported the sharp year-over-year improvement in adjusted earnings.
Texas Gas Service received approval for a $36.9 million revenue increase under its Gas Reliability Infrastructure Program. The new rates became effective in July 2026, supporting the recovery of investments in system reliability.
ONE Gas Cash Flow and Balance SheetCash and cash equivalents were $7.9 million at June 30, 2026 and $10.6 million at Dec. 31, 2025. Total cash, cash equivalents and restricted cash and cash equivalents were $30.6 million and $33.7 million, respectively
As of June 30, 2026, total long-term debt (excluding current maturities) was $2.34 billion, down from $2.36 billion as of Dec. 31, 2025.
Cash provided by operating activities totaled $387.3 million during the first six months of 2026, down from $448.8 million in the comparable 2025 period. Capital expenditures totaled $330 million compared with $347.1 million a year ago.
ONE Gas Raises 2026 Earnings ViewOGS expects its 2026 adjusted net income in the range of $306-$314 million. The company projects 2026 adjusted earnings of $4.83-$4.95 per share, with management now expecting results to fall within the upper half of this range. The Zacks Consensus Estimate for EPS is pegged at $4.91, which is slightly above the midpoint of the company’s guided range.
In 2026, OGS plans to make capital investments, including asset removal costs, of $800 million and nearly $230 million for new customer extensions.
How Have Estimates Been Moving Since Then?Investors have witnessed a upward trend in fresh estimates over the past two months.
VGM ScoresAt this time, ONE Gas has a average Growth Score of C, however its Momentum Score is doing a bit better with a B. Following the exact same course, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook ONE Gas has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Harmony Biosciences ve 2. čtvrtletí překonala odhady: EPS činil 1,28 USD a tržby vzrostly o 30 % na 261,28 milionu USD díky silnému prodeji Wakixu. Firma zároveň potvrdila celoroční výhled tržeb z Wakixu ve výši 1,0 až 1,04 miliardy USD.
A month has gone by since the last earnings report for Harmony Biosciences Holdings, Inc. (HRMY - Free Report) . Shares have added about 12.1% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Harmony Biosciences due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Harmony Biosciences Holdings, Inc. before we dive into how investors and analysts have reacted as of late.
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales
Harmony Biosciences Holdings reported second-quarter 2026 earnings of $1.28 per share, up from 68 cents in the year-ago quarter. The figure surpassed the Zacks Consensus Estimate of 97 cents.
Quarterly revenues rose 30% year over year to $261.28 million and surpassed the Zacks Consensus Estimate of $253 million. Growth was driven by sustained demand for lead drug, Wakix (pitolisant), with the estimated average patient count increasing by 450 sequentially to 8,950.
HRMY Q2 Cost Analysis
Cost of products sold represented 24.2% of product revenues compared with 19% in the prior-year quarter, primarily due to new royalties tied to the Novitium license agreement.
Research and development expenses declined 7.1% to $46.6 million, reflecting the absence of a $15-million CiRC upfront payment recorded a year ago. Sales and marketing expenses increased 13.5% to $34.1 million due to the expansion of field-based teams.
General and administrative expenses decreased 17.3% to $28.1 million due to a charge related to an ANDA settlement in the second quarter of 2025.
Cash, cash equivalents and investments totaled $962.5 million as of June 30, 2026, up from $882.5 million as of 2025-end.
Harmony Pipeline Updates Highlight BP-205
In April 2024, the company expanded into orexin-based therapies through a sublicense agreement with Bioprojet for BP-205, an investigational orexin-2 receptor agonist being developed for narcolepsy and other central nervous system (CNS) disorders.
The agreement grants exclusive rights to develop, manufacture and commercialize BP-205 in the United States and Latin America.
Harmony reported favorable phase I single-ascending-dose data for BP-205, its orexin-2 receptor agonist. The candidate demonstrated a short time to maximum plasma concentration (30-75 minutes) and a mean half-life of approximately 25 hours, supporting the potential for rapid onset and once-daily dosing.
Exposure increased proportionally across the tested doses. BP-205 was generally safe and well tolerated, with no serious or severe treatment-emergent adverse events.
Multiple-ascending-dose data in healthy volunteers are expected in the fourth quarter of 2026. Harmony also plans to begin a phase Ib study in sleep-deprived healthy volunteers during the third quarter, with data expected in early 2027.
Phase II studies across multiple central nervous system indications are scheduled to begin in mid-2027.
HRMY Advances Pitolisant and Epilepsy Assets
The FDA accepted the new drug application for pitolisant GR, assigning a target action date of April 1, 2027. The gastro-resistant formulation is designed to reduce gastrointestinal side effects and allow patients to begin treatment at a therapeutic dose without titration.
Harmony is pursuing label expansion opportunities for pitolisant beyond narcolepsy, targeting rare neurological disorders such as Prader-Willi syndrome (PWS) and myotonic dystrophy type 1 (DM1).
Phase III ONSTRIDE studies of high-dose pitolisant in narcolepsy and idiopathic hypersomnia remain underway, with top-line data expected in 2027. Top-line results are expected in mid-2027.
The company is conducting the phase III TEMPO study in PWS, supported by FDA alignment, which has the potential to serve as the registrational trial and support the company’s efforts to seek pediatric exclusivity for pitolisant.
The FDA granted Orphan Drug designation to pitolisant for the treatment of PWS in 2024.
The company also strengthened its rare epilepsy pipeline by acquiring Epygenix Therapeutics, gaining exclusive rights to develop EPX-100 (clemizole hydrochloride) for Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).
EPX-100 is being evaluated in the phase III LIGHTHOUSE study for LGS and the ARGUS study for DS. Top-line results from both rare-epilepsy programs are expected in the first half of 2027, with potential regulatory action targeted for 2028.
Harmony Reiterates 2026 Revenue Outlook
Harmony reaffirmed its 2026 Wakix net revenue guidance of $1 billion to $1.04 billion.
Wakix net product revenues rose 21% sequentially in the second quarter, reflecting a rebound from the seasonal market-access headwinds that affected patient starts during the first quarter.
Management expects patient growth to continue steadily through the second half of the year, supported by the expanded commercial infrastructure.
The average patient increase was the second highest in the product’s seven-year commercial history. Four of the past five quarters generated more than 400 patient additions, indicating steady demand within the narcolepsy market.
Management attributed the strong performance to Wakix’s position as the only non-scheduled treatment option for narcolepsy. The product has payer coverage for more than 80% of covered lives and is used both as a standalone therapy and in combination with other narcolepsy therapies.
How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended upward during the past month.
VGM ScoresAt this time, Harmony Biosciences has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. However, the stock has a grade of A on the value side, putting it in the top 20% for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Interestingly, Harmony Biosciences has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerHarmony Biosciences belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Myriad Genetics (MYGN - Free Report) , has gained 2.5% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Myriad reported revenues of $190.7 million in the last reported quarter, representing a year-over-year change of -10.5%. EPS of -$0.25 for the same period compares with $0.05 a year ago.
For the current quarter, Myriad is expected to post a loss of $0.16 per share, indicating a change of 0% from the year-ago quarter. The Zacks Consensus Estimate has changed -118.2% over the last 30 days.
Myriad has a Zacks Rank #5 (Strong Sell) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
Howmet Aerospace ve 2. čtvrtletí zvýšil tržby divize Forged Wheels o 14 % na 316 mil. USD, ale objem klesl meziročně o 8 %. Firma dál čelí slabší poptávce v komerční dopravě, zatímco ji podporuje silný letecký segment.
Key Takeaways HWM's Forged Wheels volumes fell 8% year over year but rose 7% sequentially in the second quarter.Lower OEM builds continue to weigh on commercial transportation demand, posing a near-term growth headwind.Aerospace strength, including F-35 engine spares and fastening systems, is bolstering HWM's performance. Howmet Aerospace Inc. (HWM - Free Report) continues to face weakness in the commercial transportation market, although conditions are showing early signs of improvement. In the second quarter of 2026, Forged Wheels revenues increased 14% year over year to $316 million, primarily driven by higher aluminum and other inflationary cost pass-through, despite an 8% year-over-year decline in volumes. However, volumes increased 7% sequentially, reflecting the beginning of a recovery in the North American commercial transportation market.
Despite the sequential improvement, commercial transportation demand remains a near-term headwind as lower OEM builds continue to weigh on volumes. Howmet's exposure to the market, particularly through its Forged Wheels business, may remain a drag on growth if the recovery progresses slowly.
As a global player, Howmet remains vulnerable to supply-chain volatility, which has already led to delays and higher costs in recent years. These persistent supply-chain challenges in the transportation and aerospace sectors are expected to continue affecting the company’s ability to deliver finished products to customers within the stipulated time.
Despite difficult conditions in the commercial transportation market, Howmet’s performance is being bolstered by sustained strength in the commercial and defense aerospace markets. Strong demand for engine spares for the F-35 program, aerospace fastening systems and airframe structural components further contributes to a promising outlook for the company.
Segment Snapshot of HWM’s PeersAmong its major peers, Textron Inc. (TXT - Free Report) reported 3% sales growth in the second quarter of 2026. Revenues from Textron’s Aviation segment increased 1% year over year in the same period. The solid performance of Textron’s segment was primarily driven by higher pricing.
Another peer, RTX Corporation (RTX - Free Report) , has been experiencing improving commercial OEM and commercial aftermarket sales in recent times. RTX Corp.’s second-quarter 2026 results reflected solid year-over-year sales growth of 8.2%. In particular, improvement in commercial aerospace bolstered quarterly results for both its Collins Aerospace and Pratt & Whitney business segments.
HWM's Price Performance, Valuation and EstimatesShares of Howmet have surged 45% in the past year against the industry’s decline of 7.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, HWM is trading at a forward price-to-earnings ratio of 43.02X, above the industry’s average of 30.57X. Howmet carries a Value Score of F.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HWM’s earnings has been on the rise over the past 60 days.
Image Source: Zacks Investment Research
Howmet currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DigitalOcean za poslední měsíc klesl asi o 15,7 %, přesto po zveřejnění výsledků zvýšil celoroční výhled tržeb na 1,17 až 1,18 miliardy USD. Ve 2. čtvrtletí tržby stouply o 28,6 % na 281,18 milionu USD.
A month has gone by since the last earnings report for DigitalOcean Holdings, Inc. (DOCN - Free Report) . Shares have lost about 15.7% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is DigitalOcean due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important drivers.
DOCN Q2 Earnings Beat Estimates on AI Growth, Strong MarginsDigitalOcean posted second quarter 2026 non-GAAP earnings of 45 cents per share, which fell 23.7% year over year but topped the Zacks Consensus Estimate by 73.08%.
Revenues increased 28.6% year over year to $281.18 million and beat the consensus mark by 1.23%. Annual Run-Rate Revenue (ARR) reached $1.125 billion, up 29%, while AI Customer ARR jumped 212% to $234 million.
DOCN's Large-Customer Cohorts Fueled GrowthGrowth was led by higher-spending customers. ARR from $1 million-plus customers reached $259 million, up 214% year over year and accounted for 23% of total ARR. ARR from $500,000-plus customers rose 160% to $291 million, while the $100,000-plus cohort increased 98% to $395 million.
The expansion also strengthened contracted visibility. Remaining performance obligations climbed to $894 million from $71 million a year earlier, with $366 million expected to be recognized over the next 12 months. DigitalOcean also signed its first nine-figure annual customer commitments, extending weighted average contract life from 1.6 years to more than three years.
DigitalOcean's AI-Native Cloud Gained TractionInference services grew 762% year over year, while 85% of AI customer ARR came from inference services and core cloud rather than bare metal. The Inference Engine attracted more than 6,000 customers after its late-April launch, and token volume increased roughly 30-fold over the prior 60 days.
Product expansion supported that adoption. DOCN shipped more than 80 releases across its five-layer AI-Native Cloud since April. Roughly 70% of AI customers with at least $100,000 in ARR attached a core cloud product, indicating broader use of compute, storage, databases and orchestration alongside AI workloads.
DOCN's Higher Costs Compressed GAAP MarginsGross profit increased to $154.66 million from $130.95 million, but gross margin declined to 55.0% from 59.9%.
Total operating expenses rose to $125.29 million from $95.33 million. Research and development expense climbed to $57.5 million from $39.6 million, while sales and marketing rose to $22.6 million from $19.3 million. General and administrative expense increased to $45.2 million from $36.4 million.
Adjusted EBITDA increased 26.9% to $113.56 million, while the margin edged down to 40% from 41%.
GAAP operating income fell 17.5% to $29.37 million, with operating margin contracting to 10% from 16%. Adjusted operating income rose 9.3% to $67.48 million, though its margin declined to 24% from 28%.
DigitalOcean's Cash Flow Supported Capacity BuildAs of June 2026, cash and cash equivalents totaled $767.03 million compared with $741.5 million as of March 31, 2026.
Net cash provided by operating activities rose 19.0% to $109.97 million, while the operating cash flow margin declined to 39% from 42%. Adjusted free cash flow increased 6.3% to $60.59 million, with the corresponding margin narrowing to 22% from 26%.
DOCN Raised Its 2026 OutlookFor the third quarter of 2026, DigitalOcean expects revenues of $304 million-$307 million, representing 32%-34% growth. Adjusted EBITDA margin is projected to be 38%-39%, while non-GAAP earnings are expected to be between 28 cents and 30 cents per share.
For 2026, DOCN raised revenue guidance to $1.170 billion-$1.180 billion from $1.130 billion-$1.145 billion. The company now expects 30%-31% revenue growth, a 38.5%-39.5% adjusted EBITDA margin, an 11%-13% adjusted free cash flow margin and non-GAAP earnings of $1.35-$1.40 per share. Management also expects revenue growth of at least 35% by the fourth quarter and reiterated confidence in more than 50% growth in 2027.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in estimates revision.
VGM ScoresCurrently, DigitalOcean has a subpar Growth Score of D, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a grade of F on the value side, putting it in the bottom 20% quintile for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, DigitalOcean has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerDigitalOcean belongs to the Zacks Internet - Software industry. Another stock from the same industry, Reddit Inc. (RDDT - Free Report) , has gained 1.8% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Reddit Inc. reported revenues of $804.91 million in the last reported quarter, representing a year-over-year change of +61.1%. EPS of $1.25 for the same period compares with $0.45 a year ago.
Reddit Inc. is expected to post earnings of $1.33 per share for the current quarter, representing a year-over-year change of +66.3%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.7%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Reddit Inc.. Also, the stock has a VGM Score of B.
SoFi a Payward oznámily strategické partnerství, které propojí bankovnictví, platby, likviditu a trhy s digitálními aktivy. Payward také zařadí SoFiUSD na Kraken a SoFi využije Kraken Prime jako další zdroj likvidity.
SoFi Technologies, Inc. (NASDAQ: SOFI), the everything app for digital financial services, and Payward, a unified financial infrastructure platform, today announced a strategic partnership designed to enhance banking, payments, liquidity, and digital asset markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260903466285/en/
Through the partnership, Payward will leverage SoFi’s Big Business Banking capabilities, join the SoFi Exchange Network (SEN) and list SoFiUSD on its multi-asset trading platform. SoFi will also use Kraken Prime, Payward’s full-service prime brokerage solution, as an additional source of digital asset liquidity, with qualified custody capabilities available as the relationship expands.
By joining SEN, SoFi’s real-time settlement network, Payward unlocks new pathways for institutional clients to clear and settle U.S. dollar transactions 24 hours a day, seven days a week. Extending settlement beyond traditional banking hours also enhances the money movement process, allowing clients to move money and manage liquidity on an always-on schedule.
The partnership also connects Kraken, one of the world’s largest digital asset platforms, to SEN. Kraken institutional clients will be able to use SEN’s real-time settlement rails to move USD and manage liquidity across both networks at any hour, extending settlement beyond traditional banking hours for entities that already operate around the clock.
“The financial system should not shut down when markets stay open,” said Anthony Noto, CEO of SoFi. “SoFi is building the trusted financial infrastructure for an always-on economy, combining the strength of a nationally chartered bank with technology that allows money to move seamlessly and efficiently. Our partnership with Payward is a powerful validation of that strategy and an important step toward a financial system where businesses can move money across networks and, over time, across borders without the delays and fragmentation of legacy infrastructure.”
“Money and markets are converging into a new financial paradigm, and the infrastructure underneath has to catch up,” said David Ripley, Co-CEO of Payward. “Collaborating with SoFi lets us close that gap, and it works in both directions. Millions of people will buy their first cryptoasset inside the app they already use for their paycheck, and the infrastructure behind that experience should connect them to deep, liquid markets built to operate at scale.”
Kraken Prime, one of the industry's leading prime brokerages, will serve as an additional source of liquidity behind SoFi's crypto offering. SoFi members can buy and sell crypto inside the SoFi app; Kraken Prime will enable better pricing for SoFi members on trades they already make on the app.
Payward will also list SoFiUSD on Kraken, expanding access to SoFi’s bank-issued stablecoin for millions of retail, professional and institutional clients using one of the world’s leading digital asset platforms. SoFiUSD is redeemable one-to-one for U.S. dollars and is designed to combine the utility of blockchain technology with the safeguards of a regulated financial institution.
SoFi launched Big Business Banking in April to bring its enterprise banking and digital asset capabilities together in one offering. The partnership with Payward puts that model to work at scale and creates a foundation for the companies to expand their work together across payments, treasury, lending and digital assets over time.
About SoFi
SoFi Technologies (NASDAQ: SOFI) is the everything app for digital financial services on a mission to help people achieve financial independence to realize their ambitions. 15.8 million members trust SoFi to borrow, save, spend, invest, and protect their money and buy, sell and hold their crypto – all in one app – and get access to financial planners, exclusive experiences, and a thriving community. Banks, fintechs, and brands use innovative capabilities from SoFi Tech Solutions to serve over 134 million global accounts. For more information, visit www.sofi.com or download our iOS and Android apps.
Payward, Inc. is a unified financial infrastructure platform that powers a family of products advancing an open, global financial system. Built on a single shared architecture, Payward enables customers to hold, trade, earn, pay, and invest across asset classes without friction or fragmentation.
At its core, Payward provides the infrastructure layer behind Kraken and a growing set of purpose-built products, including NinjaTrader, Breakout, xStocks, and CF Benchmarks.
Payward separates infrastructure from product expression. Each product surface is designed for a specific customer segment, regulatory regime, and use case, while operating on the same global foundation:
One global liquidity poolOne unified risk and margin engineOne collateral and settlement systemOne compliance and licensing frameworkThis shared architecture allows Payward to scale efficiently, launch new products at low marginal cost, and serve diverse global markets while maintaining consistent risk management, regulatory integrity, and operational resilience.
Disclosure:
Availability of Other Information About SoFi
Investors and others should note that SoFi communicates with investors and the public using its website (https://www.sofi.com), the investor relations website (https://investors.sofi.com), and on social media (X and LinkedIn), including but not limited to investor presentations and investor fact sheets, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that SoFi posts on these channels and websites could be deemed to be material information. As a result, SoFi encourages investors, the media, and others interested in SoFi to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on SoFi’s investor relations website and may include additional social media channels. The contents of SoFi’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
Certain of the statements above are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding expectations for the partnership between SoFi and Payward, as well as the roll-out of future products, SoFi’s ability to navigate the regulatory environment related to the products it launches, demand for SoFi and Payward products, expectations regarding the future of financial services and the adoption of digital assets, and the financial position, business strategy and plans and objectives of management for SoFi’s and Payward’s future operations. These forward-looking statements are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. Words such as “expect”, “could”, “continue”, “future”, “may”, “plan”, “will”, “will be”, “will continue”, and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Factors that could cause actual results to differ materially from those contemplated by these forward-looking statements include: (i) the impact on each of SoFi’s and Payward’s business as a result of the regulatory environment, changes in governmental policies, changes in personnel and resources of the governmental agencies that regulate us, and complexities with compliance related to such environment; (ii) SoFi’s and Payward’s ability to continue to drive brand awareness and realize the benefits of their respective marketing and advertising campaigns; (iii) SoFi’s and Payward’s ability to manage planned products and expectations regarding the development and expansion of its business effectively; (iv) SoFi’s and Payward’s ability to predict the demand for new products and the future of the financial services industry; (v) SoFi’s and Payward’s ability to develop new products, features and functionality that are competitive and meet market needs; (vi) SoFi’s and Payward’s ability to maintain the security and reliability of their respective products; and (vii) the outcome of any legal or governmental proceedings instituted against SoFi or Payward. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties set forth in the section titled “Risk Factors” in SoFi’s last annual report on Form 10-K as filed with the Securities and Exchange Commission, and those that are included in any future filings with the Securities and Exchange Commission. These forward-looking statements are based on information available as of the date hereof and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing SoFi’s or Payward’s views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
SOFI-F
View source version on businesswire.com: https://www.businesswire.com/news/home/20260903466285/en/
